id	sid	tid	token	lemma	pos
bjos-8668902	1	1	1	1	NUM
bjos-8668902	1	2	volume	volume	NOUN
bjos-8668902	1	3	22	22	NUM
bjos-8668902	1	4	2023	2023	NUM
bjos-8668902	1	5	e238902	e238902	PROPN
bjos-8668902	1	6	original	original	ADJ
bjos-8668902	1	7	article	article	NOUN
bjos-8668902	1	8	braz	braz	PROPN
bjos-8668902	1	9	j	j	PROPN
bjos-8668902	1	10	oral	oral	PROPN
bjos-8668902	1	11	sci	sci	PROPN
bjos-8668902	1	12	.	.	PUNCT
bjos-8668902	2	1	2023;22	2023;22	NUM
bjos-8668902	2	2	:	:	PUNCT
bjos-8668902	2	3	e238902http://dx.doi.org/10.20396	e238902http://dx.doi.org/10.20396	SYM
bjos-8668902	2	4	/	/	SYM
bjos-8668902	2	5	bjos.v22i00.8668902	bjos.v22i00.8668902	VERB
bjos-8668902	2	6	1	1	NUM
bjos-8668902	2	7	kaher	kaher	PROPN
bjos-8668902	2	8	’s	’s	PART
bjos-8668902	2	9	kle	kle	PROPN
bjos-8668902	2	10	vk	vk	PROPN
bjos-8668902	2	11	institute	institute	PROPN
bjos-8668902	2	12	of	of	ADP
bjos-8668902	2	13	dental	dental	ADJ
bjos-8668902	2	14	sciences	science	NOUN
bjos-8668902	2	15	,	,	PUNCT
bjos-8668902	2	16	jnmc	jnmc	PROPN
bjos-8668902	2	17	campus	campus	NOUN
bjos-8668902	2	18	,	,	PUNCT
bjos-8668902	2	19	belagavi	belagavi	VERB
bjos-8668902	2	20	590010	590010	NUM
bjos-8668902	2	21	,	,	PUNCT
bjos-8668902	2	22	india	india	PROPN
bjos-8668902	2	23	.	.	PROPN
bjos-8668902	2	24	2	2	NUM
bjos-8668902	2	25	department	department	NOUN
bjos-8668902	2	26	of	of	ADP
bjos-8668902	2	27	oral	oral	ADJ
bjos-8668902	2	28	medicine	medicine	NOUN
bjos-8668902	2	29	and	and	CCONJ
bjos-8668902	2	30	radiology	radiology	NOUN
bjos-8668902	2	31	,	,	PUNCT
bjos-8668902	2	32	kle	kle	PROPN
bjos-8668902	2	33	vk	vk	PROPN
bjos-8668902	2	34	institute	institute	PROPN
bjos-8668902	2	35	of	of	ADP
bjos-8668902	2	36	dental	dental	ADJ
bjos-8668902	2	37	sciences	science	NOUN
bjos-8668902	2	38	,	,	PUNCT
bjos-8668902	2	39	belagavi	belagavi	VERB
bjos-8668902	2	40	590010	590010	NUM
bjos-8668902	2	41	,	,	PUNCT
bjos-8668902	2	42	india	india	PROPN
bjos-8668902	2	43	.	.	PUNCT
bjos-8668902	3	1	corresponding	correspond	VERB
bjos-8668902	3	2	author	author	NOUN
bjos-8668902	3	3	:	:	PUNCT
bjos-8668902	3	4	dr	dr	PROPN
bjos-8668902	3	5	.	.	PROPN
bjos-8668902	3	6	sulem	sulem	PROPN
bjos-8668902	3	7	ansari	ansari	PROPN
bjos-8668902	3	8	3rd	3rd	ADJ
bjos-8668902	3	9	-	-	PUNCT
bjos-8668902	3	10	year	year	NOUN
bjos-8668902	3	11	post	post	ADJ
bjos-8668902	3	12	-	-	ADJ
bjos-8668902	3	13	graduate	graduate	ADJ
bjos-8668902	3	14	department	department	NOUN
bjos-8668902	3	15	of	of	ADP
bjos-8668902	3	16	oral	oral	ADJ
bjos-8668902	3	17	medicine	medicine	NOUN
bjos-8668902	3	18	and	and	CCONJ
bjos-8668902	3	19	radiology	radiology	NOUN
bjos-8668902	3	20	kaher	kaher	PROPN
bjos-8668902	3	21	’s	’s	PART
bjos-8668902	3	22	kle	kle	PROPN
bjos-8668902	3	23	vk	vk	PROPN
bjos-8668902	3	24	institute	institute	PROPN
bjos-8668902	3	25	of	of	ADP
bjos-8668902	3	26	dental	dental	ADJ
bjos-8668902	3	27	sciences	science	NOUN
bjos-8668902	3	28	,	,	PUNCT
bjos-8668902	3	29	jnmc	jnmc	VERB
bjos-8668902	3	30	campus	campus	NOUN
bjos-8668902	3	31	belagavi-590010	belagavi-590010	NOUN
bjos-8668902	3	32	,	,	PUNCT
bjos-8668902	3	33	india	india	PROPN
bjos-8668902	3	34	email	email	NOUN
bjos-8668902	3	35	:	:	PUNCT
bjos-8668902	3	36	ansarisulem@gmail.com	ansarisulem@gmail.com	X
bjos-8668902	4	1	phone	phone	NOUN
bjos-8668902	4	2	no	no	NOUN
bjos-8668902	4	3	:	:	PUNCT
bjos-8668902	4	4	9773723359	9773723359	NUM
bjos-8668902	4	5	editor	editor	NOUN
bjos-8668902	4	6	:	:	PUNCT
bjos-8668902	4	7	altair	altair	PROPN
bjos-8668902	4	8	a.	a.	PROPN
bjos-8668902	4	9	del	del	PROPN
bjos-8668902	4	10	bel	bel	PROPN
bjos-8668902	4	11	cury	cury	PROPN
bjos-8668902	4	12	received	receive	VERB
bjos-8668902	4	13	:	:	PUNCT
bjos-8668902	4	14	apr	apr	NOUN
bjos-8668902	4	15	02	02	NUM
bjos-8668902	4	16	,	,	PUNCT
bjos-8668902	4	17	2022	2022	NUM
bjos-8668902	4	18	accepted	accept	VERB
bjos-8668902	4	19	:	:	PUNCT
bjos-8668902	4	20	oct	oct	PROPN
bjos-8668902	4	21	07	07	NUM
bjos-8668902	4	22	,	,	PUNCT
bjos-8668902	4	23	2022	2022	NUM
bjos-8668902	4	24	a	a	DET
bjos-8668902	4	25	hospital	hospital	NOUN
bjos-8668902	4	26	-	-	PUNCT
bjos-8668902	4	27	based	base	VERB
bjos-8668902	4	28	observational	observational	ADJ
bjos-8668902	4	29	study	study	NOUN
bjos-8668902	4	30	on	on	ADP
bjos-8668902	4	31	clinical	clinical	ADJ
bjos-8668902	4	32	and	and	CCONJ
bjos-8668902	4	33	radiographic	radiographic	ADJ
bjos-8668902	4	34	findings	finding	NOUN
bjos-8668902	4	35	in	in	ADP
bjos-8668902	4	36	covid-19	covid-19	PROPN
bjos-8668902	4	37	associated	associate	VERB
bjos-8668902	4	38	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	4	39	mucormycosis	mucormycosis	NOUN
bjos-8668902	4	40	:	:	PUNCT
bjos-8668902	4	41	revealing	reveal	VERB
bjos-8668902	4	42	the	the	DET
bjos-8668902	4	43	pandora	pandora	PROPN
bjos-8668902	4	44	box	box	PROPN
bjos-8668902	4	45	sulem	sulem	PROPN
bjos-8668902	4	46	ansari1	ansari1	PROPN
bjos-8668902	4	47	*	*	SYM
bjos-8668902	4	48	,	,	PUNCT
bjos-8668902	4	49	shivayogi	shivayogi	PROPN
bjos-8668902	4	50	charantimath2	charantimath2	PROPN
bjos-8668902	4	51	,	,	PUNCT
bjos-8668902	5	1	vasanti	vasanti	PROPN
bjos-8668902	5	2	lagali	lagali	ADJ
bjos-8668902	5	3	jirge2	jirge2	NOUN
bjos-8668902	5	4	,	,	PUNCT
bjos-8668902	5	5	vaishali	vaishali	PROPN
bjos-8668902	5	6	keluskar2	keluskar2	PROPN
bjos-8668902	5	7	mucormycosis	mucormycosis	NOUN
bjos-8668902	5	8	is	be	AUX
bjos-8668902	5	9	a	a	DET
bjos-8668902	5	10	rare	rare	ADJ
bjos-8668902	5	11	,	,	PUNCT
bjos-8668902	5	12	rapidly	rapidly	ADV
bjos-8668902	5	13	spreading	spread	VERB
bjos-8668902	5	14	,	,	PUNCT
bjos-8668902	5	15	fulminant	fulminant	ADJ
bjos-8668902	5	16	,	,	PUNCT
bjos-8668902	5	17	opportunistic	opportunistic	ADJ
bjos-8668902	5	18	infection	infection	NOUN
bjos-8668902	5	19	that	that	PRON
bjos-8668902	5	20	is	be	AUX
bjos-8668902	5	21	caused	cause	VERB
bjos-8668902	5	22	by	by	ADP
bjos-8668902	5	23	a	a	DET
bjos-8668902	5	24	group	group	NOUN
bjos-8668902	5	25	of	of	ADP
bjos-8668902	5	26	filamentous	filamentous	ADJ
bjos-8668902	5	27	molds	mold	NOUN
bjos-8668902	5	28	.	.	PUNCT
bjos-8668902	6	1	during	during	ADP
bjos-8668902	6	2	the	the	DET
bjos-8668902	6	3	second	second	ADJ
bjos-8668902	6	4	wave	wave	NOUN
bjos-8668902	6	5	of	of	ADP
bjos-8668902	6	6	covid-19	covid-19	PROPN
bjos-8668902	6	7	india	india	PROPN
bjos-8668902	6	8	reported	report	VERB
bjos-8668902	6	9	most	most	ADJ
bjos-8668902	6	10	of	of	ADP
bjos-8668902	6	11	the	the	DET
bjos-8668902	6	12	cases	case	NOUN
bjos-8668902	6	13	of	of	ADP
bjos-8668902	6	14	mucormycosis	mucormycosis	NOUN
bjos-8668902	6	15	which	which	PRON
bjos-8668902	6	16	is	be	AUX
bjos-8668902	6	17	termed	term	VERB
bjos-8668902	6	18	as	as	ADP
bjos-8668902	6	19	covid-19	covid-19	PROPN
bjos-8668902	6	20	-	-	PUNCT
bjos-8668902	6	21	associated	associate	VERB
bjos-8668902	6	22	mucormycosis	mucormycosis	NOUN
bjos-8668902	6	23	(	(	PUNCT
bjos-8668902	6	24	cam	cam	NOUN
bjos-8668902	6	25	)	)	PUNCT
bjos-8668902	6	26	.	.	PUNCT
bjos-8668902	7	1	aim	aim	VERB
bjos-8668902	7	2	:	:	PUNCT
bjos-8668902	7	3	the	the	DET
bjos-8668902	7	4	purpose	purpose	NOUN
bjos-8668902	7	5	of	of	ADP
bjos-8668902	7	6	this	this	DET
bjos-8668902	7	7	study	study	NOUN
bjos-8668902	7	8	is	be	AUX
bjos-8668902	7	9	to	to	PART
bjos-8668902	7	10	describe	describe	VERB
bjos-8668902	7	11	and	and	CCONJ
bjos-8668902	7	12	understand	understand	VERB
bjos-8668902	7	13	the	the	DET
bjos-8668902	7	14	clinical	clinical	ADJ
bjos-8668902	7	15	and	and	CCONJ
bjos-8668902	7	16	radiographic	radiographic	ADJ
bjos-8668902	7	17	findings	finding	NOUN
bjos-8668902	7	18	related	relate	VERB
bjos-8668902	7	19	to	to	ADP
bjos-8668902	7	20	covid-19	covid-19	PROPN
bjos-8668902	7	21	associated	associate	VERB
bjos-8668902	7	22	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	7	23	mucormycosis	mucormycosis	NOUN
bjos-8668902	7	24	.	.	PUNCT
bjos-8668902	8	1	methods	method	NOUN
bjos-8668902	8	2	:	:	PUNCT
bjos-8668902	8	3	in	in	ADP
bjos-8668902	8	4	this	this	DET
bjos-8668902	8	5	observational	observational	ADJ
bjos-8668902	8	6	study	study	NOUN
bjos-8668902	8	7	76	76	NUM
bjos-8668902	8	8	individuals	individual	NOUN
bjos-8668902	8	9	with	with	ADP
bjos-8668902	8	10	proven	prove	VERB
bjos-8668902	8	11	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	8	12	mucormycosis	mucormycosis	NOUN
bjos-8668902	8	13	were	be	AUX
bjos-8668902	8	14	included	include	VERB
bjos-8668902	8	15	.	.	PUNCT
bjos-8668902	9	1	the	the	DET
bjos-8668902	9	2	demographic	demographic	ADJ
bjos-8668902	9	3	profile	profile	NOUN
bjos-8668902	9	4	,	,	PUNCT
bjos-8668902	9	5	predisposing	predispose	VERB
bjos-8668902	9	6	factors	factor	NOUN
bjos-8668902	9	7	,	,	PUNCT
bjos-8668902	9	8	anatomic	anatomic	ADJ
bjos-8668902	9	9	structures	structure	NOUN
bjos-8668902	9	10	involved	involve	VERB
bjos-8668902	9	11	,	,	PUNCT
bjos-8668902	9	12	oral	oral	ADJ
bjos-8668902	9	13	manifestations	manifestation	NOUN
bjos-8668902	9	14	,	,	PUNCT
bjos-8668902	9	15	radiographic	radiographic	ADJ
bjos-8668902	9	16	findings	finding	NOUN
bjos-8668902	9	17	management	management	NOUN
bjos-8668902	9	18	,	,	PUNCT
bjos-8668902	9	19	and	and	CCONJ
bjos-8668902	9	20	90	90	NUM
bjos-8668902	9	21	-	-	PUNCT
bjos-8668902	9	22	day	day	NOUN
bjos-8668902	9	23	mortality	mortality	NOUN
bjos-8668902	9	24	were	be	AUX
bjos-8668902	9	25	recorded	record	VERB
bjos-8668902	9	26	and	and	CCONJ
bjos-8668902	9	27	analyzed	analyze	VERB
bjos-8668902	9	28	.	.	PUNCT
bjos-8668902	10	1	results	result	NOUN
bjos-8668902	10	2	:	:	PUNCT
bjos-8668902	10	3	among	among	ADP
bjos-8668902	10	4	76	76	NUM
bjos-8668902	10	5	individuals	individual	NOUN
bjos-8668902	10	6	with	with	ADP
bjos-8668902	10	7	covid-19	covid-19	PROPN
bjos-8668902	10	8	-	-	PUNCT
bjos-8668902	10	9	associated	associate	VERB
bjos-8668902	10	10	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	10	11	mucormycosis	mucormycosis	NOUN
bjos-8668902	10	12	diabetes	diabetes	NOUN
bjos-8668902	10	13	mellitus	mellitus	NOUN
bjos-8668902	10	14	was	be	AUX
bjos-8668902	10	15	present	present	ADJ
bjos-8668902	10	16	in	in	ADP
bjos-8668902	10	17	93.42	93.42	NUM
bjos-8668902	10	18	%	%	NOUN
bjos-8668902	10	19	of	of	ADP
bjos-8668902	10	20	cases	case	NOUN
bjos-8668902	10	21	.	.	PUNCT
bjos-8668902	11	1	almost	almost	ADV
bjos-8668902	11	2	all	all	DET
bjos-8668902	11	3	patients	patient	NOUN
bjos-8668902	11	4	received	receive	VERB
bjos-8668902	11	5	corticosteroids	corticosteroid	NOUN
bjos-8668902	11	6	during	during	ADP
bjos-8668902	11	7	covid-19	covid-19	PROPN
bjos-8668902	11	8	treatment	treatment	NOUN
bjos-8668902	11	9	.	.	PUNCT
bjos-8668902	12	1	the	the	DET
bjos-8668902	12	2	maxilla	maxilla	NOUN
bjos-8668902	12	3	was	be	AUX
bjos-8668902	12	4	most	most	ADV
bjos-8668902	12	5	commonly	commonly	ADV
bjos-8668902	12	6	involved	involve	VERB
bjos-8668902	12	7	in	in	ADP
bjos-8668902	12	8	around	around	ADV
bjos-8668902	12	9	98.6	98.6	NUM
bjos-8668902	12	10	%	%	NOUN
bjos-8668902	12	11	of	of	ADP
bjos-8668902	12	12	cases	case	NOUN
bjos-8668902	12	13	.	.	PUNCT
bjos-8668902	13	1	interestingly	interestingly	ADV
bjos-8668902	13	2	1	1	NUM
bjos-8668902	13	3	case	case	NOUN
bjos-8668902	13	4	involving	involve	VERB
bjos-8668902	13	5	the	the	DET
bjos-8668902	13	6	mandible	mandible	NOUN
bjos-8668902	13	7	was	be	AUX
bjos-8668902	13	8	noted	note	VERB
bjos-8668902	13	9	and	and	CCONJ
bjos-8668902	13	10	the	the	DET
bjos-8668902	13	11	maxillary	maxillary	NOUN
bjos-8668902	13	12	sinus	sinus	NOUN
bjos-8668902	13	13	was	be	AUX
bjos-8668902	13	14	the	the	DET
bjos-8668902	13	15	most	most	ADV
bjos-8668902	13	16	commonly	commonly	ADV
bjos-8668902	13	17	involved	involve	VERB
bjos-8668902	13	18	.	.	PUNCT
bjos-8668902	14	1	mortality	mortality	NOUN
bjos-8668902	14	2	occurred	occur	VERB
bjos-8668902	14	3	in	in	ADP
bjos-8668902	14	4	1.31	1.31	NUM
bjos-8668902	14	5	%	%	NOUN
bjos-8668902	14	6	(	(	PUNCT
bjos-8668902	14	7	n=1	n=1	PROPN
bjos-8668902	14	8	)	)	PUNCT
bjos-8668902	14	9	of	of	ADP
bjos-8668902	14	10	cases	case	NOUN
bjos-8668902	14	11	.	.	PUNCT
bjos-8668902	15	1	conclusion	conclusion	NOUN
bjos-8668902	15	2	:	:	PUNCT
bjos-8668902	15	3	diabetes	diabetes	NOUN
bjos-8668902	15	4	was	be	AUX
bjos-8668902	15	5	the	the	DET
bjos-8668902	15	6	most	most	ADV
bjos-8668902	15	7	common	common	ADJ
bjos-8668902	15	8	predisposing	predispose	VERB
bjos-8668902	15	9	factor	factor	NOUN
bjos-8668902	15	10	.	.	PUNCT
bjos-8668902	16	1	administration	administration	NOUN
bjos-8668902	16	2	of	of	ADP
bjos-8668902	16	3	corticosteroids	corticosteroid	NOUN
bjos-8668902	16	4	was	be	AUX
bjos-8668902	16	5	evident	evident	ADJ
bjos-8668902	16	6	.	.	PUNCT
bjos-8668902	17	1	a	a	DET
bjos-8668902	17	2	considerable	considerable	ADJ
bjos-8668902	17	3	number	number	NOUN
bjos-8668902	17	4	of	of	ADP
bjos-8668902	17	5	patients	patient	NOUN
bjos-8668902	17	6	developed	develop	VERB
bjos-8668902	17	7	diabetes	diabete	NOUN
bjos-8668902	17	8	during	during	ADP
bjos-8668902	17	9	the	the	DET
bjos-8668902	17	10	treatment	treatment	NOUN
bjos-8668902	17	11	of	of	ADP
bjos-8668902	17	12	covid-19	covid-19	PROPN
bjos-8668902	17	13	.	.	PUNCT
bjos-8668902	18	1	early	early	ADJ
bjos-8668902	18	2	signs	sign	NOUN
bjos-8668902	18	3	and	and	CCONJ
bjos-8668902	18	4	oral	oral	ADJ
bjos-8668902	18	5	manifestations	manifestation	NOUN
bjos-8668902	18	6	of	of	ADP
bjos-8668902	18	7	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	18	8	mucormycosis	mucormycosis	NOUN
bjos-8668902	18	9	play	play	VERB
bjos-8668902	18	10	a	a	DET
bjos-8668902	18	11	pivotal	pivotal	ADJ
bjos-8668902	18	12	role	role	NOUN
bjos-8668902	18	13	in	in	ADP
bjos-8668902	18	14	the	the	DET
bjos-8668902	18	15	early	early	ADJ
bjos-8668902	18	16	diagnosis	diagnosis	NOUN
bjos-8668902	18	17	and	and	CCONJ
bjos-8668902	18	18	prompt	prompt	ADJ
bjos-8668902	18	19	treatment	treatment	NOUN
bjos-8668902	18	20	to	to	PART
bjos-8668902	18	21	reduce	reduce	VERB
bjos-8668902	18	22	mortality	mortality	NOUN
bjos-8668902	18	23	and	and	CCONJ
bjos-8668902	18	24	morbidity	morbidity	NOUN
bjos-8668902	18	25	in	in	ADP
bjos-8668902	18	26	covid-19	covid-19	PROPN
bjos-8668902	18	27	associatedrhinomaxillary	associatedrhinomaxillary	ADJ
bjos-8668902	18	28	mucormycosis	mucormycosis	NOUN
bjos-8668902	18	29	patients	patient	NOUN
bjos-8668902	18	30	.	.	PUNCT
bjos-8668902	19	1	keywords	keyword	NOUN
bjos-8668902	19	2	:	:	PUNCT
bjos-8668902	19	3	mucormycosis	mucormycosis	NOUN
bjos-8668902	19	4	.	.	PUNCT
bjos-8668902	20	1	covid-19	covid-19	PROPN
bjos-8668902	20	2	.	.	PUNCT
bjos-8668902	21	1	https://orcid.org/0000-0003-3727-5772	https://orcid.org/0000-0003-3727-5772	PROPN
bjos-8668902	21	2	https://orcid.org/0000-0002-9721-3939	https://orcid.org/0000-0002-9721-3939	PROPN
bjos-8668902	21	3	https://orcid.org/0000-0003-1752-1948	https://orcid.org/0000-0003-1752-1948	PROPN
bjos-8668902	21	4	https://orcid.org/0000-0001-6956-6035	https://orcid.org/0000-0001-6956-6035	PROPN
bjos-8668902	21	5	2	2	NUM
bjos-8668902	21	6	ansari	ansari	X
bjos-8668902	21	7	et	et	PROPN
bjos-8668902	21	8	al	al	PROPN
bjos-8668902	21	9	.	.	PROPN
bjos-8668902	21	10	braz	braz	PROPN
bjos-8668902	21	11	j	j	PROPN
bjos-8668902	21	12	oral	oral	PROPN
bjos-8668902	21	13	sci	sci	PROPN
bjos-8668902	21	14	.	.	PUNCT
bjos-8668902	22	1	2023;22	2023;22	NUM
bjos-8668902	22	2	:	:	PUNCT
bjos-8668902	22	3	e238902	e238902	PART
bjos-8668902	22	4	introduction	introduction	NOUN
bjos-8668902	22	5	although	although	SCONJ
bjos-8668902	22	6	the	the	DET
bjos-8668902	22	7	primary	primary	ADJ
bjos-8668902	22	8	pathology	pathology	NOUN
bjos-8668902	22	9	of	of	ADP
bjos-8668902	22	10	covid-19	covid-19	PROPN
bjos-8668902	22	11	is	be	AUX
bjos-8668902	22	12	pneumonia	pneumonia	NOUN
bjos-8668902	22	13	and	and	CCONJ
bjos-8668902	22	14	respiratory	respiratory	ADJ
bjos-8668902	22	15	failure	failure	NOUN
bjos-8668902	22	16	,	,	PUNCT
bjos-8668902	22	17	secondary	secondary	ADJ
bjos-8668902	22	18	infections	infection	NOUN
bjos-8668902	22	19	are	be	AUX
bjos-8668902	22	20	common	common	ADJ
bjos-8668902	22	21	and	and	CCONJ
bjos-8668902	22	22	attribute	attribute	VERB
bjos-8668902	22	23	significantly	significantly	ADV
bjos-8668902	22	24	to	to	ADP
bjos-8668902	22	25	morbidity	morbidity	NOUN
bjos-8668902	22	26	and	and	CCONJ
bjos-8668902	22	27	mortality1	mortality1	NOUN
bjos-8668902	22	28	.	.	PUNCT
bjos-8668902	23	1	fungal	fungal	ADJ
bjos-8668902	23	2	infections	infection	NOUN
bjos-8668902	23	3	are	be	AUX
bjos-8668902	23	4	least	least	ADJ
bjos-8668902	23	5	common	common	ADJ
bjos-8668902	23	6	than	than	ADP
bjos-8668902	23	7	bacterial	bacterial	ADJ
bjos-8668902	23	8	infections	infection	NOUN
bjos-8668902	23	9	,	,	PUNCT
bjos-8668902	23	10	nevertheless	nevertheless	ADV
bjos-8668902	23	11	are	be	AUX
bjos-8668902	23	12	usually	usually	ADV
bjos-8668902	23	13	more	more	ADV
bjos-8668902	23	14	invasive	invasive	ADJ
bjos-8668902	23	15	and	and	CCONJ
bjos-8668902	23	16	fatal2	fatal2	NOUN
bjos-8668902	23	17	.	.	PUNCT
bjos-8668902	24	1	mucormycosis	mucormycosis	NOUN
bjos-8668902	24	2	is	be	AUX
bjos-8668902	24	3	a	a	DET
bjos-8668902	24	4	fungal	fungal	ADJ
bjos-8668902	24	5	infection	infection	NOUN
bjos-8668902	24	6	caused	cause	VERB
bjos-8668902	24	7	by	by	ADP
bjos-8668902	24	8	fungi	fungus	NOUN
bjos-8668902	24	9	known	know	VERB
bjos-8668902	24	10	as	as	ADP
bjos-8668902	24	11	mucorales	mucorale	NOUN
bjos-8668902	24	12	.	.	PUNCT
bjos-8668902	25	1	it	it	PRON
bjos-8668902	25	2	is	be	AUX
bjos-8668902	25	3	highly	highly	ADV
bjos-8668902	25	4	aggressive	aggressive	ADJ
bjos-8668902	25	5	with	with	ADP
bjos-8668902	25	6	a	a	DET
bjos-8668902	25	7	tendency	tendency	NOUN
bjos-8668902	25	8	for	for	ADP
bjos-8668902	25	9	widespread	widespread	ADJ
bjos-8668902	25	10	infection	infection	NOUN
bjos-8668902	25	11	.	.	PUNCT
bjos-8668902	26	1	this	this	DET
bjos-8668902	26	2	infection	infection	NOUN
bjos-8668902	26	3	occurs	occur	VERB
bjos-8668902	26	4	by	by	ADP
bjos-8668902	26	5	inhalation	inhalation	NOUN
bjos-8668902	26	6	of	of	ADP
bjos-8668902	26	7	spores	spore	NOUN
bjos-8668902	26	8	.	.	PUNCT
bjos-8668902	27	1	the	the	DET
bjos-8668902	27	2	fungal	fungal	ADJ
bjos-8668902	27	3	spores	spore	NOUN
bjos-8668902	27	4	adhere	adhere	VERB
bjos-8668902	27	5	to	to	ADP
bjos-8668902	27	6	the	the	DET
bjos-8668902	27	7	respiratory	respiratory	ADJ
bjos-8668902	27	8	epithelium	epithelium	NOUN
bjos-8668902	27	9	and	and	CCONJ
bjos-8668902	27	10	transform	transform	VERB
bjos-8668902	27	11	into	into	ADP
bjos-8668902	27	12	hyphae	hyphae	ADJ
bjos-8668902	27	13	causing	cause	VERB
bjos-8668902	27	14	angioinvasion	angioinvasion	NOUN
bjos-8668902	27	15	,	,	PUNCT
bjos-8668902	27	16	leading	lead	VERB
bjos-8668902	27	17	to	to	ADP
bjos-8668902	27	18	endothelial	endothelial	ADJ
bjos-8668902	27	19	injury	injury	NOUN
bjos-8668902	27	20	,	,	PUNCT
bjos-8668902	27	21	thrombosis	thrombosis	NOUN
bjos-8668902	27	22	,	,	PUNCT
bjos-8668902	27	23	and	and	CCONJ
bjos-8668902	27	24	necrosis	necrosis	NOUN
bjos-8668902	27	25	.	.	PUNCT
bjos-8668902	28	1	the	the	DET
bjos-8668902	28	2	fungus	fungus	NOUN
bjos-8668902	28	3	can	can	AUX
bjos-8668902	28	4	then	then	ADV
bjos-8668902	28	5	spread	spread	VERB
bjos-8668902	28	6	to	to	ADP
bjos-8668902	28	7	various	various	ADJ
bjos-8668902	28	8	organs	organ	NOUN
bjos-8668902	28	9	rapidly	rapidly	ADV
bjos-8668902	28	10	to	to	PART
bjos-8668902	28	11	cause	cause	VERB
bjos-8668902	28	12	disseminated	disseminate	VERB
bjos-8668902	28	13	mucormycosis	mucormycosis	NOUN
bjos-8668902	28	14	.	.	PUNCT
bjos-8668902	29	1	if	if	SCONJ
bjos-8668902	29	2	the	the	DET
bjos-8668902	29	3	diagnosis	diagnosis	NOUN
bjos-8668902	29	4	and	and	CCONJ
bjos-8668902	29	5	management	management	NOUN
bjos-8668902	29	6	are	be	AUX
bjos-8668902	29	7	delayed	delay	VERB
bjos-8668902	29	8	,	,	PUNCT
bjos-8668902	29	9	the	the	DET
bjos-8668902	29	10	prognosis	prognosis	NOUN
bjos-8668902	29	11	is	be	AUX
bjos-8668902	29	12	poor1	poor1	VERB
bjos-8668902	29	13	.	.	PUNCT
bjos-8668902	30	1	several	several	ADJ
bjos-8668902	30	2	factors	factor	NOUN
bjos-8668902	30	3	increase	increase	VERB
bjos-8668902	30	4	the	the	DET
bjos-8668902	30	5	risk	risk	NOUN
bjos-8668902	30	6	of	of	ADP
bjos-8668902	30	7	invasive	invasive	ADJ
bjos-8668902	30	8	fungal	fungal	ADJ
bjos-8668902	30	9	infections	infection	NOUN
bjos-8668902	30	10	and	and	CCONJ
bjos-8668902	30	11	mucormycosis	mucormycosis	NOUN
bjos-8668902	30	12	in	in	ADP
bjos-8668902	30	13	patients	patient	NOUN
bjos-8668902	30	14	with	with	ADP
bjos-8668902	30	15	covid-19	covid-19	PROPN
bjos-8668902	30	16	.	.	PUNCT
bjos-8668902	31	1	the	the	DET
bjos-8668902	31	2	most	most	ADV
bjos-8668902	31	3	important	important	ADJ
bjos-8668902	31	4	predisposing	predispose	VERB
bjos-8668902	31	5	factor	factor	NOUN
bjos-8668902	31	6	is	be	AUX
bjos-8668902	31	7	hyperglycemia	hyperglycemia	NOUN
bjos-8668902	31	8	which	which	PRON
bjos-8668902	31	9	may	may	AUX
bjos-8668902	31	10	decrease	decrease	VERB
bjos-8668902	31	11	the	the	DET
bjos-8668902	31	12	ability	ability	NOUN
bjos-8668902	31	13	of	of	ADP
bjos-8668902	31	14	the	the	DET
bjos-8668902	31	15	body	body	NOUN
bjos-8668902	31	16	to	to	PART
bjos-8668902	31	17	fight	fight	VERB
bjos-8668902	31	18	infections3	infections3	PROPN
bjos-8668902	31	19	.	.	PUNCT
bjos-8668902	32	1	prolonged	prolong	VERB
bjos-8668902	32	2	use	use	NOUN
bjos-8668902	32	3	of	of	ADP
bjos-8668902	32	4	a	a	DET
bjos-8668902	32	5	high	high	ADJ
bjos-8668902	32	6	dose	dose	NOUN
bjos-8668902	32	7	of	of	ADP
bjos-8668902	32	8	corticosteroids	corticosteroid	NOUN
bjos-8668902	32	9	and	and	CCONJ
bjos-8668902	32	10	drugs	drug	NOUN
bjos-8668902	32	11	like	like	ADP
bjos-8668902	32	12	tocilizumab	tocilizumab	NOUN
bjos-8668902	32	13	used	use	VERB
bjos-8668902	32	14	in	in	ADP
bjos-8668902	32	15	moderate	moderate	ADJ
bjos-8668902	32	16	and	and	CCONJ
bjos-8668902	32	17	severe	severe	ADJ
bjos-8668902	32	18	disease	disease	NOUN
bjos-8668902	32	19	may	may	AUX
bjos-8668902	32	20	also	also	ADV
bjos-8668902	32	21	increase	increase	VERB
bjos-8668902	32	22	predisposition	predisposition	NOUN
bjos-8668902	32	23	for	for	ADP
bjos-8668902	32	24	fungal	fungal	ADJ
bjos-8668902	32	25	infections4	infections4	NOUN
bjos-8668902	32	26	.	.	PUNCT
bjos-8668902	33	1	severe	severe	ADJ
bjos-8668902	33	2	covid-19	covid-19	PROPN
bjos-8668902	33	3	disease	disease	NOUN
bjos-8668902	33	4	is	be	AUX
bjos-8668902	33	5	associated	associate	VERB
bjos-8668902	33	6	with	with	ADP
bjos-8668902	33	7	the	the	DET
bjos-8668902	33	8	cytokine	cytokine	NOUN
bjos-8668902	33	9	storm	storm	NOUN
bjos-8668902	33	10	,	,	PUNCT
bjos-8668902	33	11	and	and	CCONJ
bjos-8668902	33	12	it	it	PRON
bjos-8668902	33	13	is	be	AUX
bjos-8668902	33	14	associated	associate	VERB
bjos-8668902	33	15	with	with	ADP
bjos-8668902	33	16	producing	produce	VERB
bjos-8668902	33	17	insulin	insulin	NOUN
bjos-8668902	33	18	resistance	resistance	NOUN
bjos-8668902	33	19	and	and	CCONJ
bjos-8668902	33	20	hyperglycemia	hyperglycemia	NOUN
bjos-8668902	33	21	and	and	CCONJ
bjos-8668902	33	22	the	the	DET
bjos-8668902	33	23	use	use	NOUN
bjos-8668902	33	24	of	of	ADP
bjos-8668902	33	25	steroids	steroid	NOUN
bjos-8668902	33	26	aggravates	aggravate	VERB
bjos-8668902	33	27	it	it	PRON
bjos-8668902	33	28	,	,	PUNCT
bjos-8668902	33	29	as	as	SCONJ
bjos-8668902	33	30	corticosteroids	corticosteroid	NOUN
bjos-8668902	33	31	have	have	VERB
bjos-8668902	33	32	hyperglycemic	hyperglycemic	ADJ
bjos-8668902	33	33	action	action	NOUN
bjos-8668902	33	34	thus	thus	ADV
bjos-8668902	33	35	providing	provide	VERB
bjos-8668902	33	36	the	the	DET
bjos-8668902	33	37	milieu	milieu	NOUN
bjos-8668902	33	38	for	for	ADP
bjos-8668902	33	39	seeding	seed	VERB
bjos-8668902	33	40	by	by	ADP
bjos-8668902	33	41	mucor	mucor	NOUN
bjos-8668902	33	42	.	.	PUNCT
bjos-8668902	34	1	this	this	DET
bjos-8668902	34	2	cytokine	cytokine	NOUN
bjos-8668902	34	3	storm	storm	NOUN
bjos-8668902	34	4	triggers	trigger	VERB
bjos-8668902	34	5	a	a	DET
bjos-8668902	34	6	hyperinflammatory	hyperinflammatory	ADJ
bjos-8668902	34	7	and	and	CCONJ
bjos-8668902	34	8	hypercoagulatory	hypercoagulatory	ADJ
bjos-8668902	34	9	response	response	NOUN
bjos-8668902	34	10	,	,	PUNCT
bjos-8668902	34	11	which	which	PRON
bjos-8668902	34	12	disrupts	disrupt	VERB
bjos-8668902	34	13	endothelial	endothelial	ADJ
bjos-8668902	34	14	cell	cell	NOUN
bjos-8668902	34	15	integrity	integrity	NOUN
bjos-8668902	34	16	thus	thus	ADV
bjos-8668902	34	17	causing	cause	VERB
bjos-8668902	34	18	organ	organ	NOUN
bjos-8668902	34	19	damage	damage	NOUN
bjos-8668902	34	20	such	such	ADJ
bjos-8668902	34	21	as	as	ADP
bjos-8668902	34	22	lung	lung	NOUN
bjos-8668902	34	23	injury	injury	NOUN
bjos-8668902	34	24	and	and	CCONJ
bjos-8668902	34	25	pancreatic	pancreatic	ADJ
bjos-8668902	34	26	injury5	injury5	PROPN
bjos-8668902	34	27	.	.	PUNCT
bjos-8668902	35	1	the	the	DET
bjos-8668902	35	2	sars	sar	NOUN
bjos-8668902	35	3	-	-	PUNCT
bjos-8668902	35	4	cov-2	cov-2	PART
bjos-8668902	35	5	confers	confer	NOUN
bjos-8668902	35	6	pancreatic	pancreatic	ADJ
bjos-8668902	35	7	islet	islet	NOUN
bjos-8668902	35	8	injury	injury	NOUN
bjos-8668902	35	9	and	and	CCONJ
bjos-8668902	35	10	acute	acute	ADJ
bjos-8668902	35	11	diabetes	diabetes	NOUN
bjos-8668902	35	12	onset	onset	VERB
bjos-8668902	35	13	by	by	ADP
bjos-8668902	35	14	binding	bind	VERB
bjos-8668902	35	15	to	to	ADP
bjos-8668902	35	16	the	the	DET
bjos-8668902	35	17	ace2	ace2	PROPN
bjos-8668902	35	18	receptor	receptor	NOUN
bjos-8668902	35	19	,	,	PUNCT
bjos-8668902	35	20	one	one	NUM
bjos-8668902	35	21	more	more	ADV
bjos-8668902	35	22	assumed	assume	VERB
bjos-8668902	35	23	factor	factor	NOUN
bjos-8668902	35	24	for	for	ADP
bjos-8668902	35	25	increased	increase	VERB
bjos-8668902	35	26	risk	risk	NOUN
bjos-8668902	35	27	of	of	ADP
bjos-8668902	35	28	mucormycosis	mucormycosis	NOUN
bjos-8668902	35	29	in	in	ADP
bjos-8668902	35	30	covid-19	covid-19	PROPN
bjos-8668902	35	31	is	be	AUX
bjos-8668902	35	32	intracellular	intracellular	ADJ
bjos-8668902	35	33	iron	iron	NOUN
bjos-8668902	35	34	overload	overload	NOUN
bjos-8668902	35	35	signified	signify	VERB
bjos-8668902	35	36	by	by	ADP
bjos-8668902	35	37	increased	increase	VERB
bjos-8668902	35	38	ferritin	ferritin	ADJ
bjos-8668902	35	39	levels	level	NOUN
bjos-8668902	35	40	,	,	PUNCT
bjos-8668902	35	41	which	which	PRON
bjos-8668902	35	42	leads	lead	VERB
bjos-8668902	35	43	to	to	ADP
bjos-8668902	35	44	the	the	DET
bjos-8668902	35	45	formation	formation	NOUN
bjos-8668902	35	46	of	of	ADP
bjos-8668902	35	47	reactive	reactive	ADJ
bjos-8668902	35	48	oxygen	oxygen	NOUN
bjos-8668902	35	49	species6	species6	PROPN
bjos-8668902	35	50	.	.	PUNCT
bjos-8668902	36	1	widespread	widespread	ADJ
bjos-8668902	36	2	endothelial	endothelial	ADJ
bjos-8668902	36	3	injury	injury	NOUN
bjos-8668902	36	4	in	in	ADP
bjos-8668902	36	5	patients	patient	NOUN
bjos-8668902	36	6	with	with	ADP
bjos-8668902	36	7	severe	severe	ADJ
bjos-8668902	36	8	disease	disease	NOUN
bjos-8668902	36	9	can	can	AUX
bjos-8668902	36	10	upregulate	upregulate	VERB
bjos-8668902	36	11	endothelial	endothelial	ADJ
bjos-8668902	36	12	receptor	receptor	NOUN
bjos-8668902	36	13	glucose	glucose	NOUN
bjos-8668902	36	14	-	-	PUNCT
bjos-8668902	36	15	regulated	regulate	VERB
bjos-8668902	36	16	protein	protein	NOUN
bjos-8668902	36	17	(	(	PUNCT
bjos-8668902	36	18	grp	grp	NOUN
bjos-8668902	36	19	78	78	NUM
bjos-8668902	36	20	)	)	PUNCT
bjos-8668902	36	21	,	,	PUNCT
bjos-8668902	36	22	which	which	PRON
bjos-8668902	36	23	is	be	AUX
bjos-8668902	36	24	responsible	responsible	ADJ
bjos-8668902	36	25	for	for	ADP
bjos-8668902	36	26	increased	increase	VERB
bjos-8668902	36	27	adhesion	adhesion	NOUN
bjos-8668902	36	28	and	and	CCONJ
bjos-8668902	36	29	penetration	penetration	NOUN
bjos-8668902	36	30	of	of	ADP
bjos-8668902	36	31	mucorales	mucorale	NOUN
bjos-8668902	36	32	to	to	ADP
bjos-8668902	36	33	the	the	DET
bjos-8668902	36	34	endothelium7	endothelium7	NOUN
bjos-8668902	36	35	.	.	PUNCT
bjos-8668902	37	1	the	the	DET
bjos-8668902	37	2	treatment	treatment	NOUN
bjos-8668902	37	3	modalities	modality	NOUN
bjos-8668902	37	4	available	available	ADJ
bjos-8668902	37	5	for	for	ADP
bjos-8668902	37	6	the	the	DET
bjos-8668902	37	7	treatment	treatment	NOUN
bjos-8668902	37	8	of	of	ADP
bjos-8668902	37	9	mucormycosis	mucormycosis	NOUN
bjos-8668902	37	10	are	be	AUX
bjos-8668902	37	11	aggressive	aggressive	ADJ
bjos-8668902	37	12	debridement	debridement	NOUN
bjos-8668902	37	13	of	of	ADP
bjos-8668902	37	14	infected	infect	VERB
bjos-8668902	37	15	hard	hard	ADJ
bjos-8668902	37	16	and	and	CCONJ
bjos-8668902	37	17	soft	soft	ADJ
bjos-8668902	37	18	tissue	tissue	NOUN
bjos-8668902	37	19	and	and	CCONJ
bjos-8668902	37	20	parenteral	parenteral	ADJ
bjos-8668902	37	21	antifungal	antifungal	ADJ
bjos-8668902	37	22	therapy	therapy	NOUN
bjos-8668902	37	23	such	such	ADJ
bjos-8668902	37	24	as	as	ADP
bjos-8668902	37	25	liposomal	liposomal	NOUN
bjos-8668902	37	26	amphotericin	amphotericin	ADP
bjos-8668902	37	27	b	b	NOUN
bjos-8668902	37	28	,	,	PUNCT
bjos-8668902	37	29	lipid	lipid	NOUN
bjos-8668902	37	30	amphotericin	amphotericin	ADP
bjos-8668902	37	31	b	b	NOUN
bjos-8668902	37	32	,	,	PUNCT
bjos-8668902	37	33	posaconazole	posaconazole	NOUN
bjos-8668902	37	34	,	,	PUNCT
bjos-8668902	37	35	and	and	CCONJ
bjos-8668902	37	36	itraconazole	itraconazole	NOUN
bjos-8668902	37	37	.	.	PUNCT
bjos-8668902	38	1	functional	functional	ADJ
bjos-8668902	38	2	endoscopic	endoscopic	ADJ
bjos-8668902	38	3	sinus	sinus	NOUN
bjos-8668902	38	4	surgery	surgery	NOUN
bjos-8668902	38	5	(	(	PUNCT
bjos-8668902	38	6	fess	fess	NOUN
bjos-8668902	38	7	)	)	PUNCT
bjos-8668902	38	8	is	be	AUX
bjos-8668902	38	9	an	an	DET
bjos-8668902	38	10	endoscopic	endoscopic	ADJ
bjos-8668902	38	11	surgical	surgical	ADJ
bjos-8668902	38	12	debridement	debridement	NOUN
bjos-8668902	38	13	of	of	ADP
bjos-8668902	38	14	the	the	DET
bjos-8668902	38	15	paranasal	paranasal	ADJ
bjos-8668902	38	16	sinuses	sinus	NOUN
bjos-8668902	38	17	used	use	VERB
bjos-8668902	38	18	in	in	ADP
bjos-8668902	38	19	the	the	DET
bjos-8668902	38	20	cases	case	NOUN
bjos-8668902	38	21	of	of	ADP
bjos-8668902	38	22	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	38	23	mucormycosis8	mucormycosis8	NOUN
bjos-8668902	38	24	.	.	PUNCT
bjos-8668902	39	1	the	the	DET
bjos-8668902	39	2	commonest	commonest	NOUN
bjos-8668902	39	3	reported	report	VERB
bjos-8668902	39	4	form	form	NOUN
bjos-8668902	39	5	of	of	ADP
bjos-8668902	39	6	mucormycosis	mucormycosis	NOUN
bjos-8668902	39	7	in	in	ADP
bjos-8668902	39	8	literature	literature	NOUN
bjos-8668902	39	9	is	be	AUX
bjos-8668902	39	10	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	39	11	mucormycosis9	mucormycosis9	NOUN
bjos-8668902	39	12	.	.	PUNCT
bjos-8668902	40	1	there	there	PRON
bjos-8668902	40	2	are	be	VERB
bjos-8668902	40	3	other	other	ADJ
bjos-8668902	40	4	recently	recently	ADV
bjos-8668902	40	5	published	publish	VERB
bjos-8668902	40	6	reports	report	NOUN
bjos-8668902	40	7	as	as	ADV
bjos-8668902	40	8	well	well	ADV
bjos-8668902	40	9	as	as	ADP
bjos-8668902	40	10	case	case	NOUN
bjos-8668902	40	11	series	series	NOUN
bjos-8668902	40	12	that	that	PRON
bjos-8668902	40	13	reported	report	VERB
bjos-8668902	40	14	similar	similar	ADJ
bjos-8668902	40	15	findings10,11	findings10,11	NOUN
bjos-8668902	40	16	.	.	PUNCT
bjos-8668902	41	1	this	this	DET
bjos-8668902	41	2	study	study	NOUN
bjos-8668902	41	3	aims	aim	VERB
bjos-8668902	41	4	to	to	PART
bjos-8668902	41	5	describe	describe	VERB
bjos-8668902	41	6	and	and	CCONJ
bjos-8668902	41	7	understand	understand	VERB
bjos-8668902	41	8	the	the	DET
bjos-8668902	41	9	clinical	clinical	ADJ
bjos-8668902	41	10	and	and	CCONJ
bjos-8668902	41	11	radiographic	radiographic	ADJ
bjos-8668902	41	12	findings	finding	NOUN
bjos-8668902	41	13	related	relate	VERB
bjos-8668902	41	14	to	to	ADP
bjos-8668902	41	15	covid-19	covid-19	PROPN
bjos-8668902	41	16	-	-	PUNCT
bjos-8668902	41	17	associated	associate	VERB
bjos-8668902	41	18	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	41	19	mucormycosis	mucormycosis	NOUN
bjos-8668902	41	20	.	.	PUNCT
bjos-8668902	42	1	this	this	DET
bjos-8668902	42	2	study	study	NOUN
bjos-8668902	42	3	aimed	aim	VERB
bjos-8668902	42	4	to	to	PART
bjos-8668902	42	5	describe	describe	VERB
bjos-8668902	42	6	the	the	DET
bjos-8668902	42	7	predisposing	predispose	VERB
bjos-8668902	42	8	factors	factor	NOUN
bjos-8668902	42	9	,	,	PUNCT
bjos-8668902	42	10	gender	gender	NOUN
bjos-8668902	42	11	predilection	predilection	NOUN
bjos-8668902	42	12	,	,	PUNCT
bjos-8668902	42	13	age	age	NOUN
bjos-8668902	42	14	,	,	PUNCT
bjos-8668902	42	15	clinical	clinical	ADJ
bjos-8668902	42	16	signs	sign	NOUN
bjos-8668902	42	17	and	and	CCONJ
bjos-8668902	42	18	symptoms	symptom	NOUN
bjos-8668902	42	19	,	,	PUNCT
bjos-8668902	42	20	oral	oral	ADJ
bjos-8668902	42	21	manifestations	manifestation	NOUN
bjos-8668902	42	22	,	,	PUNCT
bjos-8668902	42	23	anatomical	anatomical	ADJ
bjos-8668902	42	24	structures	structure	NOUN
bjos-8668902	42	25	involved	involve	VERB
bjos-8668902	42	26	,	,	PUNCT
bjos-8668902	42	27	treatment	treatment	NOUN
bjos-8668902	42	28	received	receive	VERB
bjos-8668902	42	29	and	and	CCONJ
bjos-8668902	42	30	mortality	mortality	NOUN
bjos-8668902	42	31	related	relate	VERB
bjos-8668902	42	32	to	to	ADP
bjos-8668902	42	33	covid-19associated	covid-19associate	VERB
bjos-8668902	42	34	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	42	35	mucormycosis	mucormycosis	NOUN
bjos-8668902	42	36	in	in	ADP
bjos-8668902	42	37	patients	patient	NOUN
bjos-8668902	42	38	who	who	PRON
bjos-8668902	42	39	reported	report	VERB
bjos-8668902	42	40	to	to	ADP
bjos-8668902	42	41	the	the	DET
bjos-8668902	42	42	dept	dept	NOUN
bjos-8668902	42	43	of	of	ADP
bjos-8668902	42	44	oral	oral	ADJ
bjos-8668902	42	45	medicine	medicine	NOUN
bjos-8668902	42	46	and	and	CCONJ
bjos-8668902	42	47	radiology	radiology	NOUN
bjos-8668902	42	48	with	with	ADP
bjos-8668902	42	49	dental	dental	ADJ
bjos-8668902	42	50	complaints	complaint	NOUN
bjos-8668902	42	51	.	.	PUNCT
bjos-8668902	43	1	3	3	NUM
bjos-8668902	43	2	ansari	ansari	X
bjos-8668902	43	3	et	et	PROPN
bjos-8668902	43	4	al	al	PROPN
bjos-8668902	43	5	.	.	PROPN
bjos-8668902	43	6	braz	braz	PROPN
bjos-8668902	43	7	j	j	PROPN
bjos-8668902	43	8	oral	oral	PROPN
bjos-8668902	43	9	sci	sci	PROPN
bjos-8668902	43	10	.	.	PUNCT
bjos-8668902	44	1	2023;22	2023;22	NUM
bjos-8668902	44	2	:	:	PUNCT
bjos-8668902	44	3	e238902	e238902	ADJ
bjos-8668902	44	4	materials	material	NOUN
bjos-8668902	44	5	and	and	CCONJ
bjos-8668902	44	6	methods	method	NOUN
bjos-8668902	44	7	this	this	DET
bjos-8668902	44	8	observational	observational	ADJ
bjos-8668902	44	9	hospital	hospital	NOUN
bjos-8668902	44	10	-	-	PUNCT
bjos-8668902	44	11	based	base	VERB
bjos-8668902	44	12	study	study	NOUN
bjos-8668902	44	13	was	be	AUX
bjos-8668902	44	14	conducted	conduct	VERB
bjos-8668902	44	15	in	in	ADP
bjos-8668902	44	16	a	a	DET
bjos-8668902	44	17	dental	dental	ADJ
bjos-8668902	44	18	hospital	hospital	NOUN
bjos-8668902	44	19	-	-	PUNCT
bjos-8668902	44	20	based	base	VERB
bjos-8668902	44	21	setting	setting	NOUN
bjos-8668902	44	22	.	.	PUNCT
bjos-8668902	45	1	the	the	DET
bjos-8668902	45	2	study	study	NOUN
bjos-8668902	45	3	sample	sample	NOUN
bjos-8668902	45	4	consisted	consist	VERB
bjos-8668902	45	5	of	of	ADP
bjos-8668902	45	6	confirmed	confirm	VERB
bjos-8668902	45	7	cases	case	NOUN
bjos-8668902	45	8	of	of	ADP
bjos-8668902	45	9	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	45	10	mucormycosis	mucormycosis	NOUN
bjos-8668902	45	11	with	with	ADP
bjos-8668902	45	12	a	a	DET
bjos-8668902	45	13	previous	previous	ADJ
bjos-8668902	45	14	history	history	NOUN
bjos-8668902	45	15	of	of	ADP
bjos-8668902	45	16	covid-19	covid-19	PROPN
bjos-8668902	45	17	who	who	PRON
bjos-8668902	45	18	reported	report	VERB
bjos-8668902	45	19	during	during	ADP
bjos-8668902	45	20	the	the	DET
bjos-8668902	45	21	2nd	2nd	ADJ
bjos-8668902	45	22	wave	wave	NOUN
bjos-8668902	45	23	of	of	ADP
bjos-8668902	45	24	covid-19	covid-19	PROPN
bjos-8668902	45	25	from	from	ADP
bjos-8668902	45	26	march	march	PROPN
bjos-8668902	45	27	2021	2021	NUM
bjos-8668902	45	28	to	to	ADP
bjos-8668902	45	29	december	december	PROPN
bjos-8668902	45	30	2021	2021	NUM
bjos-8668902	45	31	in	in	ADP
bjos-8668902	45	32	india	india	PROPN
bjos-8668902	45	33	.	.	PUNCT
bjos-8668902	46	1	confirmation	confirmation	NOUN
bjos-8668902	46	2	of	of	ADP
bjos-8668902	46	3	diagnosis	diagnosis	NOUN
bjos-8668902	46	4	was	be	AUX
bjos-8668902	46	5	based	base	VERB
bjos-8668902	46	6	on	on	ADP
bjos-8668902	46	7	clinical	clinical	ADJ
bjos-8668902	46	8	and	and	CCONJ
bjos-8668902	46	9	radiological	radiological	ADJ
bjos-8668902	46	10	features	feature	NOUN
bjos-8668902	46	11	in	in	ADP
bjos-8668902	46	12	the	the	DET
bjos-8668902	46	13	paranasal	paranasal	ADJ
bjos-8668902	46	14	sinus	sinus	NOUN
bjos-8668902	46	15	view	view	NOUN
bjos-8668902	46	16	,	,	PUNCT
bjos-8668902	46	17	computed	compute	VERB
bjos-8668902	46	18	tomography	tomography	NOUN
bjos-8668902	46	19	(	(	PUNCT
bjos-8668902	46	20	pns	pns	PROPN
bjos-8668902	46	21	ct	ct	PROPN
bjos-8668902	46	22	)	)	PUNCT
bjos-8668902	46	23	,	,	PUNCT
bjos-8668902	46	24	and	and	CCONJ
bjos-8668902	46	25	demonstration	demonstration	NOUN
bjos-8668902	46	26	of	of	ADP
bjos-8668902	46	27	mucor	mucor	NOUN
bjos-8668902	46	28	on	on	ADP
bjos-8668902	46	29	potassium	potassium	NOUN
bjos-8668902	46	30	hydroxide	hydroxide	NOUN
bjos-8668902	46	31	(	(	PUNCT
bjos-8668902	46	32	koh	koh	PROPN
bjos-8668902	46	33	)	)	PUNCT
bjos-8668902	46	34	staining	stain	VERB
bjos-8668902	46	35	or	or	CCONJ
bjos-8668902	46	36	histopathological	histopathological	ADJ
bjos-8668902	46	37	examination	examination	NOUN
bjos-8668902	46	38	using	use	VERB
bjos-8668902	46	39	periodic	periodic	ADJ
bjos-8668902	46	40	acid	acid	NOUN
bjos-8668902	46	41	-	-	PUNCT
bjos-8668902	46	42	schiff	schiff	NOUN
bjos-8668902	46	43	stain	stain	NOUN
bjos-8668902	46	44	(	(	PUNCT
bjos-8668902	46	45	pas	pas	PROPN
bjos-8668902	46	46	)	)	PUNCT
bjos-8668902	46	47	(	(	PUNCT
bjos-8668902	46	48	figure	figure	NOUN
bjos-8668902	46	49	1	1	NUM
bjos-8668902	46	50	)	)	PUNCT
bjos-8668902	46	51	and	and	CCONJ
bjos-8668902	46	52	grocott	grocott	PROPN
bjos-8668902	46	53	’s	’s	PART
bjos-8668902	46	54	methenamine	methenamine	PROPN
bjos-8668902	46	55	silver	silver	NOUN
bjos-8668902	46	56	stain	stain	NOUN
bjos-8668902	46	57	(	(	PUNCT
bjos-8668902	46	58	gms	gms	PROPN
bjos-8668902	46	59	)	)	PUNCT
bjos-8668902	46	60	(	(	PUNCT
bjos-8668902	46	61	figure	figure	NOUN
bjos-8668902	46	62	2	2	NUM
bjos-8668902	46	63	)	)	PUNCT
bjos-8668902	46	64	.	.	PUNCT
bjos-8668902	47	1	patients	patient	NOUN
bjos-8668902	47	2	with	with	ADP
bjos-8668902	47	3	fungal	fungal	ADJ
bjos-8668902	47	4	culture	culture	NOUN
bjos-8668902	47	5	positive	positive	ADJ
bjos-8668902	47	6	for	for	ADP
bjos-8668902	47	7	mucorales	mucorale	NOUN
bjos-8668902	47	8	were	be	AUX
bjos-8668902	47	9	included	include	VERB
bjos-8668902	47	10	in	in	ADP
bjos-8668902	47	11	the	the	DET
bjos-8668902	47	12	study	study	NOUN
bjos-8668902	47	13	.	.	PUNCT
bjos-8668902	48	1	figure	figure	NOUN
bjos-8668902	48	2	1	1	NUM
bjos-8668902	48	3	.	.	PUNCT
bjos-8668902	49	1	histopathological	histopathological	ADJ
bjos-8668902	49	2	section	section	NOUN
bjos-8668902	49	3	showing	show	VERB
bjos-8668902	49	4	non	non	ADJ
bjos-8668902	49	5	-	-	ADJ
bjos-8668902	49	6	septate	septate	ADJ
bjos-8668902	49	7	fungal	fungal	ADJ
bjos-8668902	49	8	hyphae	hypha	NOUN
bjos-8668902	49	9	on	on	ADP
bjos-8668902	49	10	periodic	periodic	ADJ
bjos-8668902	49	11	acid	acid	NOUN
bjos-8668902	49	12	-	-	PUNCT
bjos-8668902	49	13	schiff	schiff	NOUN
bjos-8668902	49	14	stain	stain	NOUN
bjos-8668902	49	15	figure	figure	NOUN
bjos-8668902	49	16	2	2	NUM
bjos-8668902	49	17	.	.	PUNCT
bjos-8668902	50	1	histopathological	histopathological	ADJ
bjos-8668902	50	2	section	section	NOUN
bjos-8668902	50	3	showing	show	VERB
bjos-8668902	50	4	septate	septate	ADJ
bjos-8668902	50	5	fungal	fungal	ADJ
bjos-8668902	50	6	hyphae	hypha	NOUN
bjos-8668902	50	7	on	on	ADP
bjos-8668902	50	8	grocott	grocott	PROPN
bjos-8668902	50	9	’s	’s	PART
bjos-8668902	50	10	methenamine	methenamine	PROPN
bjos-8668902	50	11	silver	silver	NOUN
bjos-8668902	50	12	stain	stain	NOUN
bjos-8668902	50	13	(	(	PUNCT
bjos-8668902	50	14	gms	gms	NOUN
bjos-8668902	50	15	)	)	PUNCT
bjos-8668902	50	16	4	4	NUM
bjos-8668902	50	17	ansari	ansari	X
bjos-8668902	50	18	et	et	PROPN
bjos-8668902	50	19	al	al	PROPN
bjos-8668902	50	20	.	.	PROPN
bjos-8668902	50	21	braz	braz	PROPN
bjos-8668902	50	22	j	j	PROPN
bjos-8668902	50	23	oral	oral	PROPN
bjos-8668902	50	24	sci	sci	PROPN
bjos-8668902	50	25	.	.	PUNCT
bjos-8668902	51	1	2023;22	2023;22	NUM
bjos-8668902	51	2	:	:	PUNCT
bjos-8668902	51	3	e238902	e238902	VERB
bjos-8668902	51	4	a	a	DET
bjos-8668902	51	5	total	total	NOUN
bjos-8668902	51	6	of	of	ADP
bjos-8668902	51	7	76	76	NUM
bjos-8668902	51	8	patients	patient	NOUN
bjos-8668902	51	9	were	be	AUX
bjos-8668902	51	10	included	include	VERB
bjos-8668902	51	11	in	in	ADP
bjos-8668902	51	12	the	the	DET
bjos-8668902	51	13	study	study	NOUN
bjos-8668902	51	14	.	.	PUNCT
bjos-8668902	52	1	patients	patient	NOUN
bjos-8668902	52	2	who	who	PRON
bjos-8668902	52	3	had	have	VERB
bjos-8668902	52	4	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	52	5	mucormycosis	mucormycosis	NOUN
bjos-8668902	52	6	with	with	ADP
bjos-8668902	52	7	negative	negative	ADJ
bjos-8668902	52	8	history	history	NOUN
bjos-8668902	52	9	of	of	ADP
bjos-8668902	52	10	covid-19	covid-19	PROPN
bjos-8668902	52	11	were	be	AUX
bjos-8668902	52	12	excluded	exclude	VERB
bjos-8668902	52	13	from	from	ADP
bjos-8668902	52	14	this	this	DET
bjos-8668902	52	15	study	study	NOUN
bjos-8668902	52	16	.	.	PUNCT
bjos-8668902	53	1	clinical	clinical	ADJ
bjos-8668902	53	2	data	datum	NOUN
bjos-8668902	53	3	was	be	AUX
bjos-8668902	53	4	retrieved	retrieve	VERB
bjos-8668902	53	5	from	from	ADP
bjos-8668902	53	6	the	the	DET
bjos-8668902	53	7	clinical	clinical	ADJ
bjos-8668902	53	8	records	record	NOUN
bjos-8668902	53	9	.	.	PUNCT
bjos-8668902	54	1	these	these	PRON
bjos-8668902	54	2	included	include	VERB
bjos-8668902	54	3	demographic	demographic	ADJ
bjos-8668902	54	4	data	datum	NOUN
bjos-8668902	54	5	like	like	ADP
bjos-8668902	54	6	age	age	NOUN
bjos-8668902	54	7	and	and	CCONJ
bjos-8668902	54	8	gender	gender	NOUN
bjos-8668902	54	9	.	.	PUNCT
bjos-8668902	55	1	details	detail	NOUN
bjos-8668902	55	2	of	of	ADP
bjos-8668902	55	3	covid-19	covid-19	PROPN
bjos-8668902	55	4	infection	infection	NOUN
bjos-8668902	55	5	were	be	AUX
bjos-8668902	55	6	noted	note	VERB
bjos-8668902	55	7	which	which	PRON
bjos-8668902	55	8	included	include	VERB
bjos-8668902	55	9	duration	duration	NOUN
bjos-8668902	55	10	of	of	ADP
bjos-8668902	55	11	hospitalization	hospitalization	NOUN
bjos-8668902	55	12	and	and	CCONJ
bjos-8668902	55	13	intensive	intensive	ADJ
bjos-8668902	55	14	care	care	NOUN
bjos-8668902	55	15	unit	unit	NOUN
bjos-8668902	55	16	(	(	PUNCT
bjos-8668902	55	17	icu	icu	PROPN
bjos-8668902	55	18	)	)	PUNCT
bjos-8668902	55	19	stay	stay	NOUN
bjos-8668902	55	20	,	,	PUNCT
bjos-8668902	55	21	the	the	DET
bjos-8668902	55	22	need	need	NOUN
bjos-8668902	55	23	of	of	ADP
bjos-8668902	55	24	a	a	DET
bjos-8668902	55	25	ventilator	ventilator	NOUN
bjos-8668902	55	26	,	,	PUNCT
bjos-8668902	55	27	and	and	CCONJ
bjos-8668902	55	28	use	use	NOUN
bjos-8668902	55	29	of	of	ADP
bjos-8668902	55	30	corticosteroids	corticosteroid	NOUN
bjos-8668902	55	31	and	and	CCONJ
bjos-8668902	55	32	other	other	ADJ
bjos-8668902	55	33	medicines	medicine	NOUN
bjos-8668902	55	34	.	.	PUNCT
bjos-8668902	56	1	history	history	NOUN
bjos-8668902	56	2	of	of	ADP
bjos-8668902	56	3	co	co	NOUN
bjos-8668902	56	4	-	-	NOUN
bjos-8668902	56	5	morbidities	morbidity	NOUN
bjos-8668902	56	6	like	like	ADP
bjos-8668902	56	7	diabetes	diabetes	NOUN
bjos-8668902	56	8	,	,	PUNCT
bjos-8668902	56	9	coronary	coronary	ADJ
bjos-8668902	56	10	heart	heart	NOUN
bjos-8668902	56	11	disease	disease	NOUN
bjos-8668902	56	12	,	,	PUNCT
bjos-8668902	56	13	kidney	kidney	NOUN
bjos-8668902	56	14	disease	disease	NOUN
bjos-8668902	56	15	,	,	PUNCT
bjos-8668902	56	16	cancer	cancer	NOUN
bjos-8668902	56	17	,	,	PUNCT
bjos-8668902	56	18	organ	organ	NOUN
bjos-8668902	56	19	transplant	transplant	NOUN
bjos-8668902	56	20	,	,	PUNCT
bjos-8668902	56	21	chronic	chronic	ADJ
bjos-8668902	56	22	lung	lung	NOUN
bjos-8668902	56	23	diseases	disease	NOUN
bjos-8668902	56	24	,	,	PUNCT
bjos-8668902	56	25	etc	etc	X
bjos-8668902	56	26	.	.	X
bjos-8668902	56	27	was	be	AUX
bjos-8668902	56	28	recorded	record	VERB
bjos-8668902	56	29	.	.	PUNCT
bjos-8668902	57	1	finally	finally	ADV
bjos-8668902	57	2	,	,	PUNCT
bjos-8668902	57	3	the	the	DET
bjos-8668902	57	4	clinical	clinical	ADJ
bjos-8668902	57	5	details	detail	NOUN
bjos-8668902	57	6	of	of	ADP
bjos-8668902	57	7	mucormycosis	mucormycosis	NOUN
bjos-8668902	57	8	were	be	AUX
bjos-8668902	57	9	extracted	extract	VERB
bjos-8668902	57	10	including	include	VERB
bjos-8668902	57	11	the	the	DET
bjos-8668902	57	12	oral	oral	ADJ
bjos-8668902	57	13	manifestations	manifestation	NOUN
bjos-8668902	57	14	,	,	PUNCT
bjos-8668902	57	15	anatomical	anatomical	ADJ
bjos-8668902	57	16	structure	structure	NOUN
bjos-8668902	57	17	involved	involve	VERB
bjos-8668902	57	18	,	,	PUNCT
bjos-8668902	57	19	sinus	sinus	NOUN
bjos-8668902	57	20	involvement	involvement	NOUN
bjos-8668902	57	21	,	,	PUNCT
bjos-8668902	57	22	treatment	treatment	NOUN
bjos-8668902	57	23	provided	provide	VERB
bjos-8668902	57	24	,	,	PUNCT
bjos-8668902	57	25	and	and	CCONJ
bjos-8668902	57	26	outcome	outcome	NOUN
bjos-8668902	57	27	.	.	PUNCT
bjos-8668902	58	1	all	all	DET
bjos-8668902	58	2	data	datum	NOUN
bjos-8668902	58	3	were	be	AUX
bjos-8668902	58	4	entered	enter	VERB
bjos-8668902	58	5	in	in	ADP
bjos-8668902	58	6	a	a	DET
bjos-8668902	58	7	central	central	ADJ
bjos-8668902	58	8	google	google	NOUN
bjos-8668902	58	9	spreadsheet	spreadsheet	NOUN
bjos-8668902	58	10	and	and	CCONJ
bjos-8668902	58	11	the	the	DET
bjos-8668902	58	12	patient	patient	ADJ
bjos-8668902	58	13	information	information	NOUN
bjos-8668902	58	14	was	be	AUX
bjos-8668902	58	15	de	de	ADJ
bjos-8668902	58	16	-	-	ADJ
bjos-8668902	58	17	identified	identified	ADJ
bjos-8668902	58	18	.	.	PUNCT
bjos-8668902	59	1	the	the	DET
bjos-8668902	59	2	data	datum	NOUN
bjos-8668902	59	3	was	be	AUX
bjos-8668902	59	4	checked	check	VERB
bjos-8668902	59	5	by	by	ADP
bjos-8668902	59	6	two	two	NUM
bjos-8668902	59	7	investigators	investigator	NOUN
bjos-8668902	59	8	.	.	PUNCT
bjos-8668902	60	1	results	result	VERB
bjos-8668902	60	2	a	a	DET
bjos-8668902	60	3	total	total	NOUN
bjos-8668902	60	4	of	of	ADP
bjos-8668902	60	5	76	76	NUM
bjos-8668902	60	6	patients	patient	NOUN
bjos-8668902	60	7	with	with	ADP
bjos-8668902	60	8	covid-19	covid-19	PROPN
bjos-8668902	60	9	-	-	PUNCT
bjos-8668902	60	10	associated	associate	VERB
bjos-8668902	60	11	“	"	PUNCT
bjos-8668902	60	12	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	60	13	mucormycosis	mucormycosis	NOUN
bjos-8668902	60	14	”	"	PUNCT
bjos-8668902	60	15	were	be	AUX
bjos-8668902	60	16	included	include	VERB
bjos-8668902	60	17	in	in	ADP
bjos-8668902	60	18	this	this	DET
bjos-8668902	60	19	study	study	NOUN
bjos-8668902	60	20	.	.	PUNCT
bjos-8668902	61	1	the	the	DET
bjos-8668902	61	2	mean	mean	ADJ
bjos-8668902	61	3	age	age	NOUN
bjos-8668902	61	4	of	of	ADP
bjos-8668902	61	5	occurrence	occurrence	NOUN
bjos-8668902	61	6	was	be	AUX
bjos-8668902	61	7	52	52	NUM
bjos-8668902	61	8	years	year	NOUN
bjos-8668902	61	9	with	with	ADP
bjos-8668902	61	10	72	72	NUM
bjos-8668902	61	11	males	male	NOUN
bjos-8668902	61	12	(	(	PUNCT
bjos-8668902	61	13	94.73	94.73	NUM
bjos-8668902	61	14	%	%	NOUN
bjos-8668902	61	15	)	)	PUNCT
bjos-8668902	61	16	and	and	CCONJ
bjos-8668902	61	17	4	4	NUM
bjos-8668902	61	18	females	female	NOUN
bjos-8668902	61	19	(	(	PUNCT
bjos-8668902	61	20	5.26	5.26	NUM
bjos-8668902	61	21	%	%	NOUN
bjos-8668902	61	22	)	)	PUNCT
bjos-8668902	61	23	given	give	VERB
bjos-8668902	61	24	in	in	ADP
bjos-8668902	61	25	table-1	table-1	NUM
bjos-8668902	61	26	.	.	PUNCT
bjos-8668902	62	1	diabetes	diabetes	NOUN
bjos-8668902	62	2	mellitus	mellitus	NOUN
bjos-8668902	62	3	(	(	PUNCT
bjos-8668902	62	4	dm	dm	NOUN
bjos-8668902	62	5	)	)	PUNCT
bjos-8668902	62	6	type	type	NOUN
bjos-8668902	62	7	-	-	PUNCT
bjos-8668902	62	8	ii	ii	NOUN
bjos-8668902	62	9	was	be	AUX
bjos-8668902	62	10	found	find	VERB
bjos-8668902	62	11	in	in	ADP
bjos-8668902	62	12	93.42	93.42	NUM
bjos-8668902	62	13	%	%	NOUN
bjos-8668902	62	14	(	(	PUNCT
bjos-8668902	62	15	n=71	n=71	NOUN
bjos-8668902	62	16	)	)	PUNCT
bjos-8668902	62	17	of	of	ADP
bjos-8668902	62	18	the	the	DET
bjos-8668902	62	19	patients	patient	NOUN
bjos-8668902	62	20	.	.	PUNCT
bjos-8668902	63	1	the	the	DET
bjos-8668902	63	2	previous	previous	ADJ
bjos-8668902	63	3	history	history	NOUN
bjos-8668902	63	4	of	of	ADP
bjos-8668902	63	5	dm	dm	PROPN
bjos-8668902	63	6	type	type	NOUN
bjos-8668902	63	7	-	-	PUNCT
bjos-8668902	63	8	ii	ii	NOUN
bjos-8668902	63	9	was	be	AUX
bjos-8668902	63	10	noted	note	VERB
bjos-8668902	63	11	in	in	ADP
bjos-8668902	63	12	46.47	46.47	NUM
bjos-8668902	63	13	%	%	NOUN
bjos-8668902	63	14	(	(	PUNCT
bjos-8668902	63	15	n=33	n=33	NOUN
bjos-8668902	63	16	)	)	PUNCT
bjos-8668902	63	17	of	of	ADP
bjos-8668902	63	18	patients	patient	NOUN
bjos-8668902	63	19	,	,	PUNCT
bjos-8668902	63	20	and	and	CCONJ
bjos-8668902	63	21	53.52	53.52	NUM
bjos-8668902	63	22	%	%	NOUN
bjos-8668902	63	23	(	(	PUNCT
bjos-8668902	63	24	n=38	n=38	NOUN
bjos-8668902	63	25	)	)	PUNCT
bjos-8668902	63	26	developed	develop	VERB
bjos-8668902	63	27	dm	dm	PROPN
bjos-8668902	63	28	type	type	NOUN
bjos-8668902	63	29	-	-	PUNCT
bjos-8668902	63	30	ii	ii	NOUN
bjos-8668902	63	31	during	during	ADP
bjos-8668902	63	32	covid-19	covid-19	PROPN
bjos-8668902	63	33	treatment	treatment	NOUN
bjos-8668902	63	34	.	.	PUNCT
bjos-8668902	64	1	the	the	DET
bjos-8668902	64	2	list	list	NOUN
bjos-8668902	64	3	of	of	ADP
bjos-8668902	64	4	co	co	NOUN
bjos-8668902	64	5	-	-	NOUN
bjos-8668902	64	6	morbidities	morbidity	NOUN
bjos-8668902	64	7	is	be	AUX
bjos-8668902	64	8	given	give	VERB
bjos-8668902	64	9	in	in	ADP
bjos-8668902	64	10	table	table	NOUN
bjos-8668902	64	11	1	1	NUM
bjos-8668902	64	12	.	.	PUNCT
bjos-8668902	64	13	history	history	NOUN
bjos-8668902	64	14	of	of	ADP
bjos-8668902	64	15	hospitalization	hospitalization	NOUN
bjos-8668902	64	16	was	be	AUX
bjos-8668902	64	17	present	present	ADJ
bjos-8668902	64	18	in	in	ADP
bjos-8668902	64	19	71	71	NUM
bjos-8668902	64	20	patients	patient	NOUN
bjos-8668902	64	21	(	(	PUNCT
bjos-8668902	64	22	93.42	93.42	NUM
bjos-8668902	64	23	%	%	NOUN
bjos-8668902	64	24	)	)	PUNCT
bjos-8668902	64	25	.	.	PUNCT
bjos-8668902	65	1	intensive	intensive	ADJ
bjos-8668902	65	2	care	care	NOUN
bjos-8668902	65	3	(	(	PUNCT
bjos-8668902	65	4	icu	icu	PROPN
bjos-8668902	65	5	)	)	PUNCT
bjos-8668902	65	6	was	be	AUX
bjos-8668902	65	7	needed	need	VERB
bjos-8668902	65	8	in	in	ADP
bjos-8668902	65	9	22	22	NUM
bjos-8668902	65	10	patients	patient	NOUN
bjos-8668902	65	11	(	(	PUNCT
bjos-8668902	65	12	28.94	28.94	NUM
bjos-8668902	65	13	%	%	NOUN
bjos-8668902	65	14	)	)	PUNCT
bjos-8668902	65	15	.	.	PUNCT
bjos-8668902	66	1	all	all	DET
bjos-8668902	66	2	patients	patient	NOUN
bjos-8668902	66	3	had	have	AUX
bjos-8668902	66	4	received	receive	VERB
bjos-8668902	66	5	systemic	systemic	ADJ
bjos-8668902	66	6	corticosteroids	corticosteroid	NOUN
bjos-8668902	66	7	.	.	PUNCT
bjos-8668902	67	1	supplemental	supplemental	ADJ
bjos-8668902	67	2	oxygen	oxygen	NOUN
bjos-8668902	67	3	was	be	AUX
bjos-8668902	67	4	required	require	VERB
bjos-8668902	67	5	in	in	ADP
bjos-8668902	67	6	72.36	72.36	NUM
bjos-8668902	67	7	%	%	NOUN
bjos-8668902	67	8	(	(	PUNCT
bjos-8668902	67	9	n=55	n=55	ADV
bjos-8668902	67	10	)	)	PUNCT
bjos-8668902	67	11	of	of	ADP
bjos-8668902	67	12	cases	case	NOUN
bjos-8668902	67	13	.	.	PUNCT
bjos-8668902	68	1	various	various	ADJ
bjos-8668902	68	2	antifungal	antifungal	ADJ
bjos-8668902	68	3	drugs	drug	NOUN
bjos-8668902	68	4	used	use	VERB
bjos-8668902	68	5	such	such	ADJ
bjos-8668902	68	6	as	as	ADP
bjos-8668902	68	7	liposomal	liposomal	NOUN
bjos-8668902	68	8	amphotericin	amphotericin	ADP
bjos-8668902	68	9	b	b	PROPN
bjos-8668902	68	10	were	be	AUX
bjos-8668902	68	11	received	receive	VERB
bjos-8668902	68	12	by	by	ADP
bjos-8668902	68	13	34	34	NUM
bjos-8668902	68	14	%	%	NOUN
bjos-8668902	68	15	(	(	PUNCT
bjos-8668902	68	16	44.73	44.73	NUM
bjos-8668902	68	17	%	%	NOUN
bjos-8668902	68	18	)	)	PUNCT
bjos-8668902	68	19	,	,	PUNCT
bjos-8668902	68	20	although	although	SCONJ
bjos-8668902	68	21	due	due	ADP
bjos-8668902	68	22	to	to	ADP
bjos-8668902	68	23	acute	acute	ADJ
bjos-8668902	68	24	shortage	shortage	NOUN
bjos-8668902	68	25	of	of	ADP
bjos-8668902	68	26	the	the	DET
bjos-8668902	68	27	drug	drug	NOUN
bjos-8668902	68	28	37	37	NUM
bjos-8668902	68	29	(	(	PUNCT
bjos-8668902	68	30	48.68	48.68	NUM
bjos-8668902	68	31	%	%	NOUN
bjos-8668902	68	32	)	)	PUNCT
bjos-8668902	69	1	patients	patient	NOUN
bjos-8668902	69	2	received	receive	VERB
bjos-8668902	69	3	lipid	lipid	NOUN
bjos-8668902	69	4	amphotericin	amphotericin	ADP
bjos-8668902	69	5	b	b	NOUN
bjos-8668902	69	6	parenterally	parenterally	ADV
bjos-8668902	69	7	during	during	ADP
bjos-8668902	69	8	hospitalization	hospitalization	NOUN
bjos-8668902	69	9	,	,	PUNCT
bjos-8668902	69	10	non	non	ADJ
bjos-8668902	69	11	-	-	ADJ
bjos-8668902	69	12	hospitalized	hospitalize	VERB
bjos-8668902	69	13	individuals	individual	NOUN
bjos-8668902	69	14	received	receive	VERB
bjos-8668902	69	15	oral	oral	ADJ
bjos-8668902	69	16	isavuconazole	isavuconazole	NOUN
bjos-8668902	69	17	(	(	PUNCT
bjos-8668902	69	18	2.63	2.63	NUM
bjos-8668902	69	19	%	%	NOUN
bjos-8668902	69	20	)	)	PUNCT
bjos-8668902	69	21	and	and	CCONJ
bjos-8668902	69	22	posaconazole	posaconazole	NOUN
bjos-8668902	69	23	(	(	PUNCT
bjos-8668902	69	24	3.94	3.94	NUM
bjos-8668902	69	25	%	%	NOUN
bjos-8668902	69	26	)	)	PUNCT
bjos-8668902	70	1	[	[	X
bjos-8668902	70	2	table	table	NOUN
bjos-8668902	70	3	1	1	NUM
bjos-8668902	70	4	]	]	PUNCT
bjos-8668902	70	5	table	table	NOUN
bjos-8668902	70	6	1	1	NUM
bjos-8668902	70	7	.	.	X
bjos-8668902	70	8	age	age	NOUN
bjos-8668902	70	9	and	and	CCONJ
bjos-8668902	70	10	gender	gender	NOUN
bjos-8668902	70	11	correlation	correlation	NOUN
bjos-8668902	70	12	,	,	PUNCT
bjos-8668902	70	13	predisposing	predispose	VERB
bjos-8668902	70	14	factors	factor	NOUN
bjos-8668902	70	15	and	and	CCONJ
bjos-8668902	70	16	covid-19	covid-19	PROPN
bjos-8668902	70	17	treatment	treatment	NOUN
bjos-8668902	70	18	related	relate	VERB
bjos-8668902	70	19	parameters	parameter	NOUN
bjos-8668902	70	20	in	in	ADP
bjos-8668902	70	21	covid-19	covid-19	PROPN
bjos-8668902	70	22	associated	associate	VERB
bjos-8668902	70	23	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	70	24	mucormycosis	mucormycosis	NOUN
bjos-8668902	70	25	parameters	parameter	NOUN
bjos-8668902	70	26	no	no	INTJ
bjos-8668902	70	27	.	.	PUNCT
bjos-8668902	70	28	of	of	ADP
bjos-8668902	70	29	patients	patient	NOUN
bjos-8668902	70	30	(	(	PUNCT
bjos-8668902	70	31	n	n	CCONJ
bjos-8668902	70	32	)	)	PUNCT
bjos-8668902	70	33	range	range	NOUN
bjos-8668902	70	34	age	age	NOUN
bjos-8668902	70	35	76	76	NUM
bjos-8668902	70	36	32	32	NUM
bjos-8668902	70	37	-	-	SYM
bjos-8668902	70	38	75	75	NUM
bjos-8668902	70	39	years	year	NOUN
bjos-8668902	70	40	mean	mean	VERB
bjos-8668902	70	41	age52	age52	PROPN
bjos-8668902	70	42	years	year	NOUN
bjos-8668902	70	43	sex	sex	VERB
bjos-8668902	70	44	76	76	NUM
bjos-8668902	70	45	males-94.73	males-94.73	NOUN
bjos-8668902	70	46	%	%	NOUN
bjos-8668902	70	47	(	(	PUNCT
bjos-8668902	70	48	n=72	n=72	NOUN
bjos-8668902	70	49	)	)	PUNCT
bjos-8668902	70	50	,	,	PUNCT
bjos-8668902	70	51	females-5.26	females-5.26	ADJ
bjos-8668902	70	52	%	%	NOUN
bjos-8668902	70	53	(	(	PUNCT
bjos-8668902	70	54	n=4	n=4	NOUN
bjos-8668902	70	55	)	)	PUNCT
bjos-8668902	70	56	m	m	ADP
bjos-8668902	70	57	:	:	PUNCT
bjos-8668902	70	58	f	f	X
bjos-8668902	70	59	ratio	ratio	NOUN
bjos-8668902	70	60	–	–	PUNCT
bjos-8668902	70	61	16:1	16:1	NUM
bjos-8668902	70	62	predisposing	predispose	VERB
bjos-8668902	70	63	factors	factor	NOUN
bjos-8668902	70	64	no	no	INTJ
bjos-8668902	70	65	.	.	PUNCT
bjos-8668902	71	1	of	of	ADP
bjos-8668902	71	2	patients	patient	NOUN
bjos-8668902	71	3	(	(	PUNCT
bjos-8668902	71	4	n	n	CCONJ
bjos-8668902	71	5	)	)	PUNCT
bjos-8668902	71	6	percentage	percentage	NOUN
bjos-8668902	71	7	(	(	PUNCT
bjos-8668902	71	8	%	%	NOUN
bjos-8668902	71	9	)	)	PUNCT
bjos-8668902	71	10	1	1	NUM
bjos-8668902	71	11	)	)	PUNCT
bjos-8668902	71	12	diabetes	diabetes	NOUN
bjos-8668902	71	13	mellitus	mellitus	NOUN
bjos-8668902	71	14	type	type	PROPN
bjos-8668902	71	15	-	-	PUNCT
bjos-8668902	71	16	ii	ii	NOUN
bjos-8668902	71	17	71	71	NUM
bjos-8668902	71	18	93.42	93.42	NUM
bjos-8668902	71	19	%	%	NOUN
bjos-8668902	71	20	a	a	NOUN
bjos-8668902	71	21	)	)	PUNCT
bjos-8668902	71	22	previous	previous	ADJ
bjos-8668902	71	23	history	history	NOUN
bjos-8668902	71	24	of	of	ADP
bjos-8668902	71	25	diabetes	diabetes	NOUN
bjos-8668902	71	26	33	33	NUM
bjos-8668902	71	27	46.47	46.47	NUM
bjos-8668902	71	28	%	%	NOUN
bjos-8668902	71	29	b	b	NOUN
bjos-8668902	71	30	)	)	PUNCT
bjos-8668902	71	31	developed	develop	VERB
bjos-8668902	71	32	diabetes	diabetes	NOUN
bjos-8668902	71	33	type	type	NOUN
bjos-8668902	71	34	-	-	PUNCT
bjos-8668902	71	35	ii	ii	NOUN
bjos-8668902	71	36	during	during	ADP
bjos-8668902	71	37	covid	covid	PROPN
bjos-8668902	71	38	19	19	NUM
bjos-8668902	71	39	treatment	treatment	NOUN
bjos-8668902	71	40	38	38	NUM
bjos-8668902	71	41	53.52	53.52	NUM
bjos-8668902	71	42	%	%	NOUN
bjos-8668902	71	43	2	2	NUM
bjos-8668902	71	44	)	)	PUNCT
bjos-8668902	71	45	renal	renal	ADJ
bjos-8668902	71	46	disease	disease	NOUN
bjos-8668902	71	47	2	2	NUM
bjos-8668902	71	48	2.63	2.63	NUM
bjos-8668902	71	49	%	%	NOUN
bjos-8668902	71	50	3	3	NUM
bjos-8668902	71	51	)	)	PUNCT
bjos-8668902	71	52	myocardial	myocardial	ADJ
bjos-8668902	71	53	infarction	infarction	NOUN
bjos-8668902	71	54	1	1	NUM
bjos-8668902	71	55	1.31	1.31	NUM
bjos-8668902	71	56	%	%	NOUN
bjos-8668902	71	57	parameters	parameter	NOUN
bjos-8668902	71	58	no	no	INTJ
bjos-8668902	71	59	.	.	PUNCT
bjos-8668902	72	1	of	of	ADP
bjos-8668902	72	2	patients	patient	NOUN
bjos-8668902	72	3	(	(	PUNCT
bjos-8668902	72	4	n	n	CCONJ
bjos-8668902	72	5	)	)	PUNCT
bjos-8668902	72	6	percentage	percentage	NOUN
bjos-8668902	72	7	(	(	PUNCT
bjos-8668902	72	8	%	%	INTJ
bjos-8668902	72	9	)	)	PUNCT
bjos-8668902	72	10	hospitalization	hospitalization	NOUN
bjos-8668902	72	11	71	71	NUM
bjos-8668902	72	12	93.42	93.42	NUM
bjos-8668902	72	13	%	%	NOUN
bjos-8668902	72	14	continue	continue	VERB
bjos-8668902	72	15	5	5	NUM
bjos-8668902	72	16	ansari	ansari	X
bjos-8668902	72	17	et	et	PROPN
bjos-8668902	72	18	al	al	PROPN
bjos-8668902	72	19	.	.	PROPN
bjos-8668902	73	1	braz	braz	PROPN
bjos-8668902	73	2	j	j	PROPN
bjos-8668902	73	3	oral	oral	PROPN
bjos-8668902	73	4	sci	sci	PROPN
bjos-8668902	73	5	.	.	PUNCT
bjos-8668902	74	1	2023;22	2023;22	NUM
bjos-8668902	74	2	:	:	PUNCT
bjos-8668902	74	3	e238902	e238902	PROPN
bjos-8668902	74	4	continuation	continuation	NOUN
bjos-8668902	74	5	stay	stay	VERB
bjos-8668902	74	6	in	in	ADP
bjos-8668902	74	7	intensive	intensive	ADJ
bjos-8668902	74	8	care	care	NOUN
bjos-8668902	74	9	unit	unit	NOUN
bjos-8668902	74	10	(	(	PUNCT
bjos-8668902	74	11	icu	icu	PROPN
bjos-8668902	74	12	)	)	PUNCT
bjos-8668902	74	13	22	22	NUM
bjos-8668902	74	14	28.94	28.94	NUM
bjos-8668902	74	15	%	%	NOUN
bjos-8668902	74	16	oxygen	oxygen	NOUN
bjos-8668902	74	17	support	support	NOUN
bjos-8668902	74	18	40	40	NUM
bjos-8668902	74	19	56.33	56.33	NUM
bjos-8668902	74	20	%	%	NOUN
bjos-8668902	74	21	systemic	systemic	ADJ
bjos-8668902	74	22	corticosteroids	corticosteroid	NOUN
bjos-8668902	74	23	76	76	NUM
bjos-8668902	74	24	100	100	NUM
bjos-8668902	74	25	%	%	NOUN
bjos-8668902	74	26	oral	oral	ADJ
bjos-8668902	74	27	5	5	NUM
bjos-8668902	74	28	6.58	6.58	NUM
bjos-8668902	74	29	%	%	NOUN
bjos-8668902	74	30	iv	iv	NUM
bjos-8668902	74	31	71	71	NUM
bjos-8668902	74	32	93.42	93.42	NUM
bjos-8668902	74	33	%	%	NOUN
bjos-8668902	74	34	antifungal	antifungal	ADJ
bjos-8668902	74	35	agents	agent	NOUN
bjos-8668902	74	36	i	i	NOUN
bjos-8668902	74	37	)	)	PUNCT
bjos-8668902	74	38	liposomal	liposomal	NOUN
bjos-8668902	74	39	amphotericin	amphotericin	ADP
bjos-8668902	74	40	b	b	PROPN
bjos-8668902	74	41	(	(	PUNCT
bjos-8668902	74	42	iv	iv	X
bjos-8668902	74	43	)	)	PUNCT
bjos-8668902	74	44	34	34	NUM
bjos-8668902	74	45	44.73	44.73	NUM
bjos-8668902	74	46	%	%	NOUN
bjos-8668902	74	47	ii	ii	NOUN
bjos-8668902	74	48	)	)	PUNCT
bjos-8668902	74	49	lipid	lipid	NOUN
bjos-8668902	74	50	amphotericin	amphotericin	ADP
bjos-8668902	74	51	b	b	PROPN
bjos-8668902	74	52	(	(	PUNCT
bjos-8668902	74	53	iv	iv	X
bjos-8668902	74	54	)	)	PUNCT
bjos-8668902	74	55	37	37	NUM
bjos-8668902	74	56	48.68	48.68	NUM
bjos-8668902	74	57	%	%	NOUN
bjos-8668902	74	58	iii	iii	NOUN
bjos-8668902	74	59	)	)	PUNCT
bjos-8668902	74	60	isavuconzole	isavuconzole	NOUN
bjos-8668902	74	61	(	(	PUNCT
bjos-8668902	74	62	oral	oral	ADJ
bjos-8668902	74	63	)	)	PUNCT
bjos-8668902	74	64	2	2	NUM
bjos-8668902	74	65	2.63	2.63	NUM
bjos-8668902	74	66	%	%	NOUN
bjos-8668902	74	67	iv	iv	NUM
bjos-8668902	74	68	)	)	PUNCT
bjos-8668902	74	69	posaconazole	posaconazole	NOUN
bjos-8668902	74	70	(	(	PUNCT
bjos-8668902	74	71	oral	oral	ADJ
bjos-8668902	74	72	)	)	PUNCT
bjos-8668902	74	73	3	3	NUM
bjos-8668902	74	74	3.94	3.94	NUM
bjos-8668902	74	75	%	%	NOUN
bjos-8668902	74	76	the	the	DET
bjos-8668902	74	77	maxilla	maxilla	NOUN
bjos-8668902	74	78	was	be	AUX
bjos-8668902	74	79	the	the	DET
bjos-8668902	74	80	most	most	ADV
bjos-8668902	74	81	commonly	commonly	ADV
bjos-8668902	74	82	involved	involve	VERB
bjos-8668902	74	83	anatomic	anatomic	ADJ
bjos-8668902	74	84	structure	structure	NOUN
bjos-8668902	74	85	in	in	ADP
bjos-8668902	74	86	98.6	98.6	NUM
bjos-8668902	74	87	%	%	NOUN
bjos-8668902	74	88	(	(	PUNCT
bjos-8668902	74	89	n=75	n=75	PROPN
bjos-8668902	74	90	)	)	PUNCT
bjos-8668902	74	91	of	of	ADP
bjos-8668902	74	92	the	the	DET
bjos-8668902	74	93	cases	case	NOUN
bjos-8668902	74	94	,	,	PUNCT
bjos-8668902	74	95	although	although	SCONJ
bjos-8668902	74	96	1	1	NUM
bjos-8668902	74	97	case	case	NOUN
bjos-8668902	74	98	of	of	ADP
bjos-8668902	74	99	mucormycosis	mucormycosis	NOUN
bjos-8668902	74	100	involving	involve	VERB
bjos-8668902	74	101	the	the	DET
bjos-8668902	74	102	mandible	mandible	NOUN
bjos-8668902	74	103	was	be	AUX
bjos-8668902	74	104	noted	note	VERB
bjos-8668902	74	105	.	.	PUNCT
bjos-8668902	75	1	the	the	DET
bjos-8668902	75	2	right	right	ADJ
bjos-8668902	75	3	maxilla	maxilla	NOUN
bjos-8668902	75	4	64	64	NUM
bjos-8668902	75	5	%	%	NOUN
bjos-8668902	75	6	(	(	PUNCT
bjos-8668902	75	7	n=48	n=48	NOUN
bjos-8668902	75	8	)	)	PUNCT
bjos-8668902	75	9	was	be	AUX
bjos-8668902	75	10	more	more	ADV
bjos-8668902	75	11	commonly	commonly	ADV
bjos-8668902	75	12	involved	involve	VERB
bjos-8668902	75	13	than	than	ADP
bjos-8668902	75	14	the	the	DET
bjos-8668902	75	15	left	left	ADJ
bjos-8668902	75	16	maxilla	maxilla	NOUN
bjos-8668902	75	17	36	36	NUM
bjos-8668902	75	18	%	%	NOUN
bjos-8668902	75	19	(	(	PUNCT
bjos-8668902	75	20	n=27	n=27	PROPN
bjos-8668902	75	21	)	)	PUNCT
bjos-8668902	75	22	.	.	PUNCT
bjos-8668902	76	1	the	the	DET
bjos-8668902	76	2	most	most	ADV
bjos-8668902	76	3	common	common	ADJ
bjos-8668902	76	4	oral	oral	ADJ
bjos-8668902	76	5	manifestation	manifestation	NOUN
bjos-8668902	76	6	was	be	AUX
bjos-8668902	76	7	a	a	DET
bjos-8668902	76	8	periodontal	periodontal	ADJ
bjos-8668902	76	9	abscess	abscess	NOUN
bjos-8668902	76	10	(	(	PUNCT
bjos-8668902	76	11	figure	figure	NOUN
bjos-8668902	76	12	3	3	NUM
bjos-8668902	76	13	)	)	PUNCT
bjos-8668902	76	14	with	with	ADP
bjos-8668902	76	15	mobility	mobility	NOUN
bjos-8668902	76	16	seen	see	VERB
bjos-8668902	76	17	in	in	ADP
bjos-8668902	76	18	50	50	NUM
bjos-8668902	76	19	%	%	NOUN
bjos-8668902	76	20	(	(	PUNCT
bjos-8668902	76	21	n=38	n=38	NOUN
bjos-8668902	76	22	)	)	PUNCT
bjos-8668902	76	23	of	of	ADP
bjos-8668902	76	24	patients	patient	NOUN
bjos-8668902	76	25	,	,	PUNCT
bjos-8668902	76	26	followed	follow	VERB
bjos-8668902	76	27	by	by	ADP
bjos-8668902	76	28	necrotic	necrotic	ADJ
bjos-8668902	76	29	bone	bone	NOUN
bjos-8668902	76	30	(	(	PUNCT
bjos-8668902	76	31	figure	figure	NOUN
bjos-8668902	76	32	4	4	NUM
bjos-8668902	76	33	)	)	PUNCT
bjos-8668902	76	34	with	with	ADP
bjos-8668902	76	35	pus	pus	ADJ
bjos-8668902	76	36	discharge	discharge	NOUN
bjos-8668902	76	37	in	in	ADP
bjos-8668902	76	38	42.1	42.1	NUM
bjos-8668902	76	39	%	%	NOUN
bjos-8668902	76	40	(	(	PUNCT
bjos-8668902	76	41	n=32	n=32	PROPN
bjos-8668902	76	42	)	)	PUNCT
bjos-8668902	76	43	of	of	ADP
bjos-8668902	76	44	patients	patient	NOUN
bjos-8668902	77	1	[	[	X
bjos-8668902	77	2	table	table	NOUN
bjos-8668902	77	3	2	2	NUM
bjos-8668902	77	4	]	]	PUNCT
bjos-8668902	77	5	.	.	PUNCT
bjos-8668902	78	1	in	in	ADP
bjos-8668902	78	2	radiographic	radiographic	ADJ
bjos-8668902	78	3	findings	finding	NOUN
bjos-8668902	78	4	,	,	PUNCT
bjos-8668902	78	5	right	right	ADJ
bjos-8668902	78	6	maxillary	maxillary	NOUN
bjos-8668902	78	7	sinus	sinus	NOUN
bjos-8668902	78	8	36	36	NUM
bjos-8668902	78	9	%	%	NOUN
bjos-8668902	78	10	(	(	PUNCT
bjos-8668902	78	11	n=27	n=27	PROPN
bjos-8668902	78	12	)	)	PUNCT
bjos-8668902	78	13	was	be	AUX
bjos-8668902	78	14	more	more	ADV
bjos-8668902	78	15	commonly	commonly	ADV
bjos-8668902	78	16	involved	involve	VERB
bjos-8668902	78	17	than	than	ADP
bjos-8668902	78	18	the	the	DET
bjos-8668902	78	19	left	left	ADJ
bjos-8668902	78	20	side	side	NOUN
bjos-8668902	78	21	26.6	26.6	NUM
bjos-8668902	78	22	%	%	NOUN
bjos-8668902	78	23	(	(	PUNCT
bjos-8668902	78	24	n=20	n=20	PROPN
bjos-8668902	78	25	)	)	PUNCT
bjos-8668902	78	26	,	,	PUNCT
bjos-8668902	78	27	although	although	SCONJ
bjos-8668902	78	28	in	in	ADP
bjos-8668902	78	29	advanced	advanced	ADJ
bjos-8668902	78	30	cases	case	NOUN
bjos-8668902	78	31	a	a	DET
bjos-8668902	78	32	bilateral	bilateral	ADJ
bjos-8668902	78	33	sinus	sinus	NOUN
bjos-8668902	78	34	involvement	involvement	NOUN
bjos-8668902	78	35	was	be	AUX
bjos-8668902	78	36	observed	observe	VERB
bjos-8668902	78	37	in	in	ADP
bjos-8668902	78	38	37.3	37.3	NUM
bjos-8668902	78	39	%	%	NOUN
bjos-8668902	78	40	(	(	PUNCT
bjos-8668902	78	41	n=28	n=28	NOUN
bjos-8668902	78	42	)	)	PUNCT
bjos-8668902	78	43	.	.	PUNCT
bjos-8668902	79	1	other	other	ADJ
bjos-8668902	79	2	paranasal	paranasal	ADJ
bjos-8668902	79	3	sinuses	sinus	NOUN
bjos-8668902	79	4	were	be	AUX
bjos-8668902	79	5	involved	involve	VERB
bjos-8668902	79	6	in	in	ADP
bjos-8668902	79	7	clinically	clinically	ADV
bjos-8668902	79	8	advanced	advanced	ADJ
bjos-8668902	79	9	disease	disease	NOUN
bjos-8668902	79	10	.	.	PUNCT
bjos-8668902	80	1	orbit	orbit	NOUN
bjos-8668902	80	2	involvement	involvement	NOUN
bjos-8668902	80	3	and	and	CCONJ
bjos-8668902	80	4	other	other	ADJ
bjos-8668902	80	5	structures	structure	NOUN
bjos-8668902	80	6	of	of	ADP
bjos-8668902	80	7	the	the	DET
bjos-8668902	80	8	skull	skull	NOUN
bjos-8668902	80	9	were	be	AUX
bjos-8668902	80	10	involved	involve	VERB
bjos-8668902	80	11	in	in	ADP
bjos-8668902	80	12	severe	severe	ADJ
bjos-8668902	80	13	cases	case	NOUN
bjos-8668902	80	14	.	.	PUNCT
bjos-8668902	81	1	none	none	NOUN
bjos-8668902	81	2	of	of	ADP
bjos-8668902	81	3	the	the	DET
bjos-8668902	81	4	patients	patient	NOUN
bjos-8668902	81	5	showed	show	VERB
bjos-8668902	81	6	evidence	evidence	NOUN
bjos-8668902	81	7	of	of	ADP
bjos-8668902	81	8	brain	brain	NOUN
bjos-8668902	81	9	involvement	involvement	NOUN
bjos-8668902	81	10	.	.	PUNCT
bjos-8668902	82	1	[	[	X
bjos-8668902	82	2	table	table	NOUN
bjos-8668902	82	3	3	3	NUM
bjos-8668902	82	4	]	]	PUNCT
bjos-8668902	82	5	.	.	PUNCT
bjos-8668902	83	1	figure	figure	NOUN
bjos-8668902	84	1	3	3	NUM
bjos-8668902	84	2	.	.	PUNCT
bjos-8668902	85	1	necrotic	necrotic	ADJ
bjos-8668902	85	2	bone	bone	NOUN
bjos-8668902	85	3	involving	involve	VERB
bjos-8668902	85	4	the	the	DET
bjos-8668902	85	5	right	right	ADJ
bjos-8668902	85	6	maxilla	maxilla	NOUN
bjos-8668902	85	7	in	in	ADP
bjos-8668902	85	8	a	a	DET
bjos-8668902	85	9	patient	patient	NOUN
bjos-8668902	85	10	with	with	ADP
bjos-8668902	85	11	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	85	12	mucormycosis	mucormycosis	NOUN
bjos-8668902	85	13	6	6	NUM
bjos-8668902	85	14	ansari	ansari	PROPN
bjos-8668902	85	15	et	et	PROPN
bjos-8668902	85	16	al	al	PROPN
bjos-8668902	85	17	.	.	PROPN
bjos-8668902	86	1	braz	braz	PROPN
bjos-8668902	86	2	j	j	PROPN
bjos-8668902	86	3	oral	oral	PROPN
bjos-8668902	86	4	sci	sci	PROPN
bjos-8668902	86	5	.	.	PUNCT
bjos-8668902	87	1	2023;22	2023;22	NUM
bjos-8668902	87	2	:	:	PUNCT
bjos-8668902	87	3	e238902	e238902	PRON
bjos-8668902	87	4	figure	figure	NOUN
bjos-8668902	87	5	4	4	NUM
bjos-8668902	87	6	.	.	PUNCT
bjos-8668902	88	1	periodontal	periodontal	ADJ
bjos-8668902	88	2	abscess	abscess	NOUN
bjos-8668902	88	3	i.r.t	i.r.t	VERB
bjos-8668902	88	4	left	leave	VERB
bjos-8668902	88	5	maxillary	maxillary	NOUN
bjos-8668902	88	6	premolar	premolar	ADJ
bjos-8668902	88	7	in	in	ADP
bjos-8668902	88	8	a	a	DET
bjos-8668902	88	9	patient	patient	NOUN
bjos-8668902	88	10	with	with	ADP
bjos-8668902	88	11	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	88	12	mucormycosis	mucormycosis	NOUN
bjos-8668902	88	13	table	table	NOUN
bjos-8668902	88	14	2	2	NUM
bjos-8668902	88	15	.	.	PUNCT
bjos-8668902	88	16	oral	oral	ADJ
bjos-8668902	88	17	manifestations	manifestation	NOUN
bjos-8668902	88	18	and	and	CCONJ
bjos-8668902	88	19	anatomic	anatomic	ADJ
bjos-8668902	88	20	structures	structure	NOUN
bjos-8668902	88	21	involvement	involvement	NOUN
bjos-8668902	88	22	in	in	ADP
bjos-8668902	88	23	covid-19	covid-19	PROPN
bjos-8668902	88	24	associated	associated	ADJ
bjos-8668902	88	25	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	88	26	mucormycosis	mucormycosis	NOUN
bjos-8668902	88	27	parameters	parameter	NOUN
bjos-8668902	88	28	no	no	INTJ
bjos-8668902	88	29	.	.	PUNCT
bjos-8668902	89	1	of	of	ADP
bjos-8668902	89	2	individuals	individual	NOUN
bjos-8668902	89	3	(	(	PUNCT
bjos-8668902	89	4	n	n	CCONJ
bjos-8668902	89	5	)	)	PUNCT
bjos-8668902	89	6	percentage	percentage	NOUN
bjos-8668902	89	7	(	(	PUNCT
bjos-8668902	89	8	%	%	INTJ
bjos-8668902	89	9	)	)	PUNCT
bjos-8668902	89	10	maxilla	maxilla	NOUN
bjos-8668902	89	11	involvement	involvement	NOUN
bjos-8668902	89	12	75	75	NUM
bjos-8668902	89	13	98.6	98.6	NUM
bjos-8668902	89	14	%	%	NOUN
bjos-8668902	89	15	mandible	mandible	ADJ
bjos-8668902	89	16	involvement	involvement	NOUN
bjos-8668902	89	17	1	1	NUM
bjos-8668902	89	18	1.31	1.31	NUM
bjos-8668902	89	19	%	%	NOUN
bjos-8668902	89	20	oral	oral	ADJ
bjos-8668902	89	21	manifestations	manifestation	NOUN
bjos-8668902	89	22	i	i	NOUN
bjos-8668902	89	23	)	)	PUNCT
bjos-8668902	89	24	necrotic	necrotic	ADJ
bjos-8668902	89	25	bone	bone	NOUN
bjos-8668902	89	26	with	with	ADP
bjos-8668902	89	27	pus	pus	ADJ
bjos-8668902	89	28	discharge	discharge	NOUN
bjos-8668902	89	29	32	32	NUM
bjos-8668902	89	30	42.1	42.1	NUM
bjos-8668902	89	31	%	%	NOUN
bjos-8668902	89	32	ii	ii	NOUN
bjos-8668902	89	33	)	)	PUNCT
bjos-8668902	89	34	single/	single/	NUM
bjos-8668902	89	35	multiple	multiple	ADJ
bjos-8668902	89	36	periodontal	periodontal	ADJ
bjos-8668902	89	37	abscess	abscess	NOUN
bjos-8668902	89	38	with	with	ADP
bjos-8668902	89	39	mobility	mobility	NOUN
bjos-8668902	89	40	38	38	NUM
bjos-8668902	89	41	50	50	NUM
bjos-8668902	89	42	%	%	NOUN
bjos-8668902	89	43	iii	iii	NOUN
bjos-8668902	89	44	)	)	PUNCT
bjos-8668902	89	45	extra	extra	ADJ
bjos-8668902	89	46	-	-	ADJ
bjos-8668902	89	47	oral	oral	ADJ
bjos-8668902	89	48	swelling	swelling	NOUN
bjos-8668902	89	49	with	with	ADP
bjos-8668902	89	50	necrotic	necrotic	ADJ
bjos-8668902	89	51	bone	bone	NOUN
bjos-8668902	89	52	6	6	NUM
bjos-8668902	89	53	7.89	7.89	NUM
bjos-8668902	89	54	%	%	NOUN
bjos-8668902	89	55	table	table	NOUN
bjos-8668902	89	56	3	3	NUM
bjos-8668902	89	57	.	.	PUNCT
bjos-8668902	89	58	radiographic	radiographic	ADJ
bjos-8668902	89	59	findings	finding	NOUN
bjos-8668902	89	60	of	of	ADP
bjos-8668902	89	61	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	89	62	mucormycosis	mucormycosis	NOUN
bjos-8668902	89	63	in	in	ADP
bjos-8668902	89	64	covid-19	covid-19	PROPN
bjos-8668902	89	65	associated	associated	ADJ
bjos-8668902	89	66	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	89	67	mucormycosis	mucormycosis	NOUN
bjos-8668902	89	68	parameters	parameter	NOUN
bjos-8668902	90	1	no	no	INTJ
bjos-8668902	90	2	.	.	PUNCT
bjos-8668902	90	3	of	of	ADP
bjos-8668902	90	4	individuals	individual	NOUN
bjos-8668902	90	5	(	(	PUNCT
bjos-8668902	90	6	n	n	CCONJ
bjos-8668902	90	7	)	)	PUNCT
bjos-8668902	90	8	percentage	percentage	NOUN
bjos-8668902	90	9	(	(	PUNCT
bjos-8668902	90	10	%	%	INTJ
bjos-8668902	90	11	)	)	PUNCT
bjos-8668902	90	12	paranasal	paranasal	ADJ
bjos-8668902	90	13	sinus	sinus	NOUN
bjos-8668902	90	14	involvement	involvement	NOUN
bjos-8668902	90	15	75	75	NUM
bjos-8668902	90	16	98.6	98.6	NUM
bjos-8668902	90	17	%	%	NOUN
bjos-8668902	90	18	i	i	NOUN
bjos-8668902	90	19	)	)	PUNCT
bjos-8668902	90	20	maxillary	maxillary	NOUN
bjos-8668902	90	21	sinus	sinus	NOUN
bjos-8668902	90	22	75	75	NUM
bjos-8668902	90	23	98.6	98.6	NUM
bjos-8668902	90	24	%	%	NOUN
bjos-8668902	90	25	a	a	NOUN
bjos-8668902	90	26	)	)	PUNCT
bjos-8668902	91	1	right	right	NOUN
bjos-8668902	91	2	27	27	NUM
bjos-8668902	91	3	36	36	NUM
bjos-8668902	91	4	%	%	NOUN
bjos-8668902	91	5	b	b	NOUN
bjos-8668902	91	6	)	)	PUNCT
bjos-8668902	91	7	left	leave	VERB
bjos-8668902	91	8	20	20	NUM
bjos-8668902	91	9	26.6	26.6	NUM
bjos-8668902	91	10	%	%	NOUN
bjos-8668902	91	11	c	c	NOUN
bjos-8668902	91	12	)	)	PUNCT
bjos-8668902	91	13	bilateral	bilateral	ADJ
bjos-8668902	91	14	involvement	involvement	NOUN
bjos-8668902	91	15	28	28	NUM
bjos-8668902	91	16	37.3	37.3	NUM
bjos-8668902	91	17	%	%	NOUN
bjos-8668902	91	18	ii	ii	NOUN
bjos-8668902	91	19	)	)	PUNCT
bjos-8668902	91	20	ethmoid	ethmoid	NOUN
bjos-8668902	91	21	sinus	sinus	NOUN
bjos-8668902	91	22	18	18	NUM
bjos-8668902	91	23	24	24	NUM
bjos-8668902	91	24	%	%	NOUN
bjos-8668902	91	25	a	a	NOUN
bjos-8668902	91	26	)	)	PUNCT
bjos-8668902	91	27	right	right	ADJ
bjos-8668902	91	28	8	8	NUM
bjos-8668902	91	29	44.4	44.4	NUM
bjos-8668902	91	30	%	%	NOUN
bjos-8668902	91	31	b	b	NOUN
bjos-8668902	91	32	)	)	PUNCT
bjos-8668902	91	33	left	leave	VERB
bjos-8668902	91	34	7	7	NUM
bjos-8668902	91	35	38.8	38.8	NUM
bjos-8668902	91	36	c	c	NOUN
bjos-8668902	91	37	)	)	PUNCT
bjos-8668902	91	38	bilateral	bilateral	ADJ
bjos-8668902	91	39	involvement	involvement	NOUN
bjos-8668902	91	40	3	3	NUM
bjos-8668902	91	41	16.6	16.6	NUM
bjos-8668902	91	42	%	%	NOUN
bjos-8668902	91	43	iii	iii	NOUN
bjos-8668902	91	44	)	)	PUNCT
bjos-8668902	91	45	orbital	orbital	ADJ
bjos-8668902	91	46	involvement	involvement	NOUN
bjos-8668902	91	47	a	a	DET
bjos-8668902	91	48	)	)	PUNCT
bjos-8668902	91	49	medial	medial	ADJ
bjos-8668902	91	50	wall	wall	NOUN
bjos-8668902	91	51	2	2	NUM
bjos-8668902	91	52	2.6	2.6	NUM
bjos-8668902	91	53	%	%	NOUN
bjos-8668902	91	54	b	b	NOUN
bjos-8668902	91	55	)	)	PUNCT
bjos-8668902	91	56	lateral	lateral	ADJ
bjos-8668902	91	57	wall	wall	NOUN
bjos-8668902	91	58	2	2	NUM
bjos-8668902	91	59	2.6	2.6	NUM
bjos-8668902	91	60	%	%	NOUN
bjos-8668902	91	61	c	c	NOUN
bjos-8668902	91	62	)	)	PUNCT
bjos-8668902	91	63	intra	intra	ADJ
bjos-8668902	91	64	-	-	ADJ
bjos-8668902	91	65	orbital	orbital	ADJ
bjos-8668902	91	66	extension	extension	NOUN
bjos-8668902	91	67	3	3	NUM
bjos-8668902	91	68	3.9	3.9	NUM
bjos-8668902	91	69	%	%	NOUN
bjos-8668902	91	70	continue	continue	VERB
bjos-8668902	91	71	7	7	NUM
bjos-8668902	91	72	ansari	ansari	PROPN
bjos-8668902	92	1	et	et	PROPN
bjos-8668902	92	2	al	al	PROPN
bjos-8668902	92	3	.	.	PROPN
bjos-8668902	92	4	braz	braz	PROPN
bjos-8668902	92	5	j	j	PROPN
bjos-8668902	92	6	oral	oral	PROPN
bjos-8668902	92	7	sci	sci	PROPN
bjos-8668902	92	8	.	.	PUNCT
bjos-8668902	93	1	2023;22	2023;22	NUM
bjos-8668902	93	2	:	:	PUNCT
bjos-8668902	93	3	e238902	e238902	PROPN
bjos-8668902	93	4	continuation	continuation	NOUN
bjos-8668902	93	5	other	other	ADJ
bjos-8668902	93	6	structures	structure	NOUN
bjos-8668902	93	7	pterygopalatine	pterygopalatine	VERB
bjos-8668902	93	8	fossa	fossa	ADJ
bjos-8668902	93	9	3	3	NUM
bjos-8668902	93	10	3.9	3.9	NUM
bjos-8668902	93	11	%	%	NOUN
bjos-8668902	93	12	infra	infra	NOUN
bjos-8668902	93	13	-	-	PUNCT
bjos-8668902	93	14	temporal	temporal	ADJ
bjos-8668902	93	15	fossa	fossa	ADJ
bjos-8668902	93	16	2	2	NUM
bjos-8668902	93	17	2.6	2.6	NUM
bjos-8668902	93	18	%	%	NOUN
bjos-8668902	93	19	sphenopalatine	sphenopalatine	NOUN
bjos-8668902	93	20	foramen	foraman	NOUN
bjos-8668902	93	21	1	1	NUM
bjos-8668902	93	22	1.3	1.3	NUM
bjos-8668902	93	23	%	%	NOUN
bjos-8668902	93	24	ethmoid	ethmoid	NOUN
bjos-8668902	93	25	air	air	NOUN
bjos-8668902	93	26	cells	cell	NOUN
bjos-8668902	93	27	2	2	NUM
bjos-8668902	93	28	2.6	2.6	NUM
bjos-8668902	93	29	%	%	NOUN
bjos-8668902	93	30	nasal	nasal	ADJ
bjos-8668902	93	31	cavity	cavity	NOUN
bjos-8668902	93	32	20	20	NUM
bjos-8668902	93	33	26.3	26.3	NUM
bjos-8668902	93	34	%	%	NOUN
bjos-8668902	93	35	sphenoid	sphenoid	NOUN
bjos-8668902	93	36	bone	bone	NOUN
bjos-8668902	93	37	2	2	NUM
bjos-8668902	93	38	2.6	2.6	NUM
bjos-8668902	93	39	%	%	NOUN
bjos-8668902	93	40	zygoma	zygoma	NOUN
bjos-8668902	93	41	1	1	NUM
bjos-8668902	93	42	1.3	1.3	NUM
bjos-8668902	93	43	%	%	NOUN
bjos-8668902	93	44	functional	functional	ADJ
bjos-8668902	93	45	endoscopic	endoscopic	ADJ
bjos-8668902	93	46	sinus	sinus	NOUN
bjos-8668902	93	47	surgery	surgery	NOUN
bjos-8668902	93	48	(	(	PUNCT
bjos-8668902	93	49	fess	fess	NOUN
bjos-8668902	93	50	)	)	PUNCT
bjos-8668902	93	51	under	under	ADP
bjos-8668902	93	52	general	general	ADJ
bjos-8668902	93	53	anesthesia	anesthesia	PROPN
bjos-8668902	93	54	(	(	PUNCT
bjos-8668902	93	55	ga	ga	NOUN
bjos-8668902	93	56	)	)	PUNCT
bjos-8668902	93	57	was	be	AUX
bjos-8668902	93	58	done	do	VERB
bjos-8668902	93	59	in	in	ADP
bjos-8668902	93	60	96.68	96.68	NUM
bjos-8668902	93	61	%	%	NOUN
bjos-8668902	93	62	(	(	PUNCT
bjos-8668902	93	63	n	n	NOUN
bjos-8668902	93	64	=	=	SYM
bjos-8668902	93	65	75	75	NUM
bjos-8668902	93	66	)	)	PUNCT
bjos-8668902	93	67	of	of	ADP
bjos-8668902	93	68	patients	patient	NOUN
bjos-8668902	93	69	.	.	PUNCT
bjos-8668902	94	1	orbital	orbital	ADJ
bjos-8668902	94	2	decompression	decompression	NOUN
bjos-8668902	94	3	was	be	AUX
bjos-8668902	94	4	done	do	VERB
bjos-8668902	94	5	in	in	ADP
bjos-8668902	94	6	3.94	3.94	NUM
bjos-8668902	94	7	%	%	NOUN
bjos-8668902	94	8	(	(	PUNCT
bjos-8668902	94	9	n	n	NOUN
bjos-8668902	94	10	=	=	SYM
bjos-8668902	94	11	3	3	NUM
bjos-8668902	94	12	)	)	PUNCT
bjos-8668902	94	13	of	of	ADP
bjos-8668902	94	14	patients	patient	NOUN
bjos-8668902	94	15	.	.	PUNCT
bjos-8668902	95	1	depending	depend	VERB
bjos-8668902	95	2	upon	upon	SCONJ
bjos-8668902	95	3	the	the	DET
bjos-8668902	95	4	bone	bone	NOUN
bjos-8668902	95	5	involvement	involvement	NOUN
bjos-8668902	95	6	various	various	ADJ
bjos-8668902	95	7	surgical	surgical	ADJ
bjos-8668902	95	8	procedures	procedure	NOUN
bjos-8668902	95	9	were	be	AUX
bjos-8668902	95	10	performed	perform	VERB
bjos-8668902	95	11	as	as	ADP
bjos-8668902	95	12	given	give	VERB
bjos-8668902	95	13	in	in	ADP
bjos-8668902	95	14	table-4	table-4	NUM
bjos-8668902	95	15	.	.	PUNCT
bjos-8668902	96	1	mortality	mortality	NOUN
bjos-8668902	96	2	occurred	occur	VERB
bjos-8668902	96	3	in	in	ADP
bjos-8668902	96	4	1.31	1.31	NUM
bjos-8668902	96	5	%	%	NOUN
bjos-8668902	96	6	(	(	PUNCT
bjos-8668902	96	7	n=1	n=1	PROPN
bjos-8668902	96	8	)	)	PUNCT
bjos-8668902	96	9	of	of	ADP
bjos-8668902	96	10	the	the	DET
bjos-8668902	96	11	patient	patient	NOUN
bjos-8668902	96	12	,	,	PUNCT
bjos-8668902	96	13	it	it	PRON
bjos-8668902	96	14	was	be	AUX
bjos-8668902	96	15	due	due	ADJ
bjos-8668902	96	16	to	to	ADP
bjos-8668902	96	17	a	a	DET
bjos-8668902	96	18	delay	delay	NOUN
bjos-8668902	96	19	in	in	ADP
bjos-8668902	96	20	the	the	DET
bjos-8668902	96	21	treatment	treatment	NOUN
bjos-8668902	96	22	due	due	ADP
bjos-8668902	96	23	to	to	ADP
bjos-8668902	96	24	underlying	underlie	VERB
bjos-8668902	96	25	cardiac	cardiac	ADJ
bjos-8668902	96	26	disease	disease	NOUN
bjos-8668902	96	27	.	.	PUNCT
bjos-8668902	97	1	[	[	X
bjos-8668902	97	2	table	table	NOUN
bjos-8668902	97	3	4	4	NUM
bjos-8668902	97	4	]	]	PUNCT
bjos-8668902	97	5	table	table	NOUN
bjos-8668902	97	6	4	4	NUM
bjos-8668902	97	7	.	.	PUNCT
bjos-8668902	98	1	treatment	treatment	NOUN
bjos-8668902	98	2	provided	provide	VERB
bjos-8668902	98	3	and	and	CCONJ
bjos-8668902	98	4	mortality	mortality	NOUN
bjos-8668902	98	5	associated	associate	VERB
bjos-8668902	98	6	with	with	ADP
bjos-8668902	98	7	in	in	ADP
bjos-8668902	98	8	covid-19	covid-19	PROPN
bjos-8668902	98	9	associated	associate	VERB
bjos-8668902	98	10	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	98	11	mucormycosis	mucormycosis	NOUN
bjos-8668902	98	12	parameters	parameter	NOUN
bjos-8668902	98	13	no	no	INTJ
bjos-8668902	98	14	.	.	PUNCT
bjos-8668902	98	15	of	of	ADP
bjos-8668902	98	16	individuals	individual	NOUN
bjos-8668902	98	17	(	(	PUNCT
bjos-8668902	98	18	n	n	CCONJ
bjos-8668902	98	19	)	)	PUNCT
bjos-8668902	98	20	percentage	percentage	NOUN
bjos-8668902	98	21	(	(	PUNCT
bjos-8668902	98	22	%	%	NOUN
bjos-8668902	98	23	)	)	PUNCT
bjos-8668902	98	24	treatment	treatment	NOUN
bjos-8668902	98	25	provided	provide	VERB
bjos-8668902	98	26	76	76	NUM
bjos-8668902	98	27	100	100	NUM
bjos-8668902	98	28	%	%	NOUN
bjos-8668902	98	29	i	i	NOUN
bjos-8668902	98	30	)	)	PUNCT
bjos-8668902	98	31	fess	fess	VERB
bjos-8668902	98	32	75	75	NUM
bjos-8668902	98	33	96.6	96.6	NUM
bjos-8668902	98	34	%	%	NOUN
bjos-8668902	98	35	ii	ii	NOUN
bjos-8668902	98	36	)	)	PUNCT
bjos-8668902	98	37	micro	micro	NOUN
bjos-8668902	98	38	-	-	NOUN
bjos-8668902	98	39	debridement	debridement	NOUN
bjos-8668902	98	40	of	of	ADP
bjos-8668902	98	41	orbit	orbit	NOUN
bjos-8668902	98	42	4	4	NUM
bjos-8668902	98	43	5.26	5.26	NUM
bjos-8668902	98	44	%	%	NOUN
bjos-8668902	98	45	iii	iii	NOUN
bjos-8668902	98	46	)	)	PUNCT
bjos-8668902	98	47	orbital	orbital	ADJ
bjos-8668902	98	48	decompression	decompression	NOUN
bjos-8668902	98	49	3	3	NUM
bjos-8668902	98	50	3.94	3.94	NUM
bjos-8668902	98	51	%	%	NOUN
bjos-8668902	98	52	iv	iv	X
bjos-8668902	98	53	)	)	PUNCT
bjos-8668902	98	54	partial	partial	ADJ
bjos-8668902	98	55	maxillectomy	maxillectomy	NOUN
bjos-8668902	98	56	28	28	NUM
bjos-8668902	98	57	39.47	39.47	NUM
bjos-8668902	98	58	%	%	NOUN
bjos-8668902	98	59	v	v	NOUN
bjos-8668902	98	60	)	)	PUNCT
bjos-8668902	98	61	alveolectomy	alveolectomy	NOUN
bjos-8668902	98	62	46	46	NUM
bjos-8668902	98	63	60.52	60.52	NUM
bjos-8668902	98	64	%	%	NOUN
bjos-8668902	98	65	vi	vi	NOUN
bjos-8668902	98	66	)	)	PUNCT
bjos-8668902	98	67	subtotal	subtotal	ADJ
bjos-8668902	98	68	maxillectomy	maxillectomy	NOUN
bjos-8668902	98	69	1	1	NUM
bjos-8668902	98	70	1.31	1.31	NUM
bjos-8668902	98	71	%	%	NOUN
bjos-8668902	98	72	vii	vii	PROPN
bjos-8668902	98	73	)	)	PUNCT
bjos-8668902	98	74	debridement	debridement	NOUN
bjos-8668902	98	75	1	1	NUM
bjos-8668902	98	76	1.31	1.31	NUM
bjos-8668902	98	77	%	%	NOUN
bjos-8668902	98	78	mortality	mortality	NOUN
bjos-8668902	98	79	associated	associate	VERB
bjos-8668902	98	80	1	1	NUM
bjos-8668902	98	81	1.31	1.31	NUM
bjos-8668902	98	82	%	%	NOUN
bjos-8668902	98	83	discussion	discussion	NOUN
bjos-8668902	98	84	mucormycosis	mucormycosis	NOUN
bjos-8668902	98	85	was	be	AUX
bjos-8668902	98	86	one	one	NUM
bjos-8668902	98	87	of	of	ADP
bjos-8668902	98	88	the	the	DET
bjos-8668902	98	89	comorbidities	comorbiditie	NOUN
bjos-8668902	98	90	associated	associate	VERB
bjos-8668902	98	91	with	with	ADP
bjos-8668902	98	92	covid	covid	PROPN
bjos-8668902	98	93	19	19	NUM
bjos-8668902	98	94	.	.	PUNCT
bjos-8668902	99	1	in	in	ADP
bjos-8668902	99	2	this	this	DET
bjos-8668902	99	3	observational	observational	ADJ
bjos-8668902	99	4	study	study	NOUN
bjos-8668902	99	5	majority	majority	NOUN
bjos-8668902	99	6	of	of	ADP
bjos-8668902	99	7	patients	patient	NOUN
bjos-8668902	99	8	had	have	VERB
bjos-8668902	99	9	diabetes	diabetes	NOUN
bjos-8668902	99	10	.	.	PUNCT
bjos-8668902	100	1	covid-19	covid-19	PROPN
bjos-8668902	100	2	-	-	PUNCT
bjos-8668902	100	3	associated	associate	VERB
bjos-8668902	100	4	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	100	5	mucormycosis	mucormycosis	NOUN
bjos-8668902	100	6	was	be	AUX
bjos-8668902	100	7	more	more	ADV
bjos-8668902	100	8	prevalent	prevalent	ADJ
bjos-8668902	100	9	in	in	ADP
bjos-8668902	100	10	males	male	NOUN
bjos-8668902	100	11	(	(	PUNCT
bjos-8668902	100	12	94.73	94.73	NUM
bjos-8668902	100	13	%	%	NOUN
bjos-8668902	100	14	)	)	PUNCT
bjos-8668902	100	15	than	than	ADP
bjos-8668902	100	16	females	female	NOUN
bjos-8668902	100	17	(	(	PUNCT
bjos-8668902	100	18	5.26	5.26	NUM
bjos-8668902	100	19	%	%	NOUN
bjos-8668902	100	20	)	)	PUNCT
bjos-8668902	100	21	and	and	CCONJ
bjos-8668902	100	22	m	m	PROPN
bjos-8668902	100	23	:	:	PUNCT
bjos-8668902	100	24	f	f	X
bjos-8668902	100	25	ratio	ratio	NOUN
bjos-8668902	100	26	was	be	AUX
bjos-8668902	100	27	16:1	16:1	NUM
bjos-8668902	100	28	.	.	PUNCT
bjos-8668902	101	1	the	the	DET
bjos-8668902	101	2	age	age	NOUN
bjos-8668902	101	3	range	range	NOUN
bjos-8668902	101	4	was	be	AUX
bjos-8668902	101	5	between	between	ADP
bjos-8668902	101	6	32	32	NUM
bjos-8668902	101	7	-	-	SYM
bjos-8668902	101	8	75	75	NUM
bjos-8668902	101	9	years	year	NOUN
bjos-8668902	101	10	with	with	ADP
bjos-8668902	101	11	a	a	DET
bjos-8668902	101	12	mean	mean	ADJ
bjos-8668902	101	13	age	age	NOUN
bjos-8668902	101	14	of	of	ADP
bjos-8668902	101	15	52	52	NUM
bjos-8668902	101	16	years	year	NOUN
bjos-8668902	101	17	.	.	PUNCT
bjos-8668902	102	1	the	the	DET
bjos-8668902	102	2	majority	majority	NOUN
bjos-8668902	102	3	of	of	ADP
bjos-8668902	102	4	patients	patient	NOUN
bjos-8668902	102	5	had	have	VERB
bjos-8668902	102	6	diabetes	diabetes	NOUN
bjos-8668902	102	7	mellitus	mellitus	NOUN
bjos-8668902	102	8	in	in	ADP
bjos-8668902	102	9	this	this	DET
bjos-8668902	102	10	observational	observational	ADJ
bjos-8668902	102	11	study	study	NOUN
bjos-8668902	102	12	;	;	PUNCT
bjos-8668902	102	13	a	a	DET
bjos-8668902	102	14	study	study	NOUN
bjos-8668902	102	15	conducted	conduct	VERB
bjos-8668902	102	16	by	by	ADP
bjos-8668902	102	17	gupta	gupta	PROPN
bjos-8668902	102	18	et	et	PROPN
bjos-8668902	102	19	al	al	PROPN
bjos-8668902	102	20	2021	2021	NUM
bjos-8668902	102	21	reported	report	VERB
bjos-8668902	102	22	the	the	DET
bjos-8668902	102	23	presence	presence	NOUN
bjos-8668902	102	24	of	of	ADP
bjos-8668902	102	25	diabetes	diabetes	NOUN
bjos-8668902	102	26	in	in	ADP
bjos-8668902	102	27	the	the	DET
bjos-8668902	102	28	majority	majority	NOUN
bjos-8668902	102	29	of	of	ADP
bjos-8668902	102	30	patients12	patients12	NOUN
bjos-8668902	102	31	.	.	PUNCT
bjos-8668902	103	1	prominently	prominently	ADV
bjos-8668902	103	2	,	,	PUNCT
bjos-8668902	103	3	the	the	DET
bjos-8668902	103	4	majority	majority	NOUN
bjos-8668902	103	5	of	of	ADP
bjos-8668902	103	6	the	the	DET
bjos-8668902	103	7	reported	report	VERB
bjos-8668902	103	8	mucormycosis	mucormycosis	NOUN
bjos-8668902	103	9	cases	case	NOUN
bjos-8668902	103	10	during	during	ADP
bjos-8668902	103	11	the	the	DET
bjos-8668902	103	12	covid-19	covid-19	PROPN
bjos-8668902	103	13	pandemic	pandemic	NOUN
bjos-8668902	103	14	were	be	AUX
bjos-8668902	103	15	from	from	ADP
bjos-8668902	103	16	india	india	PROPN
bjos-8668902	103	17	.	.	PUNCT
bjos-8668902	104	1	a	a	DET
bjos-8668902	104	2	systematic	systematic	ADJ
bjos-8668902	104	3	review	review	NOUN
bjos-8668902	104	4	of	of	ADP
bjos-8668902	104	5	101	101	NUM
bjos-8668902	104	6	cases	case	NOUN
bjos-8668902	104	7	of	of	ADP
bjos-8668902	104	8	cam	cam	NOUN
bjos-8668902	104	9	8	8	NUM
bjos-8668902	104	10	ansari	ansari	PROPN
bjos-8668902	104	11	et	et	PROPN
bjos-8668902	104	12	al	al	PROPN
bjos-8668902	104	13	.	.	PROPN
bjos-8668902	105	1	braz	braz	PROPN
bjos-8668902	105	2	j	j	PROPN
bjos-8668902	105	3	oral	oral	PROPN
bjos-8668902	105	4	sci	sci	PROPN
bjos-8668902	105	5	.	.	PUNCT
bjos-8668902	106	1	2023;22	2023;22	NUM
bjos-8668902	106	2	:	:	PUNCT
bjos-8668902	106	3	e238902	e238902	X
bjos-8668902	106	4	globally	globally	ADV
bjos-8668902	106	5	published	publish	VERB
bjos-8668902	106	6	in	in	ADP
bjos-8668902	106	7	july	july	PROPN
bjos-8668902	106	8	2021	2021	NUM
bjos-8668902	106	9	revealed	reveal	VERB
bjos-8668902	106	10	diabetes	diabetes	NOUN
bjos-8668902	106	11	in	in	ADP
bjos-8668902	106	12	80	80	NUM
bjos-8668902	106	13	%	%	NOUN
bjos-8668902	106	14	of	of	ADP
bjos-8668902	106	15	patients	patient	NOUN
bjos-8668902	106	16	and	and	CCONJ
bjos-8668902	106	17	steroid	steroid	NOUN
bjos-8668902	106	18	use	use	NOUN
bjos-8668902	106	19	in	in	ADP
bjos-8668902	106	20	76	76	NUM
bjos-8668902	106	21	%	%	NOUN
bjos-8668902	106	22	of	of	ADP
bjos-8668902	106	23	patients13	patients13	NOUN
bjos-8668902	106	24	.	.	PUNCT
bjos-8668902	107	1	a	a	DET
bjos-8668902	107	2	retrospective	retrospective	ADJ
bjos-8668902	107	3	countrywide	countrywide	NOUN
bjos-8668902	107	4	study	study	NOUN
bjos-8668902	107	5	revealed	reveal	VERB
bjos-8668902	107	6	that	that	SCONJ
bjos-8668902	107	7	diabetes	diabetes	NOUN
bjos-8668902	107	8	mellitus	mellitus	NOUN
bjos-8668902	107	9	is	be	AUX
bjos-8668902	107	10	predominant	predominant	ADJ
bjos-8668902	107	11	in	in	ADP
bjos-8668902	107	12	79	79	NUM
bjos-8668902	107	13	%	%	NOUN
bjos-8668902	107	14	and	and	CCONJ
bjos-8668902	107	15	steroid	steroid	NOUN
bjos-8668902	107	16	use	use	NOUN
bjos-8668902	107	17	in	in	ADP
bjos-8668902	107	18	87	87	NUM
bjos-8668902	107	19	%	%	NOUN
bjos-8668902	107	20	of	of	ADP
bjos-8668902	107	21	patients	patient	NOUN
bjos-8668902	107	22	with	with	ADP
bjos-8668902	107	23	rhino	rhino	NOUN
bjos-8668902	107	24	-	-	PUNCT
bjos-8668902	107	25	orbito	orbito	ADJ
bjos-8668902	107	26	-	-	PUNCT
bjos-8668902	107	27	cerebral	cerebral	ADJ
bjos-8668902	107	28	mucormycosis	mucormycosis	NOUN
bjos-8668902	107	29	associated	associate	VERB
bjos-8668902	107	30	with	with	ADP
bjos-8668902	107	31	covid-1911	covid-1911	NOUN
bjos-8668902	107	32	.	.	PUNCT
bjos-8668902	108	1	in	in	ADP
bjos-8668902	108	2	an	an	DET
bjos-8668902	108	3	updated	update	VERB
bjos-8668902	108	4	systematic	systematic	ADJ
bjos-8668902	108	5	review	review	NOUN
bjos-8668902	108	6	comprised	comprise	VERB
bjos-8668902	108	7	of	of	ADP
bjos-8668902	108	8	233	233	NUM
bjos-8668902	108	9	patients	patient	NOUN
bjos-8668902	108	10	from	from	ADP
bjos-8668902	108	11	india	india	PROPN
bjos-8668902	108	12	and	and	CCONJ
bjos-8668902	108	13	42	42	NUM
bjos-8668902	108	14	from	from	ADP
bjos-8668902	108	15	the	the	DET
bjos-8668902	108	16	rest	rest	NOUN
bjos-8668902	108	17	of	of	ADP
bjos-8668902	108	18	the	the	DET
bjos-8668902	108	19	world	world	NOUN
bjos-8668902	108	20	,	,	PUNCT
bjos-8668902	108	21	diabetes	diabete	NOUN
bjos-8668902	108	22	was	be	AUX
bjos-8668902	108	23	identified	identify	VERB
bjos-8668902	108	24	as	as	ADP
bjos-8668902	108	25	the	the	DET
bjos-8668902	108	26	most	most	ADV
bjos-8668902	108	27	common	common	ADJ
bjos-8668902	108	28	primary	primary	ADJ
bjos-8668902	108	29	risk	risk	NOUN
bjos-8668902	108	30	factor	factor	NOUN
bjos-8668902	108	31	for	for	ADP
bjos-8668902	108	32	cam	cam	NOUN
bjos-8668902	108	33	in	in	ADP
bjos-8668902	108	34	india	india	PROPN
bjos-8668902	108	35	than	than	ADP
bjos-8668902	108	36	in	in	ADP
bjos-8668902	108	37	other	other	ADJ
bjos-8668902	108	38	countries	country	NOUN
bjos-8668902	108	39	.	.	PUNCT
bjos-8668902	109	1	a	a	DET
bjos-8668902	109	2	study	study	NOUN
bjos-8668902	109	3	from	from	ADP
bjos-8668902	109	4	egypt	egypt	PROPN
bjos-8668902	109	5	in	in	ADP
bjos-8668902	109	6	21	21	NUM
bjos-8668902	109	7	patients	patient	NOUN
bjos-8668902	109	8	with	with	ADP
bjos-8668902	109	9	cam	cam	NOUN
bjos-8668902	109	10	also	also	ADV
bjos-8668902	109	11	found	find	VERB
bjos-8668902	109	12	a	a	DET
bjos-8668902	109	13	high	high	ADJ
bjos-8668902	109	14	prevalence	prevalence	NOUN
bjos-8668902	109	15	of	of	ADP
bjos-8668902	109	16	diabetes	diabetes	NOUN
bjos-8668902	109	17	(	(	PUNCT
bjos-8668902	109	18	90%)14	90%)14	NUM
bjos-8668902	109	19	.	.	PUNCT
bjos-8668902	110	1	in	in	ADP
bjos-8668902	110	2	our	our	PRON
bjos-8668902	110	3	study	study	NOUN
bjos-8668902	110	4	,	,	PUNCT
bjos-8668902	110	5	all	all	DET
bjos-8668902	110	6	patients	patient	NOUN
bjos-8668902	110	7	received	receive	VERB
bjos-8668902	110	8	systemic	systemic	ADJ
bjos-8668902	110	9	corticosteroids	corticosteroid	NOUN
bjos-8668902	110	10	during	during	ADP
bjos-8668902	110	11	the	the	DET
bjos-8668902	110	12	treatment	treatment	NOUN
bjos-8668902	110	13	of	of	ADP
bjos-8668902	110	14	covid-19	covid-19	PROPN
bjos-8668902	110	15	.	.	PUNCT
bjos-8668902	111	1	the	the	DET
bjos-8668902	111	2	interesting	interesting	ADJ
bjos-8668902	111	3	fact	fact	NOUN
bjos-8668902	111	4	here	here	ADV
bjos-8668902	111	5	is	be	AUX
bjos-8668902	111	6	although	although	SCONJ
bjos-8668902	111	7	the	the	DET
bjos-8668902	111	8	prevalence	prevalence	NOUN
bjos-8668902	111	9	of	of	ADP
bjos-8668902	111	10	diabetes	diabetes	NOUN
bjos-8668902	111	11	was	be	AUX
bjos-8668902	111	12	similar	similar	ADJ
bjos-8668902	111	13	in	in	ADP
bjos-8668902	111	14	most	most	ADJ
bjos-8668902	111	15	studies	study	NOUN
bjos-8668902	111	16	,	,	PUNCT
bjos-8668902	111	17	the	the	DET
bjos-8668902	111	18	use	use	NOUN
bjos-8668902	111	19	of	of	ADP
bjos-8668902	111	20	corticosteroids	corticosteroid	NOUN
bjos-8668902	111	21	is	be	AUX
bjos-8668902	111	22	less	less	ADJ
bjos-8668902	111	23	in	in	ADP
bjos-8668902	111	24	some	some	DET
bjos-8668902	111	25	studies	study	NOUN
bjos-8668902	111	26	(	(	PUNCT
bjos-8668902	111	27	85	85	NUM
bjos-8668902	111	28	%	%	NOUN
bjos-8668902	111	29	in	in	ADP
bjos-8668902	111	30	a	a	DET
bjos-8668902	111	31	recent	recent	ADJ
bjos-8668902	111	32	systemic	systemic	ADJ
bjos-8668902	111	33	review)15	review)15	NOUN
bjos-8668902	111	34	.	.	PUNCT
bjos-8668902	112	1	another	another	DET
bjos-8668902	112	2	notable	notable	ADJ
bjos-8668902	112	3	finding	finding	NOUN
bjos-8668902	112	4	was	be	AUX
bjos-8668902	112	5	that	that	SCONJ
bjos-8668902	112	6	,	,	PUNCT
bjos-8668902	112	7	53.52	53.52	NUM
bjos-8668902	112	8	%	%	NOUN
bjos-8668902	112	9	developed	develop	VERB
bjos-8668902	112	10	diabetes	diabetes	NOUN
bjos-8668902	112	11	mellitus	mellitus	NOUN
bjos-8668902	112	12	during	during	ADP
bjos-8668902	112	13	the	the	DET
bjos-8668902	112	14	covid-19	covid-19	PROPN
bjos-8668902	112	15	treatment	treatment	NOUN
bjos-8668902	112	16	,	,	PUNCT
bjos-8668902	112	17	new	new	ADJ
bjos-8668902	112	18	onset	onset	NOUN
bjos-8668902	112	19	of	of	ADP
bjos-8668902	112	20	diabetes	diabetes	NOUN
bjos-8668902	112	21	was	be	AUX
bjos-8668902	112	22	reported	report	VERB
bjos-8668902	112	23	in	in	ADP
bjos-8668902	112	24	association	association	NOUN
bjos-8668902	112	25	with	with	ADP
bjos-8668902	112	26	covid-1916	covid-1916	NOUN
bjos-8668902	112	27	.	.	PUNCT
bjos-8668902	113	1	the	the	DET
bjos-8668902	113	2	nasal	nasal	PROPN
bjos-8668902	113	3	mucociliary	mucociliary	NOUN
bjos-8668902	113	4	clearance	clearance	NOUN
bjos-8668902	113	5	is	be	AUX
bjos-8668902	113	6	the	the	DET
bjos-8668902	113	7	primary	primary	ADJ
bjos-8668902	113	8	distinctive	distinctive	ADJ
bjos-8668902	113	9	defense	defense	NOUN
bjos-8668902	113	10	mechanism	mechanism	NOUN
bjos-8668902	113	11	of	of	ADP
bjos-8668902	113	12	the	the	DET
bjos-8668902	113	13	paranasal	paranasal	ADJ
bjos-8668902	113	14	sinus	sinus	NOUN
bjos-8668902	113	15	against	against	ADP
bjos-8668902	113	16	various	various	ADJ
bjos-8668902	113	17	antigens	antigen	NOUN
bjos-8668902	113	18	.	.	PUNCT
bjos-8668902	114	1	this	this	DET
bjos-8668902	114	2	mechanism	mechanism	NOUN
bjos-8668902	114	3	guards	guard	VERB
bjos-8668902	114	4	the	the	DET
bjos-8668902	114	5	upper	upper	ADJ
bjos-8668902	114	6	respiratory	respiratory	ADJ
bjos-8668902	114	7	system	system	NOUN
bjos-8668902	114	8	against	against	ADP
bjos-8668902	114	9	numerous	numerous	ADJ
bjos-8668902	114	10	inhaled	inhaled	ADJ
bjos-8668902	114	11	particles	particle	NOUN
bjos-8668902	114	12	and	and	CCONJ
bjos-8668902	114	13	microorganisms	microorganism	NOUN
bjos-8668902	114	14	.	.	PUNCT
bjos-8668902	115	1	however	however	ADV
bjos-8668902	115	2	,	,	PUNCT
bjos-8668902	115	3	it	it	PRON
bjos-8668902	115	4	becomes	become	VERB
bjos-8668902	115	5	one	one	NUM
bjos-8668902	115	6	of	of	ADP
bjos-8668902	115	7	the	the	DET
bjos-8668902	115	8	critical	critical	ADJ
bjos-8668902	115	9	factors	factor	NOUN
bjos-8668902	115	10	for	for	ADP
bjos-8668902	115	11	the	the	DET
bjos-8668902	115	12	growth	growth	NOUN
bjos-8668902	115	13	of	of	ADP
bjos-8668902	115	14	fungus	fungus	NOUN
bjos-8668902	115	15	together	together	ADV
bjos-8668902	115	16	with	with	ADP
bjos-8668902	115	17	the	the	DET
bjos-8668902	115	18	inflammation	inflammation	NOUN
bjos-8668902	115	19	of	of	ADP
bjos-8668902	115	20	the	the	DET
bjos-8668902	115	21	upper	upper	ADJ
bjos-8668902	115	22	airway	airway	NOUN
bjos-8668902	115	23	,	,	PUNCT
bjos-8668902	115	24	in	in	ADP
bjos-8668902	115	25	patients	patient	NOUN
bjos-8668902	115	26	requiring	require	VERB
bjos-8668902	115	27	prolonged	prolonged	ADJ
bjos-8668902	115	28	hospital	hospital	NOUN
bjos-8668902	115	29	stay	stay	VERB
bjos-8668902	115	30	with	with	ADP
bjos-8668902	115	31	supplemental	supplemental	ADJ
bjos-8668902	115	32	oxygen	oxygen	NOUN
bjos-8668902	115	33	therapy17	therapy17	NOUN
bjos-8668902	115	34	,	,	PUNCT
bjos-8668902	115	35	mild	mild	ADJ
bjos-8668902	115	36	thrombocytopenia	thrombocytopenia	NOUN
bjos-8668902	115	37	has	have	AUX
bjos-8668902	115	38	been	be	AUX
bjos-8668902	115	39	detected	detect	VERB
bjos-8668902	115	40	in	in	ADP
bjos-8668902	115	41	58–95	58–95	NUM
bjos-8668902	115	42	%	%	NOUN
bjos-8668902	115	43	of	of	ADP
bjos-8668902	115	44	patients	patient	NOUN
bjos-8668902	115	45	with	with	ADP
bjos-8668902	115	46	sars	sar	NOUN
bjos-8668902	115	47	-	-	PUNCT
bjos-8668902	115	48	cov-2	cov-2	PART
bjos-8668902	115	49	infection	infection	NOUN
bjos-8668902	115	50	.	.	PUNCT
bjos-8668902	116	1	platelets	platelet	NOUN
bjos-8668902	116	2	possibly	possibly	ADV
bjos-8668902	116	3	hamper	hamper	VERB
bjos-8668902	116	4	the	the	DET
bjos-8668902	116	5	growth	growth	NOUN
bjos-8668902	116	6	of	of	ADP
bjos-8668902	116	7	fungi	fungus	NOUN
bjos-8668902	116	8	are	be	AUX
bjos-8668902	116	9	(	(	PUNCT
bjos-8668902	116	10	i	i	NOUN
bjos-8668902	116	11	)	)	PUNCT
bjos-8668902	116	12	directly	directly	ADV
bjos-8668902	116	13	by	by	ADP
bjos-8668902	116	14	adhering	adhere	VERB
bjos-8668902	116	15	to	to	ADP
bjos-8668902	116	16	mucorales	mucorale	NOUN
bjos-8668902	116	17	hyphae	hyphae	ADJ
bjos-8668902	116	18	to	to	PART
bjos-8668902	116	19	form	form	VERB
bjos-8668902	116	20	a	a	DET
bjos-8668902	116	21	thrombus	thrombus	NOUN
bjos-8668902	116	22	.	.	PUNCT
bjos-8668902	117	1	(	(	PUNCT
bjos-8668902	117	2	ii	ii	NOUN
bjos-8668902	117	3	)	)	PUNCT
bjos-8668902	117	4	indirectly	indirectly	ADV
bjos-8668902	117	5	,	,	PUNCT
bjos-8668902	117	6	platelets	platelet	VERB
bjos-8668902	117	7	secrete	secrete	VERB
bjos-8668902	117	8	pro	pro	ADJ
bjos-8668902	117	9	-	-	ADJ
bjos-8668902	117	10	inflammatory	inflammatory	ADJ
bjos-8668902	117	11	and	and	CCONJ
bjos-8668902	117	12	anti	anti	ADJ
bjos-8668902	117	13	-	-	ADJ
bjos-8668902	117	14	inflammatory	inflammatory	ADJ
bjos-8668902	117	15	cytokines	cytokine	NOUN
bjos-8668902	117	16	such	such	ADJ
bjos-8668902	117	17	as	as	ADP
bjos-8668902	117	18	tgf	tgf	PROPN
bjos-8668902	117	19	-	-	PUNCT
bjos-8668902	117	20	β	β	NOUN
bjos-8668902	117	21	and	and	CCONJ
bjos-8668902	117	22	thrombocidins	thrombocidin	NOUN
bjos-8668902	117	23	which	which	PRON
bjos-8668902	117	24	may	may	AUX
bjos-8668902	117	25	act	act	VERB
bjos-8668902	117	26	against	against	ADP
bjos-8668902	117	27	mucorales18	mucorales18	NOUN
bjos-8668902	117	28	.	.	PUNCT
bjos-8668902	118	1	corticosteroids	corticosteroid	NOUN
bjos-8668902	118	2	used	use	VERB
bjos-8668902	118	3	for	for	ADP
bjos-8668902	118	4	suppression	suppression	NOUN
bjos-8668902	118	5	of	of	ADP
bjos-8668902	118	6	inflammatory	inflammatory	ADJ
bjos-8668902	118	7	mediators	mediator	NOUN
bjos-8668902	118	8	and	and	CCONJ
bjos-8668902	118	9	cytokines	cytokine	NOUN
bjos-8668902	118	10	in	in	ADP
bjos-8668902	118	11	severe	severe	ADJ
bjos-8668902	118	12	covid-19	covid-19	PROPN
bjos-8668902	118	13	cause	cause	VERB
bjos-8668902	118	14	suppression	suppression	NOUN
bjos-8668902	118	15	of	of	ADP
bjos-8668902	118	16	lymphocytes	lymphocyte	NOUN
bjos-8668902	118	17	and	and	CCONJ
bjos-8668902	118	18	also	also	ADV
bjos-8668902	118	19	cause	cause	VERB
bjos-8668902	118	20	hyperglycemia	hyperglycemia	NOUN
bjos-8668902	118	21	by	by	ADP
bjos-8668902	118	22	promoting	promote	VERB
bjos-8668902	118	23	gluconeogenesis	gluconeogenesis	NOUN
bjos-8668902	118	24	and	and	CCONJ
bjos-8668902	118	25	inhibiting	inhibit	VERB
bjos-8668902	118	26	glycolysis	glycolysis	NOUN
bjos-8668902	118	27	thus	thus	ADV
bjos-8668902	118	28	there	there	PRON
bjos-8668902	118	29	is	be	VERB
bjos-8668902	118	30	an	an	DET
bjos-8668902	118	31	increased	increase	VERB
bjos-8668902	118	32	incidence	incidence	NOUN
bjos-8668902	118	33	of	of	ADP
bjos-8668902	118	34	mucormycosis	mucormycosis	NOUN
bjos-8668902	118	35	in	in	ADP
bjos-8668902	118	36	patients	patient	NOUN
bjos-8668902	118	37	with	with	ADP
bjos-8668902	118	38	a	a	DET
bjos-8668902	118	39	history	history	NOUN
bjos-8668902	118	40	of	of	ADP
bjos-8668902	118	41	corticosteroid	corticosteroid	ADJ
bjos-8668902	118	42	use19	use19	ADJ
bjos-8668902	118	43	.	.	PUNCT
bjos-8668902	119	1	the	the	DET
bjos-8668902	119	2	maxilla	maxilla	NOUN
bjos-8668902	119	3	(	(	PUNCT
bjos-8668902	119	4	98.6	98.6	NUM
bjos-8668902	119	5	%	%	NOUN
bjos-8668902	119	6	)	)	PUNCT
bjos-8668902	119	7	was	be	AUX
bjos-8668902	119	8	the	the	DET
bjos-8668902	119	9	most	most	ADV
bjos-8668902	119	10	commonly	commonly	ADV
bjos-8668902	119	11	involved	involve	VERB
bjos-8668902	119	12	jaw	jaw	NOUN
bjos-8668902	119	13	bone	bone	NOUN
bjos-8668902	119	14	in	in	ADP
bjos-8668902	119	15	our	our	PRON
bjos-8668902	119	16	study	study	NOUN
bjos-8668902	119	17	.	.	PUNCT
bjos-8668902	120	1	interestingly	interestingly	ADV
bjos-8668902	120	2	1	1	NUM
bjos-8668902	120	3	case	case	NOUN
bjos-8668902	120	4	involving	involve	VERB
bjos-8668902	120	5	the	the	DET
bjos-8668902	120	6	mandible	mandible	NOUN
bjos-8668902	120	7	was	be	AUX
bjos-8668902	120	8	seen	see	VERB
bjos-8668902	120	9	,	,	PUNCT
bjos-8668902	120	10	although	although	SCONJ
bjos-8668902	120	11	in	in	ADP
bjos-8668902	120	12	bacterial	bacterial	ADJ
bjos-8668902	120	13	osteomyelitis	osteomyelitis	NOUN
bjos-8668902	120	14	,	,	PUNCT
bjos-8668902	120	15	the	the	DET
bjos-8668902	120	16	mandible	mandible	NOUN
bjos-8668902	120	17	is	be	AUX
bjos-8668902	120	18	most	most	ADV
bjos-8668902	120	19	common	common	ADJ
bjos-8668902	120	20	than	than	ADP
bjos-8668902	120	21	the	the	DET
bjos-8668902	120	22	maxilla20	maxilla20	NOUN
bjos-8668902	120	23	.	.	PUNCT
bjos-8668902	121	1	the	the	DET
bjos-8668902	121	2	most	most	ADV
bjos-8668902	121	3	common	common	ADJ
bjos-8668902	121	4	oral	oral	ADJ
bjos-8668902	121	5	manifestations	manifestation	NOUN
bjos-8668902	121	6	were	be	AUX
bjos-8668902	121	7	multiple	multiple	ADJ
bjos-8668902	121	8	periodontal	periodontal	ADJ
bjos-8668902	121	9	abscesses	abscess	NOUN
bjos-8668902	121	10	with	with	ADP
bjos-8668902	121	11	mobility	mobility	NOUN
bjos-8668902	121	12	(	(	PUNCT
bjos-8668902	121	13	50	50	NUM
bjos-8668902	121	14	%	%	NOUN
bjos-8668902	121	15	)	)	PUNCT
bjos-8668902	121	16	and	and	CCONJ
bjos-8668902	121	17	necrotic	necrotic	ADJ
bjos-8668902	121	18	bone	bone	NOUN
bjos-8668902	121	19	with	with	ADP
bjos-8668902	121	20	pus	pus	ADJ
bjos-8668902	121	21	discharge	discharge	NOUN
bjos-8668902	121	22	(	(	PUNCT
bjos-8668902	121	23	42.1	42.1	NUM
bjos-8668902	121	24	%	%	NOUN
bjos-8668902	121	25	)	)	PUNCT
bjos-8668902	121	26	followed	follow	VERB
bjos-8668902	121	27	by	by	ADP
bjos-8668902	121	28	extra	extra	ADJ
bjos-8668902	121	29	-	-	ADJ
bjos-8668902	121	30	oral	oral	ADJ
bjos-8668902	121	31	swelling	swelling	NOUN
bjos-8668902	121	32	with	with	ADP
bjos-8668902	121	33	necrotic	necrotic	ADJ
bjos-8668902	121	34	bone	bone	NOUN
bjos-8668902	121	35	(	(	PUNCT
bjos-8668902	121	36	7.89	7.89	NUM
bjos-8668902	121	37	%	%	NOUN
bjos-8668902	121	38	)	)	PUNCT
bjos-8668902	121	39	.	.	PUNCT
bjos-8668902	122	1	bacterial	bacterial	ADJ
bjos-8668902	122	2	osteomyelitis	osteomyelitis	NOUN
bjos-8668902	122	3	is	be	AUX
bjos-8668902	122	4	associated	associate	VERB
bjos-8668902	122	5	with	with	ADP
bjos-8668902	122	6	the	the	DET
bjos-8668902	122	7	symptoms	symptom	NOUN
bjos-8668902	122	8	of	of	ADP
bjos-8668902	122	9	localized	localized	ADJ
bjos-8668902	122	10	intense	intense	ADJ
bjos-8668902	122	11	pain	pain	NOUN
bjos-8668902	122	12	,	,	PUNCT
bjos-8668902	122	13	fever	fever	NOUN
bjos-8668902	122	14	,	,	PUNCT
bjos-8668902	122	15	tenderness	tenderness	NOUN
bjos-8668902	122	16	,	,	PUNCT
bjos-8668902	122	17	etc.21	etc.21	ADJ
bjos-8668902	122	18	although	although	SCONJ
bjos-8668902	122	19	in	in	ADP
bjos-8668902	122	20	the	the	DET
bjos-8668902	122	21	cases	case	NOUN
bjos-8668902	122	22	of	of	ADP
bjos-8668902	122	23	covid-19	covid-19	PROPN
bjos-8668902	122	24	-	-	PUNCT
bjos-8668902	122	25	associated	associate	VERB
bjos-8668902	122	26	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	122	27	mucormycosis	mucormycosis	NOUN
bjos-8668902	122	28	no	no	DET
bjos-8668902	122	29	such	such	ADJ
bjos-8668902	122	30	symptoms	symptom	NOUN
bjos-8668902	122	31	were	be	AUX
bjos-8668902	122	32	reported	report	VERB
bjos-8668902	122	33	by	by	ADP
bjos-8668902	122	34	the	the	DET
bjos-8668902	122	35	patients	patient	NOUN
bjos-8668902	122	36	.	.	PUNCT
bjos-8668902	123	1	on	on	ADP
bjos-8668902	123	2	radiographic	radiographic	ADJ
bjos-8668902	123	3	examination	examination	NOUN
bjos-8668902	123	4	,	,	PUNCT
bjos-8668902	123	5	the	the	DET
bjos-8668902	123	6	maxillary	maxillary	NOUN
bjos-8668902	123	7	sinus	sinus	NOUN
bjos-8668902	123	8	was	be	AUX
bjos-8668902	123	9	the	the	DET
bjos-8668902	123	10	most	most	ADV
bjos-8668902	123	11	commonly	commonly	ADV
bjos-8668902	123	12	involved	involve	VERB
bjos-8668902	123	13	.	.	PUNCT
bjos-8668902	124	1	bilateral	bilateral	ADJ
bjos-8668902	124	2	maxillary	maxillary	NOUN
bjos-8668902	124	3	sinus	sinus	NOUN
bjos-8668902	124	4	involvement	involvement	NOUN
bjos-8668902	124	5	(	(	PUNCT
bjos-8668902	124	6	37.3	37.3	NUM
bjos-8668902	124	7	%	%	NOUN
bjos-8668902	124	8	)	)	PUNCT
bjos-8668902	124	9	was	be	AUX
bjos-8668902	124	10	most	most	ADV
bjos-8668902	124	11	commonly	commonly	ADV
bjos-8668902	124	12	seen	see	VERB
bjos-8668902	124	13	followed	follow	VERB
bjos-8668902	124	14	by	by	ADP
bjos-8668902	124	15	right	right	ADJ
bjos-8668902	124	16	maxillary	maxillary	NOUN
bjos-8668902	124	17	sinus	sinus	NOUN
bjos-8668902	124	18	involvement	involvement	NOUN
bjos-8668902	124	19	(	(	PUNCT
bjos-8668902	124	20	36	36	NUM
bjos-8668902	124	21	%	%	NOUN
bjos-8668902	124	22	)	)	PUNCT
bjos-8668902	124	23	.	.	PUNCT
bjos-8668902	125	1	ethmoidal	ethmoidal	ADJ
bjos-8668902	125	2	sinus	sinus	NOUN
bjos-8668902	125	3	was	be	AUX
bjos-8668902	125	4	the	the	DET
bjos-8668902	125	5	second	second	ADJ
bjos-8668902	125	6	most	most	ADV
bjos-8668902	125	7	involved	involved	ADJ
bjos-8668902	125	8	paranasal	paranasal	ADJ
bjos-8668902	125	9	sinus	sinu	NOUN
bjos-8668902	125	10	.	.	PUNCT
bjos-8668902	126	1	orbital	orbital	ADJ
bjos-8668902	126	2	involvement	involvement	NOUN
bjos-8668902	126	3	was	be	AUX
bjos-8668902	126	4	found	find	VERB
bjos-8668902	126	5	in	in	ADP
bjos-8668902	126	6	advanced	advanced	ADJ
bjos-8668902	126	7	cases	case	NOUN
bjos-8668902	126	8	of	of	ADP
bjos-8668902	126	9	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	126	10	mucormycosis	mucormycosis	NOUN
bjos-8668902	126	11	.	.	PUNCT
bjos-8668902	127	1	other	other	ADJ
bjos-8668902	127	2	vital	vital	ADJ
bjos-8668902	127	3	structures	structure	NOUN
bjos-8668902	127	4	such	such	ADJ
bjos-8668902	127	5	as	as	ADP
bjos-8668902	127	6	infratemporal	infratemporal	ADJ
bjos-8668902	127	7	fossa	fossa	NOUN
bjos-8668902	127	8	,	,	PUNCT
bjos-8668902	127	9	pterygopalatine	pterygopalatine	ADJ
bjos-8668902	127	10	fossa	fossa	NOUN
bjos-8668902	127	11	,	,	PUNCT
bjos-8668902	127	12	sphenopalatine	sphenopalatine	ADJ
bjos-8668902	127	13	foramen	foraman	NOUN
bjos-8668902	127	14	,	,	PUNCT
bjos-8668902	127	15	ethmoid	ethmoid	NOUN
bjos-8668902	127	16	air	air	NOUN
bjos-8668902	127	17	cells	cell	NOUN
bjos-8668902	127	18	,	,	PUNCT
bjos-8668902	127	19	sphenoid	sphenoid	NOUN
bjos-8668902	127	20	bone	bone	NOUN
bjos-8668902	127	21	,	,	PUNCT
bjos-8668902	127	22	and	and	CCONJ
bjos-8668902	127	23	zygoma	zygoma	NOUN
bjos-8668902	127	24	were	be	AUX
bjos-8668902	127	25	seen	see	VERB
bjos-8668902	127	26	in	in	ADP
bjos-8668902	127	27	clinically	clinically	ADV
bjos-8668902	127	28	advanced	advanced	ADJ
bjos-8668902	127	29	cases	case	NOUN
bjos-8668902	127	30	.	.	PUNCT
bjos-8668902	128	1	this	this	PRON
bjos-8668902	128	2	is	be	AUX
bjos-8668902	128	3	the	the	DET
bjos-8668902	128	4	first	first	ADJ
bjos-8668902	128	5	study	study	NOUN
bjos-8668902	128	6	reporting	report	VERB
bjos-8668902	128	7	oral	oral	ADJ
bjos-8668902	128	8	manifestations	manifestation	NOUN
bjos-8668902	128	9	and	and	CCONJ
bjos-8668902	128	10	radiographic	radiographic	ADJ
bjos-8668902	128	11	findings	finding	NOUN
bjos-8668902	128	12	of	of	ADP
bjos-8668902	128	13	covid-19associated	covid-19associate	VERB
bjos-8668902	128	14	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	128	15	mucormycosis	mucormycosis	NOUN
bjos-8668902	128	16	.	.	PUNCT
bjos-8668902	129	1	functional	functional	ADJ
bjos-8668902	129	2	endoscopic	endoscopic	ADJ
bjos-8668902	129	3	sinus	sinus	NOUN
bjos-8668902	129	4	surgery	surgery	NOUN
bjos-8668902	129	5	under	under	ADP
bjos-8668902	129	6	9	9	NUM
bjos-8668902	129	7	ansari	ansari	X
bjos-8668902	129	8	et	et	PROPN
bjos-8668902	129	9	al	al	PROPN
bjos-8668902	129	10	.	.	PROPN
bjos-8668902	130	1	braz	braz	PROPN
bjos-8668902	130	2	j	j	PROPN
bjos-8668902	130	3	oral	oral	PROPN
bjos-8668902	130	4	sci	sci	PROPN
bjos-8668902	130	5	.	.	PUNCT
bjos-8668902	131	1	2023;22	2023;22	NUM
bjos-8668902	131	2	:	:	PUNCT
bjos-8668902	131	3	e238902	e238902	PROPN
bjos-8668902	131	4	general	general	ADJ
bjos-8668902	131	5	anesthesia	anesthesia	PROPN
bjos-8668902	131	6	(	(	PUNCT
bjos-8668902	131	7	fess	fess	NOUN
bjos-8668902	131	8	)	)	PUNCT
bjos-8668902	131	9	was	be	AUX
bjos-8668902	131	10	employed	employ	VERB
bjos-8668902	131	11	in	in	ADP
bjos-8668902	131	12	the	the	DET
bjos-8668902	131	13	majority	majority	NOUN
bjos-8668902	131	14	of	of	ADP
bjos-8668902	131	15	patients	patient	NOUN
bjos-8668902	131	16	reported	report	VERB
bjos-8668902	131	17	with	with	ADP
bjos-8668902	131	18	sinus	sinus	NOUN
bjos-8668902	131	19	involvement	involvement	NOUN
bjos-8668902	131	20	.	.	PUNCT
bjos-8668902	132	1	depending	depend	VERB
bjos-8668902	132	2	upon	upon	SCONJ
bjos-8668902	132	3	the	the	DET
bjos-8668902	132	4	area	area	NOUN
bjos-8668902	132	5	of	of	ADP
bjos-8668902	132	6	bone	bone	NOUN
bjos-8668902	132	7	involvement	involvement	NOUN
bjos-8668902	132	8	resection	resection	NOUN
bjos-8668902	132	9	of	of	ADP
bjos-8668902	132	10	jaw	jaw	NOUN
bjos-8668902	132	11	bone	bone	NOUN
bjos-8668902	132	12	was	be	AUX
bjos-8668902	132	13	done	do	VERB
bjos-8668902	132	14	.	.	PUNCT
bjos-8668902	133	1	due	due	ADP
bjos-8668902	133	2	to	to	ADP
bjos-8668902	133	3	resection	resection	NOUN
bjos-8668902	133	4	of	of	ADP
bjos-8668902	133	5	the	the	DET
bjos-8668902	133	6	bone	bone	NOUN
bjos-8668902	133	7	,	,	PUNCT
bjos-8668902	133	8	there	there	PRON
bjos-8668902	133	9	was	be	VERB
bjos-8668902	133	10	loss	loss	NOUN
bjos-8668902	133	11	of	of	ADP
bjos-8668902	133	12	a	a	DET
bjos-8668902	133	13	masticatory	masticatory	ADJ
bjos-8668902	133	14	function	function	NOUN
bjos-8668902	133	15	.	.	PUNCT
bjos-8668902	134	1	the	the	DET
bjos-8668902	134	2	mortality	mortality	NOUN
bjos-8668902	134	3	rate	rate	NOUN
bjos-8668902	134	4	observed	observe	VERB
bjos-8668902	134	5	was	be	AUX
bjos-8668902	134	6	1.31	1.31	NUM
bjos-8668902	134	7	%	%	NOUN
bjos-8668902	134	8	,	,	PUNCT
bjos-8668902	134	9	possibly	possibly	ADV
bjos-8668902	134	10	due	due	ADP
bjos-8668902	134	11	to	to	ADP
bjos-8668902	134	12	early	early	ADJ
bjos-8668902	134	13	diagnosis	diagnosis	NOUN
bjos-8668902	134	14	and	and	CCONJ
bjos-8668902	134	15	aggressive	aggressive	ADJ
bjos-8668902	134	16	treatment	treatment	NOUN
bjos-8668902	134	17	.	.	PUNCT
bjos-8668902	135	1	another	another	DET
bjos-8668902	135	2	interesting	interesting	ADJ
bjos-8668902	135	3	fact	fact	NOUN
bjos-8668902	135	4	is	be	AUX
bjos-8668902	135	5	that	that	SCONJ
bjos-8668902	135	6	the	the	DET
bjos-8668902	135	7	fatality	fatality	NOUN
bjos-8668902	135	8	rate	rate	NOUN
bjos-8668902	135	9	of	of	ADP
bjos-8668902	135	10	cases	case	NOUN
bjos-8668902	135	11	reported	report	VERB
bjos-8668902	135	12	from	from	ADP
bjos-8668902	135	13	india	india	PROPN
bjos-8668902	135	14	(	(	PUNCT
bjos-8668902	135	15	36.5	36.5	NUM
bjos-8668902	135	16	%	%	NOUN
bjos-8668902	135	17	)	)	PUNCT
bjos-8668902	135	18	is	be	AUX
bjos-8668902	135	19	less	less	ADJ
bjos-8668902	135	20	than	than	ADP
bjos-8668902	135	21	the	the	DET
bjos-8668902	135	22	globally	globally	ADV
bjos-8668902	135	23	reported	report	VERB
bjos-8668902	135	24	cases	case	NOUN
bjos-8668902	135	25	(	(	PUNCT
bjos-8668902	135	26	61.9	61.9	NUM
bjos-8668902	135	27	%	%	NOUN
bjos-8668902	135	28	)	)	PUNCT
bjos-8668902	135	29	this	this	PRON
bjos-8668902	135	30	might	might	AUX
bjos-8668902	135	31	be	be	AUX
bjos-8668902	135	32	due	due	ADJ
bjos-8668902	135	33	to	to	ADP
bjos-8668902	135	34	the	the	DET
bjos-8668902	135	35	predominance	predominance	NOUN
bjos-8668902	135	36	of	of	ADP
bjos-8668902	135	37	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	135	38	mucormycosis	mucormycosis	NOUN
bjos-8668902	135	39	type	type	NOUN
bjos-8668902	135	40	of	of	ADP
bjos-8668902	135	41	mucormycosis18	mucormycosis18	NOUN
bjos-8668902	135	42	.	.	PUNCT
bjos-8668902	136	1	the	the	DET
bjos-8668902	136	2	aggressive	aggressive	ADJ
bjos-8668902	136	3	nature	nature	NOUN
bjos-8668902	136	4	of	of	ADP
bjos-8668902	136	5	mucor	mucor	NOUN
bjos-8668902	136	6	species	specie	NOUN
bjos-8668902	136	7	and	and	CCONJ
bjos-8668902	136	8	mucormycosis	mucormycosis	NOUN
bjos-8668902	136	9	warrants	warrant	NOUN
bjos-8668902	136	10	attention	attention	NOUN
bjos-8668902	136	11	.	.	PUNCT
bjos-8668902	137	1	dentists	dentist	NOUN
bjos-8668902	137	2	should	should	AUX
bjos-8668902	137	3	be	be	AUX
bjos-8668902	137	4	able	able	ADJ
bjos-8668902	137	5	to	to	PART
bjos-8668902	137	6	identify	identify	VERB
bjos-8668902	137	7	the	the	DET
bjos-8668902	137	8	early	early	ADJ
bjos-8668902	137	9	signs	sign	NOUN
bjos-8668902	137	10	of	of	ADP
bjos-8668902	137	11	mucormycosis	mucormycosis	NOUN
bjos-8668902	137	12	so	so	SCONJ
bjos-8668902	137	13	that	that	SCONJ
bjos-8668902	137	14	early	early	ADJ
bjos-8668902	137	15	treatment	treatment	NOUN
bjos-8668902	137	16	is	be	AUX
bjos-8668902	137	17	instituted	institute	VERB
bjos-8668902	137	18	thereby	thereby	ADV
bjos-8668902	137	19	reducing	reduce	VERB
bjos-8668902	137	20	morbidity	morbidity	NOUN
bjos-8668902	137	21	and	and	CCONJ
bjos-8668902	137	22	mortality	mortality	NOUN
bjos-8668902	137	23	.	.	PUNCT
bjos-8668902	138	1	delay	delay	NOUN
bjos-8668902	138	2	in	in	ADP
bjos-8668902	138	3	the	the	DET
bjos-8668902	138	4	diagnosis	diagnosis	NOUN
bjos-8668902	138	5	of	of	ADP
bjos-8668902	138	6	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	138	7	mucormycosis	mucormycosis	NOUN
bjos-8668902	138	8	has	have	AUX
bjos-8668902	138	9	led	lead	VERB
bjos-8668902	138	10	to	to	ADP
bjos-8668902	138	11	many	many	ADJ
bjos-8668902	138	12	patients	patient	NOUN
bjos-8668902	138	13	becoming	become	VERB
bjos-8668902	138	14	severely	severely	ADV
bjos-8668902	138	15	disfigured19,22	disfigured19,22	X
bjos-8668902	138	16	.	.	PUNCT
bjos-8668902	139	1	the	the	DET
bjos-8668902	139	2	increase	increase	NOUN
bjos-8668902	139	3	in	in	ADP
bjos-8668902	139	4	mucormycosis	mucormycosis	NOUN
bjos-8668902	139	5	cases	case	NOUN
bjos-8668902	139	6	in	in	ADP
bjos-8668902	139	7	the	the	DET
bjos-8668902	139	8	indian	indian	ADJ
bjos-8668902	139	9	context	context	NOUN
bjos-8668902	139	10	appears	appear	VERB
bjos-8668902	139	11	to	to	PART
bjos-8668902	139	12	be	be	AUX
bjos-8668902	139	13	due	due	ADJ
bjos-8668902	139	14	to	to	ADP
bjos-8668902	139	15	diabetes	diabetes	NOUN
bjos-8668902	139	16	(	(	PUNCT
bjos-8668902	139	17	high	high	ADJ
bjos-8668902	139	18	prevalence	prevalence	NOUN
bjos-8668902	139	19	genetically	genetically	ADV
bjos-8668902	139	20	)	)	PUNCT
bjos-8668902	139	21	.	.	PUNCT
bjos-8668902	140	1	rampant	rampant	ADJ
bjos-8668902	140	2	use	use	NOUN
bjos-8668902	140	3	of	of	ADP
bjos-8668902	140	4	corticosteroids	corticosteroid	NOUN
bjos-8668902	140	5	in	in	ADP
bjos-8668902	140	6	covid-19	covid-19	PROPN
bjos-8668902	140	7	was	be	AUX
bjos-8668902	140	8	reported	report	VERB
bjos-8668902	140	9	in	in	ADP
bjos-8668902	140	10	many	many	ADJ
bjos-8668902	140	11	studies	study	NOUN
bjos-8668902	140	12	.	.	PUNCT
bjos-8668902	141	1	corticosteorids	corticosteorid	NOUN
bjos-8668902	141	2	lead	lead	VERB
bjos-8668902	141	3	to	to	ADP
bjos-8668902	141	4	an	an	DET
bjos-8668902	141	5	increase	increase	NOUN
bjos-8668902	141	6	in	in	ADP
bjos-8668902	141	7	blood	blood	NOUN
bjos-8668902	141	8	glucose	glucose	NOUN
bjos-8668902	141	9	and	and	CCONJ
bjos-8668902	141	10	consequently	consequently	ADV
bjos-8668902	141	11	increase	increase	VERB
bjos-8668902	141	12	the	the	DET
bjos-8668902	141	13	chances	chance	NOUN
bjos-8668902	141	14	of	of	ADP
bjos-8668902	141	15	developing	develop	VERB
bjos-8668902	141	16	opportunistic	opportunistic	ADJ
bjos-8668902	141	17	fungal	fungal	ADJ
bjos-8668902	141	18	infection	infection	NOUN
bjos-8668902	141	19	.	.	PUNCT
bjos-8668902	142	1	covid-19	covid-19	PROPN
bjos-8668902	142	2	leads	lead	VERB
bjos-8668902	142	3	to	to	ADP
bjos-8668902	142	4	reduced	reduced	ADJ
bjos-8668902	142	5	immune	immune	ADJ
bjos-8668902	142	6	functions	function	NOUN
bjos-8668902	142	7	due	due	ADP
bjos-8668902	142	8	to	to	ADP
bjos-8668902	142	9	cytokine	cytokine	ADJ
bjos-8668902	142	10	storm	storm	NOUN
bjos-8668902	142	11	,	,	PUNCT
bjos-8668902	142	12	lymphopenia	lymphopenia	NOUN
bjos-8668902	142	13	,	,	PUNCT
bjos-8668902	142	14	and	and	CCONJ
bjos-8668902	142	15	endothelial	endothelial	ADJ
bjos-8668902	142	16	damage	damage	NOUN
bjos-8668902	142	17	.	.	PUNCT
bjos-8668902	143	1	the	the	DET
bjos-8668902	143	2	combined	combined	ADJ
bjos-8668902	143	3	damaging	damaging	ADJ
bjos-8668902	143	4	effects	effect	NOUN
bjos-8668902	143	5	of	of	ADP
bjos-8668902	143	6	corticosteroid	corticosteroid	NOUN
bjos-8668902	143	7	therapy	therapy	NOUN
bjos-8668902	143	8	and	and	CCONJ
bjos-8668902	143	9	sars	sars	PROPN
bjos-8668902	143	10	-	-	PUNCT
bjos-8668902	143	11	cov	cov	NOUN
bjos-8668902	143	12	2	2	NUM
bjos-8668902	143	13	virus	virus	NOUN
bjos-8668902	143	14	seem	seem	VERB
bjos-8668902	143	15	to	to	PART
bjos-8668902	143	16	have	have	AUX
bjos-8668902	143	17	led	lead	VERB
bjos-8668902	143	18	to	to	ADP
bjos-8668902	143	19	a	a	DET
bjos-8668902	143	20	high	high	ADJ
bjos-8668902	143	21	prevalence	prevalence	NOUN
bjos-8668902	143	22	of	of	ADP
bjos-8668902	143	23	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	143	24	mucormycosis23	mucormycosis23	NOUN
bjos-8668902	143	25	.	.	PUNCT
bjos-8668902	144	1	all	all	DET
bjos-8668902	144	2	efforts	effort	NOUN
bjos-8668902	144	3	should	should	AUX
bjos-8668902	144	4	be	be	AUX
bjos-8668902	144	5	made	make	VERB
bjos-8668902	144	6	to	to	PART
bjos-8668902	144	7	maintain	maintain	VERB
bjos-8668902	144	8	optimal	optimal	ADJ
bjos-8668902	144	9	hyperglycaemia	hyperglycaemia	NOUN
bjos-8668902	144	10	and	and	CCONJ
bjos-8668902	144	11	only	only	ADV
bjos-8668902	144	12	judicious	judicious	ADJ
bjos-8668902	144	13	evidence	evidence	NOUN
bjos-8668902	144	14	-	-	PUNCT
bjos-8668902	144	15	based	base	VERB
bjos-8668902	144	16	use	use	NOUN
bjos-8668902	144	17	of	of	ADP
bjos-8668902	144	18	corticosteroids	corticosteroid	NOUN
bjos-8668902	144	19	in	in	ADP
bjos-8668902	144	20	patients	patient	NOUN
bjos-8668902	144	21	with	with	ADP
bjos-8668902	144	22	covid-19	covid-19	PROPN
bjos-8668902	144	23	is	be	AUX
bjos-8668902	144	24	recommended	recommend	VERB
bjos-8668902	144	25	to	to	PART
bjos-8668902	144	26	reduce	reduce	VERB
bjos-8668902	144	27	the	the	DET
bjos-8668902	144	28	burden	burden	NOUN
bjos-8668902	144	29	of	of	ADP
bjos-8668902	144	30	fatal	fatal	ADJ
bjos-8668902	144	31	mucormycosis23	mucormycosis23	NOUN
bjos-8668902	144	32	.	.	PUNCT
bjos-8668902	145	1	oral	oral	ADJ
bjos-8668902	145	2	manifestations	manifestation	NOUN
bjos-8668902	145	3	of	of	ADP
bjos-8668902	145	4	mucormycosis	mucormycosis	NOUN
bjos-8668902	145	5	in	in	ADP
bjos-8668902	145	6	covid-19	covid-19	PROPN
bjos-8668902	145	7	patients	patient	NOUN
bjos-8668902	145	8	are	be	AUX
bjos-8668902	145	9	frequently	frequently	ADV
bjos-8668902	145	10	seen	see	VERB
bjos-8668902	145	11	in	in	ADP
bjos-8668902	145	12	the	the	DET
bjos-8668902	145	13	palate	palate	NOUN
bjos-8668902	145	14	and	and	CCONJ
bjos-8668902	145	15	may	may	AUX
bjos-8668902	145	16	include	include	VERB
bjos-8668902	145	17	varying	vary	VERB
bjos-8668902	145	18	degrees	degree	NOUN
bjos-8668902	145	19	of	of	ADP
bjos-8668902	145	20	mucosal	mucosal	NOUN
bjos-8668902	145	21	discoloration	discoloration	NOUN
bjos-8668902	145	22	,	,	PUNCT
bjos-8668902	145	23	swelling	swelling	NOUN
bjos-8668902	145	24	,	,	PUNCT
bjos-8668902	145	25	ulcerations	ulceration	NOUN
bjos-8668902	145	26	,	,	PUNCT
bjos-8668902	145	27	and	and	CCONJ
bjos-8668902	145	28	superficial	superficial	ADJ
bjos-8668902	145	29	necrotic	necrotic	ADJ
bjos-8668902	145	30	areas	area	NOUN
bjos-8668902	145	31	involving	involve	VERB
bjos-8668902	145	32	the	the	DET
bjos-8668902	145	33	palate	palate	NOUN
bjos-8668902	145	34	(	(	PUNCT
bjos-8668902	145	35	figure	figure	NOUN
bjos-8668902	145	36	1	1	NUM
bjos-8668902	145	37	)	)	PUNCT
bjos-8668902	145	38	,	,	PUNCT
bjos-8668902	145	39	tooth	tooth	NOUN
bjos-8668902	145	40	mobility	mobility	NOUN
bjos-8668902	145	41	,	,	PUNCT
bjos-8668902	145	42	multiple	multiple	ADJ
bjos-8668902	145	43	periodontal	periodontal	ADJ
bjos-8668902	145	44	abscess	abscess	NOUN
bjos-8668902	145	45	,	,	PUNCT
bjos-8668902	145	46	bone	bone	NOUN
bjos-8668902	145	47	necrosis	necrosis	NOUN
bjos-8668902	145	48	and	and	CCONJ
bjos-8668902	145	49	exposure	exposure	NOUN
bjos-8668902	145	50	with	with	ADP
bjos-8668902	145	51	dark	dark	ADJ
bjos-8668902	145	52	eschar	eschar	PROPN
bjos-8668902	145	53	formation24	formation24	PROPN
bjos-8668902	145	54	.	.	PUNCT
bjos-8668902	146	1	hence	hence	ADV
bjos-8668902	146	2	,	,	PUNCT
bjos-8668902	146	3	palatal	palatal	ADJ
bjos-8668902	146	4	ulcerations	ulceration	NOUN
bjos-8668902	146	5	could	could	AUX
bjos-8668902	146	6	be	be	AUX
bjos-8668902	146	7	the	the	DET
bjos-8668902	146	8	primary	primary	ADJ
bjos-8668902	146	9	presenting	present	VERB
bjos-8668902	146	10	symptom	symptom	NOUN
bjos-8668902	146	11	,	,	PUNCT
bjos-8668902	146	12	leading	lead	VERB
bjos-8668902	146	13	the	the	DET
bjos-8668902	146	14	patient	patient	NOUN
bjos-8668902	146	15	to	to	ADP
bjos-8668902	146	16	the	the	DET
bjos-8668902	146	17	dentist	dentist	NOUN
bjos-8668902	146	18	,	,	PUNCT
bjos-8668902	146	19	who	who	PRON
bjos-8668902	146	20	can	can	AUX
bjos-8668902	146	21	be	be	AUX
bjos-8668902	146	22	the	the	DET
bjos-8668902	146	23	first	first	ADJ
bjos-8668902	146	24	clinician	clinician	NOUN
bjos-8668902	146	25	to	to	PART
bjos-8668902	146	26	recognize	recognize	VERB
bjos-8668902	146	27	an	an	DET
bjos-8668902	146	28	infection	infection	NOUN
bjos-8668902	146	29	leading	lead	VERB
bjos-8668902	146	30	to	to	ADP
bjos-8668902	146	31	the	the	DET
bjos-8668902	146	32	diagnosis	diagnosis	NOUN
bjos-8668902	146	33	of	of	ADP
bjos-8668902	146	34	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	146	35	mucormycosis25	mucormycosis25	NOUN
bjos-8668902	146	36	.	.	PUNCT
bjos-8668902	147	1	therefore	therefore	ADV
bjos-8668902	147	2	,	,	PUNCT
bjos-8668902	147	3	a	a	DET
bjos-8668902	147	4	non	non	ADJ
bjos-8668902	147	5	-	-	ADJ
bjos-8668902	147	6	specific	specific	ADJ
bjos-8668902	147	7	palatal	palatal	ADJ
bjos-8668902	147	8	ulcer	ulcer	NOUN
bjos-8668902	147	9	can	can	AUX
bjos-8668902	147	10	be	be	AUX
bjos-8668902	147	11	considered	consider	VERB
bjos-8668902	147	12	as	as	ADP
bjos-8668902	147	13	the	the	DET
bjos-8668902	147	14	presenting	presenting	NOUN
bjos-8668902	147	15	sign	sign	NOUN
bjos-8668902	147	16	of	of	ADP
bjos-8668902	147	17	mucormycosis	mucormycosis	NOUN
bjos-8668902	147	18	,	,	PUNCT
bjos-8668902	147	19	and	and	CCONJ
bjos-8668902	147	20	a	a	DET
bjos-8668902	147	21	dental	dental	ADJ
bjos-8668902	147	22	practitioner	practitioner	NOUN
bjos-8668902	147	23	must	must	AUX
bjos-8668902	147	24	be	be	AUX
bjos-8668902	147	25	alert	alert	ADJ
bjos-8668902	147	26	to	to	ADP
bjos-8668902	147	27	initial	initial	ADJ
bjos-8668902	147	28	signs	sign	NOUN
bjos-8668902	147	29	and	and	CCONJ
bjos-8668902	147	30	symptoms	symptom	NOUN
bjos-8668902	147	31	of	of	ADP
bjos-8668902	147	32	this	this	DET
bjos-8668902	147	33	disease	disease	NOUN
bjos-8668902	147	34	,	,	PUNCT
bjos-8668902	147	35	specifically	specifically	ADV
bjos-8668902	147	36	when	when	SCONJ
bjos-8668902	147	37	evaluating	evaluate	VERB
bjos-8668902	147	38	the	the	DET
bjos-8668902	147	39	high	high	ADJ
bjos-8668902	147	40	-	-	PUNCT
bjos-8668902	147	41	risk	risk	NOUN
bjos-8668902	147	42	patients	patient	NOUN
bjos-8668902	147	43	.	.	PUNCT
bjos-8668902	148	1	early	early	ADJ
bjos-8668902	148	2	diagnosis	diagnosis	NOUN
bjos-8668902	148	3	of	of	ADP
bjos-8668902	148	4	mucormycosis	mucormycosis	NOUN
bjos-8668902	148	5	is	be	AUX
bjos-8668902	148	6	critical	critical	ADJ
bjos-8668902	148	7	,	,	PUNCT
bjos-8668902	148	8	as	as	SCONJ
bjos-8668902	148	9	treatment	treatment	NOUN
bjos-8668902	148	10	should	should	AUX
bjos-8668902	148	11	start	start	VERB
bjos-8668902	148	12	as	as	ADV
bjos-8668902	148	13	soon	soon	ADV
bjos-8668902	148	14	as	as	ADP
bjos-8668902	148	15	possible	possible	ADJ
bjos-8668902	148	16	in	in	ADP
bjos-8668902	148	17	an	an	DET
bjos-8668902	148	18	attempt	attempt	NOUN
bjos-8668902	148	19	to	to	PART
bjos-8668902	148	20	decrease	decrease	VERB
bjos-8668902	148	21	mortality26	mortality26	NOUN
bjos-8668902	148	22	.	.	PUNCT
bjos-8668902	149	1	the	the	DET
bjos-8668902	149	2	role	role	NOUN
bjos-8668902	149	3	of	of	ADP
bjos-8668902	149	4	dentists	dentist	NOUN
bjos-8668902	149	5	is	be	AUX
bjos-8668902	149	6	critical	critical	ADJ
bjos-8668902	149	7	because	because	SCONJ
bjos-8668902	149	8	mucormycosis	mucormycosis	NOUN
bjos-8668902	149	9	primarily	primarily	ADV
bjos-8668902	149	10	occurs	occur	VERB
bjos-8668902	149	11	around	around	ADP
bjos-8668902	149	12	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	149	13	or	or	CCONJ
bjos-8668902	149	14	rhinocerebral	rhinocerebral	ADJ
bjos-8668902	149	15	areas	area	NOUN
bjos-8668902	149	16	involving	involve	VERB
bjos-8668902	149	17	facial	facial	ADJ
bjos-8668902	149	18	tissues	tissue	NOUN
bjos-8668902	149	19	,	,	PUNCT
bjos-8668902	149	20	palate	palate	VERB
bjos-8668902	149	21	,	,	PUNCT
bjos-8668902	149	22	alveolar	alveolar	ADJ
bjos-8668902	149	23	bone	bone	NOUN
bjos-8668902	149	24	,	,	PUNCT
bjos-8668902	149	25	and	and	CCONJ
bjos-8668902	149	26	mandibular	mandibular	ADJ
bjos-8668902	149	27	bone	bone	NOUN
bjos-8668902	149	28	.	.	PUNCT
bjos-8668902	150	1	therefore	therefore	ADV
bjos-8668902	150	2	,	,	PUNCT
bjos-8668902	150	3	dental	dental	ADJ
bjos-8668902	150	4	professionals	professional	NOUN
bjos-8668902	150	5	should	should	AUX
bjos-8668902	150	6	be	be	AUX
bjos-8668902	150	7	alert	alert	ADJ
bjos-8668902	150	8	of	of	ADP
bjos-8668902	150	9	symptoms	symptom	NOUN
bjos-8668902	150	10	of	of	ADP
bjos-8668902	150	11	mucormycosis	mucormycosis	NOUN
bjos-8668902	150	12	.	.	PUNCT
bjos-8668902	151	1	in	in	ADP
bjos-8668902	151	2	addition	addition	NOUN
bjos-8668902	151	3	to	to	ADP
bjos-8668902	151	4	palatal	palatal	ADJ
bjos-8668902	151	5	lesions	lesion	NOUN
bjos-8668902	151	6	,	,	PUNCT
bjos-8668902	151	7	atypical	atypical	ADJ
bjos-8668902	151	8	symptoms	symptom	NOUN
bjos-8668902	151	9	such	such	ADJ
bjos-8668902	151	10	as	as	ADP
bjos-8668902	151	11	sinus	sinus	NOUN
bjos-8668902	151	12	pain	pain	NOUN
bjos-8668902	151	13	,	,	PUNCT
bjos-8668902	151	14	facial	facial	ADJ
bjos-8668902	151	15	pain	pain	NOUN
bjos-8668902	151	16	,	,	PUNCT
bjos-8668902	151	17	unanticipated	unanticipated	ADJ
bjos-8668902	151	18	odontalgia	odontalgia	NOUN
bjos-8668902	151	19	of	of	ADP
bjos-8668902	151	20	otherwise	otherwise	ADV
bjos-8668902	151	21	sound	sound	ADJ
bjos-8668902	151	22	teeth	tooth	NOUN
bjos-8668902	151	23	,	,	PUNCT
bjos-8668902	151	24	or	or	CCONJ
bjos-8668902	151	25	patient	patient	ADJ
bjos-8668902	151	26	deterioration	deterioration	NOUN
bjos-8668902	151	27	after	after	ADP
bjos-8668902	151	28	dental	dental	ADJ
bjos-8668902	151	29	therapeutic	therapeutic	ADJ
bjos-8668902	151	30	interventions	intervention	NOUN
bjos-8668902	151	31	should	should	AUX
bjos-8668902	151	32	alert	alert	VERB
bjos-8668902	151	33	clinicians	clinician	NOUN
bjos-8668902	151	34	to	to	PART
bjos-8668902	151	35	seek	seek	VERB
bjos-8668902	151	36	confirmation	confirmation	NOUN
bjos-8668902	151	37	of	of	ADP
bjos-8668902	151	38	the	the	DET
bjos-8668902	151	39	diagnosis	diagnosis	NOUN
bjos-8668902	151	40	and	and	CCONJ
bjos-8668902	151	41	promptly	promptly	ADV
bjos-8668902	151	42	start	start	VERB
bjos-8668902	151	43	optimal	optimal	ADJ
bjos-8668902	151	44	treatment27	treatment27	NOUN
bjos-8668902	151	45	.	.	PUNCT
bjos-8668902	152	1	limitations	limitation	NOUN
bjos-8668902	152	2	we	we	PRON
bjos-8668902	152	3	could	could	AUX
bjos-8668902	152	4	not	not	PART
bjos-8668902	152	5	assess	assess	VERB
bjos-8668902	152	6	the	the	DET
bjos-8668902	152	7	prevalence	prevalence	NOUN
bjos-8668902	152	8	of	of	ADP
bjos-8668902	152	9	covid-19	covid-19	PROPN
bjos-8668902	152	10	associated	associated	ADJ
bjos-8668902	152	11	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	152	12	mucormycosis	mucormycosis	NOUN
bjos-8668902	152	13	as	as	SCONJ
bjos-8668902	152	14	this	this	PRON
bjos-8668902	152	15	is	be	AUX
bjos-8668902	152	16	a	a	DET
bjos-8668902	152	17	single	single	ADJ
bjos-8668902	152	18	-	-	PUNCT
bjos-8668902	152	19	center	center	NOUN
bjos-8668902	152	20	study	study	NOUN
bjos-8668902	152	21	conducted	conduct	VERB
bjos-8668902	152	22	in	in	ADP
bjos-8668902	152	23	a	a	DET
bjos-8668902	152	24	dental	dental	ADJ
bjos-8668902	152	25	opd	opd	NOUN
bjos-8668902	152	26	in	in	ADP
bjos-8668902	152	27	india	india	PROPN
bjos-8668902	152	28	.	.	PUNCT
bjos-8668902	153	1	10	10	NUM
bjos-8668902	153	2	ansari	ansari	PROPN
bjos-8668902	153	3	et	et	PROPN
bjos-8668902	153	4	al	al	PROPN
bjos-8668902	153	5	.	.	PROPN
bjos-8668902	153	6	braz	braz	PROPN
bjos-8668902	153	7	j	j	PROPN
bjos-8668902	153	8	oral	oral	PROPN
bjos-8668902	153	9	sci	sci	PROPN
bjos-8668902	153	10	.	.	PUNCT
bjos-8668902	154	1	2023;22	2023;22	NUM
bjos-8668902	154	2	:	:	PUNCT
bjos-8668902	154	3	e238902	e238902	X
bjos-8668902	154	4	in	in	ADP
bjos-8668902	154	5	conclusion	conclusion	NOUN
bjos-8668902	154	6	,	,	PUNCT
bjos-8668902	154	7	this	this	DET
bjos-8668902	154	8	single	single	ADJ
bjos-8668902	154	9	-	-	PUNCT
bjos-8668902	154	10	center	center	NOUN
bjos-8668902	154	11	observational	observational	ADJ
bjos-8668902	154	12	study	study	NOUN
bjos-8668902	154	13	from	from	ADP
bjos-8668902	154	14	india	india	PROPN
bjos-8668902	154	15	found	find	VERB
bjos-8668902	154	16	a	a	DET
bjos-8668902	154	17	higher	high	ADJ
bjos-8668902	154	18	prevalence	prevalence	NOUN
bjos-8668902	154	19	of	of	ADP
bjos-8668902	154	20	diabetes	diabetes	NOUN
bjos-8668902	154	21	mellitus	mellitus	NOUN
bjos-8668902	154	22	and	and	CCONJ
bjos-8668902	154	23	steroid	steroid	PROPN
bjos-8668902	154	24	administration	administration	NOUN
bjos-8668902	154	25	in	in	ADP
bjos-8668902	154	26	covid-19	covid-19	PROPN
bjos-8668902	154	27	-	-	PUNCT
bjos-8668902	154	28	associated	associate	VERB
bjos-8668902	154	29	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	154	30	mucormycosis	mucormycosis	NOUN
bjos-8668902	154	31	.	.	PUNCT
bjos-8668902	155	1	maxillary	maxillary	NOUN
bjos-8668902	155	2	sinus	sinus	NOUN
bjos-8668902	155	3	was	be	AUX
bjos-8668902	155	4	most	most	ADV
bjos-8668902	155	5	commonly	commonly	ADV
bjos-8668902	155	6	involved	involve	VERB
bjos-8668902	155	7	in	in	ADP
bjos-8668902	155	8	the	the	DET
bjos-8668902	155	9	paranasal	paranasal	ADJ
bjos-8668902	155	10	sinus	sinu	NOUN
bjos-8668902	155	11	.	.	PUNCT
bjos-8668902	156	1	many	many	ADJ
bjos-8668902	156	2	patients	patient	NOUN
bjos-8668902	156	3	presented	present	VERB
bjos-8668902	156	4	with	with	ADP
bjos-8668902	156	5	aggressive	aggressive	ADJ
bjos-8668902	156	6	periodontal	periodontal	ADJ
bjos-8668902	156	7	disease	disease	NOUN
bjos-8668902	156	8	.	.	PUNCT
bjos-8668902	157	1	in	in	ADP
bjos-8668902	157	2	the	the	DET
bjos-8668902	157	3	era	era	NOUN
bjos-8668902	157	4	of	of	ADP
bjos-8668902	157	5	the	the	DET
bjos-8668902	157	6	covid	covid	PROPN
bjos-8668902	157	7	-19	-19	PUNCT
bjos-8668902	157	8	pandemic	pandemic	ADJ
bjos-8668902	157	9	,	,	PUNCT
bjos-8668902	157	10	any	any	DET
bjos-8668902	157	11	patient	patient	NOUN
bjos-8668902	157	12	who	who	PRON
bjos-8668902	157	13	presents	present	VERB
bjos-8668902	157	14	with	with	ADP
bjos-8668902	157	15	aggressive	aggressive	ADJ
bjos-8668902	157	16	periodontal	periodontal	ADJ
bjos-8668902	157	17	disease	disease	NOUN
bjos-8668902	157	18	and	and	CCONJ
bjos-8668902	157	19	palatal	palatal	ADJ
bjos-8668902	157	20	ulcerations	ulceration	NOUN
bjos-8668902	157	21	should	should	AUX
bjos-8668902	157	22	be	be	AUX
bjos-8668902	157	23	investigated	investigate	VERB
bjos-8668902	157	24	for	for	ADP
bjos-8668902	157	25	mucormycosis	mucormycosis	NOUN
bjos-8668902	157	26	.	.	PUNCT
bjos-8668902	158	1	conflict	conflict	NOUN
bjos-8668902	158	2	of	of	ADP
bjos-8668902	158	3	interest	interest	NOUN
bjos-8668902	158	4	authors	author	NOUN
bjos-8668902	158	5	declare	declare	VERB
bjos-8668902	158	6	no	no	DET
bjos-8668902	158	7	conflict	conflict	NOUN
bjos-8668902	158	8	of	of	ADP
bjos-8668902	158	9	interest	interest	NOUN
bjos-8668902	158	10	.	.	PUNCT
bjos-8668902	159	1	this	this	DET
bjos-8668902	159	2	study	study	NOUN
bjos-8668902	159	3	is	be	AUX
bjos-8668902	159	4	self	self	NOUN
bjos-8668902	159	5	-	-	PUNCT
bjos-8668902	159	6	funded	fund	VERB
bjos-8668902	159	7	.	.	PUNCT
bjos-8668902	160	1	ethics	ethic	NOUN
bjos-8668902	160	2	obtained	obtain	VERB
bjos-8668902	160	3	ethical	ethical	ADJ
bjos-8668902	160	4	clearance	clearance	NOUN
bjos-8668902	160	5	from	from	ADP
bjos-8668902	160	6	the	the	DET
bjos-8668902	160	7	institutional	institutional	ADJ
bjos-8668902	160	8	ethical	ethical	ADJ
bjos-8668902	160	9	committee	committee	NOUN
bjos-8668902	160	10	.	.	PUNCT
bjos-8668902	161	1	ethical	ethical	ADJ
bjos-8668902	161	2	clearance	clearance	NOUN
bjos-8668902	161	3	no	no	INTJ
bjos-8668902	161	4	:	:	PUNCT
bjos-8668902	161	5	1382	1382	NUM
bjos-8668902	161	6	source	source	NOUN
bjos-8668902	161	7	of	of	ADP
bjos-8668902	161	8	funding	fund	VERB
bjos-8668902	161	9	self	self	NOUN
bjos-8668902	161	10	-	-	PUNCT
bjos-8668902	161	11	funded	fund	VERB
bjos-8668902	161	12	.	.	PUNCT
bjos-8668902	162	1	author	author	NOUN
bjos-8668902	162	2	contribution	contribution	NOUN
bjos-8668902	162	3	1	1	NUM
bjos-8668902	162	4	)	)	PUNCT
bjos-8668902	162	5	dr	dr	PROPN
bjos-8668902	162	6	.	.	PROPN
bjos-8668902	162	7	sulem	sulem	PROPN
bjos-8668902	162	8	ansari	ansari	PROPN
bjos-8668902	162	9	1	1	NUM
bjos-8668902	162	10	*	*	NOUN
bjos-8668902	162	11	study	study	NOUN
bjos-8668902	162	12	design	design	NOUN
bjos-8668902	162	13	,	,	PUNCT
bjos-8668902	162	14	collection	collection	NOUN
bjos-8668902	162	15	of	of	ADP
bjos-8668902	162	16	data	datum	NOUN
bjos-8668902	162	17	,	,	PUNCT
bjos-8668902	162	18	interpretation	interpretation	NOUN
bjos-8668902	162	19	of	of	ADP
bjos-8668902	162	20	ct	ct	PROPN
bjos-8668902	162	21	scans	scan	NOUN
bjos-8668902	162	22	,	,	PUNCT
bjos-8668902	162	23	statistical	statistical	ADJ
bjos-8668902	162	24	analysis	analysis	NOUN
bjos-8668902	162	25	2	2	NUM
bjos-8668902	162	26	)	)	PUNCT
bjos-8668902	162	27	dr	dr	PROPN
bjos-8668902	162	28	.	.	PROPN
bjos-8668902	162	29	shivayogi	shivayogi	PROPN
bjos-8668902	162	30	charantimath	charantimath	VERB
bjos-8668902	162	31	2	2	NUM
bjos-8668902	162	32	–	–	PUNCT
bjos-8668902	162	33	interpretation	interpretation	NOUN
bjos-8668902	162	34	of	of	ADP
bjos-8668902	162	35	ct	ct	PROPN
bjos-8668902	162	36	scans	scan	NOUN
bjos-8668902	162	37	3	3	NUM
bjos-8668902	162	38	)	)	PUNCT
bjos-8668902	162	39	dr	dr	PROPN
bjos-8668902	162	40	.	.	PROPN
bjos-8668902	162	41	vasanti	vasanti	PROPN
bjos-8668902	162	42	jirge	jirge	NOUN
bjos-8668902	162	43	3	3	NUM
bjos-8668902	162	44	–	–	PUNCT
bjos-8668902	162	45	study	study	NOUN
bjos-8668902	162	46	design	design	NOUN
bjos-8668902	162	47	,	,	PUNCT
bjos-8668902	162	48	editing	editing	NOUN
bjos-8668902	162	49	of	of	ADP
bjos-8668902	162	50	the	the	DET
bjos-8668902	162	51	manuscript	manuscript	NOUN
bjos-8668902	162	52	4	4	NUM
bjos-8668902	162	53	)	)	PUNCT
bjos-8668902	162	54	dr	dr	PROPN
bjos-8668902	162	55	.	.	PROPN
bjos-8668902	162	56	vaishali	vaishali	PROPN
bjos-8668902	162	57	keluskar	keluskar	PROPN
bjos-8668902	162	58	4	4	NUM
bjos-8668902	162	59	–	–	PUNCT
bjos-8668902	162	60	final	final	ADJ
bjos-8668902	162	61	editing	editing	NOUN
bjos-8668902	162	62	of	of	ADP
bjos-8668902	162	63	the	the	DET
bjos-8668902	162	64	manuscript	manuscript	NOUN
bjos-8668902	162	65	all	all	DET
bjos-8668902	162	66	authors	author	NOUN
bjos-8668902	162	67	have	have	AUX
bjos-8668902	162	68	revised	revise	VERB
bjos-8668902	162	69	and	and	CCONJ
bjos-8668902	162	70	approved	approve	VERB
bjos-8668902	162	71	the	the	DET
bjos-8668902	162	72	final	final	ADJ
bjos-8668902	162	73	version	version	NOUN
bjos-8668902	162	74	of	of	ADP
bjos-8668902	162	75	the	the	DET
bjos-8668902	162	76	manuscript	manuscript	NOUN
bjos-8668902	162	77	.	.	PUNCT
bjos-8668902	163	1	data	datum	NOUN
bjos-8668902	163	2	availability	availability	NOUN
bjos-8668902	163	3	datasets	dataset	NOUN
bjos-8668902	163	4	related	relate	VERB
bjos-8668902	163	5	to	to	ADP
bjos-8668902	163	6	this	this	DET
bjos-8668902	163	7	article	article	NOUN
bjos-8668902	163	8	will	will	AUX
bjos-8668902	163	9	be	be	AUX
bjos-8668902	163	10	available	available	ADJ
bjos-8668902	163	11	upon	upon	SCONJ
bjos-8668902	163	12	request	request	NOUN
bjos-8668902	163	13	to	to	ADP
bjos-8668902	163	14	the	the	DET
bjos-8668902	163	15	corresponding	corresponding	ADJ
bjos-8668902	163	16	author	author	NOUN
bjos-8668902	163	17	.	.	PUNCT
bjos-8668902	164	1	references	reference	NOUN
bjos-8668902	164	2	1	1	NUM
bjos-8668902	164	3	.	.	PUNCT
bjos-8668902	164	4	palanisamy	palanisamy	PROPN
bjos-8668902	164	5	n	n	CCONJ
bjos-8668902	164	6	,	,	PUNCT
bjos-8668902	164	7	vihari	vihari	PROPN
bjos-8668902	164	8	n	n	CCONJ
bjos-8668902	164	9	,	,	PUNCT
bjos-8668902	164	10	meena	meena	PROPN
bjos-8668902	164	11	ds	ds	PROPN
bjos-8668902	164	12	,	,	PUNCT
bjos-8668902	164	13	kumar	kumar	PROPN
bjos-8668902	164	14	d	d	PROPN
bjos-8668902	164	15	,	,	PUNCT
bjos-8668902	164	16	midha	midha	PROPN
bjos-8668902	164	17	n	n	CCONJ
bjos-8668902	164	18	,	,	PUNCT
bjos-8668902	164	19	tak	tak	NOUN
bjos-8668902	164	20	v	v	NOUN
bjos-8668902	164	21	,	,	PUNCT
bjos-8668902	164	22	et	et	PROPN
bjos-8668902	164	23	al	al	PROPN
bjos-8668902	164	24	.	.	PUNCT
bjos-8668902	165	1	clinical	clinical	ADJ
bjos-8668902	165	2	profile	profile	NOUN
bjos-8668902	165	3	of	of	ADP
bjos-8668902	165	4	bloodstream	bloodstream	NOUN
bjos-8668902	165	5	infections	infection	NOUN
bjos-8668902	165	6	in	in	ADP
bjos-8668902	165	7	covid-19	covid-19	PROPN
bjos-8668902	165	8	patients	patient	NOUN
bjos-8668902	165	9	:	:	PUNCT
bjos-8668902	165	10	a	a	DET
bjos-8668902	165	11	retrospective	retrospective	ADJ
bjos-8668902	165	12	cohort	cohort	NOUN
bjos-8668902	165	13	study	study	NOUN
bjos-8668902	165	14	.	.	PUNCT
bjos-8668902	166	1	bmc	bmc	PROPN
bjos-8668902	166	2	infect	infect	PROPN
bjos-8668902	166	3	dis	dis	PROPN
bjos-8668902	166	4	.	.	PUNCT
bjos-8668902	166	5	2021	2021	NUM
bjos-8668902	166	6	sep;21(1):933	sep;21(1):933	PROPN
bjos-8668902	166	7	.	.	PUNCT
bjos-8668902	166	8	doi	doi	PROPN
bjos-8668902	166	9	:	:	PUNCT
bjos-8668902	166	10	10.1186	10.1186	NUM
bjos-8668902	166	11	/	/	SYM
bjos-8668902	166	12	s12879	s12879	ADJ
bjos-8668902	166	13	-	-	PUNCT
bjos-8668902	166	14	021	021	NUM
bjos-8668902	166	15	-	-	PUNCT
bjos-8668902	166	16	06647	06647	NUM
bjos-8668902	166	17	-	-	PUNCT
bjos-8668902	166	18	x.	x.	NOUN
bjos-8668902	166	19	2	2	NUM
bjos-8668902	166	20	.	.	PROPN
bjos-8668902	166	21	zia	zia	PROPN
bjos-8668902	166	22	m	m	PROPN
bjos-8668902	166	23	,	,	PUNCT
bjos-8668902	166	24	goli	goli	PROPN
bjos-8668902	166	25	m.	m.	NOUN
bjos-8668902	166	26	predisposing	predispose	VERB
bjos-8668902	166	27	factors	factor	NOUN
bjos-8668902	166	28	of	of	ADP
bjos-8668902	166	29	important	important	ADJ
bjos-8668902	166	30	invasive	invasive	ADJ
bjos-8668902	166	31	fungal	fungal	ADJ
bjos-8668902	166	32	coinfections	coinfection	NOUN
bjos-8668902	166	33	in	in	ADP
bjos-8668902	166	34	covid-19	covid-19	PROPN
bjos-8668902	166	35	patients	patient	NOUN
bjos-8668902	166	36	:	:	PUNCT
bjos-8668902	166	37	a	a	DET
bjos-8668902	166	38	review	review	NOUN
bjos-8668902	166	39	article	article	NOUN
bjos-8668902	166	40	.	.	PUNCT
bjos-8668902	167	1	j	j	PROPN
bjos-8668902	167	2	int	int	PROPN
bjos-8668902	167	3	med	med	PROPN
bjos-8668902	167	4	res	re	NOUN
bjos-8668902	167	5	.	.	PUNCT
bjos-8668902	168	1	2021	2021	NUM
bjos-8668902	168	2	sep;49(9):3000605211043413	sep;49(9):3000605211043413	PROPN
bjos-8668902	168	3	.	.	PUNCT
bjos-8668902	168	4	doi	doi	NOUN
bjos-8668902	168	5	:	:	PUNCT
bjos-8668902	168	6	10.1177/03000605211043413	10.1177/03000605211043413	NUM
bjos-8668902	168	7	.	.	NOUN
bjos-8668902	169	1	3	3	X
bjos-8668902	169	2	.	.	X
bjos-8668902	169	3	unnikrishnan	unnikrishnan	PROPN
bjos-8668902	169	4	r	r	PROPN
bjos-8668902	169	5	,	,	PUNCT
bjos-8668902	169	6	misra	misra	ADJ
bjos-8668902	169	7	a.	a.	NOUN
bjos-8668902	169	8	infections	infection	NOUN
bjos-8668902	169	9	and	and	CCONJ
bjos-8668902	169	10	diabetes	diabete	NOUN
bjos-8668902	169	11	:	:	PUNCT
bjos-8668902	169	12	risks	risk	NOUN
bjos-8668902	169	13	and	and	CCONJ
bjos-8668902	169	14	mitigation	mitigation	NOUN
bjos-8668902	169	15	with	with	ADP
bjos-8668902	169	16	reference	reference	NOUN
bjos-8668902	169	17	to	to	ADP
bjos-8668902	169	18	india	india	PROPN
bjos-8668902	169	19	.	.	PUNCT
bjos-8668902	170	1	diabetes	diabete	VERB
bjos-8668902	170	2	metab	metab	ADJ
bjos-8668902	170	3	syndr	syndr	NOUN
bjos-8668902	170	4	.	.	PUNCT
bjos-8668902	171	1	2020	2020	NUM
bjos-8668902	171	2	nov	nov	PROPN
bjos-8668902	171	3	-	-	PUNCT
bjos-8668902	171	4	dec;14(6):1889	dec;14(6):1889	PROPN
bjos-8668902	171	5	-	-	PUNCT
bjos-8668902	171	6	94	94	NUM
bjos-8668902	171	7	.	.	PUNCT
bjos-8668902	172	1	doi	doi	NOUN
bjos-8668902	172	2	:	:	PUNCT
bjos-8668902	172	3	10.1016	10.1016	NUM
bjos-8668902	172	4	/	/	SYM
bjos-8668902	172	5	j.dsx.2020.09.022	j.dsx.2020.09.022	PROPN
bjos-8668902	172	6	.	.	PUNCT
bjos-8668902	173	1	4	4	X
bjos-8668902	173	2	.	.	X
bjos-8668902	173	3	garg	garg	PROPN
bjos-8668902	173	4	d	d	PROPN
bjos-8668902	173	5	,	,	PUNCT
bjos-8668902	173	6	muthu	muthu	PROPN
bjos-8668902	173	7	v	v	NOUN
bjos-8668902	173	8	,	,	PUNCT
bjos-8668902	173	9	sehgal	sehgal	PROPN
bjos-8668902	173	10	is	be	AUX
bjos-8668902	173	11	,	,	PUNCT
bjos-8668902	173	12	ramachandran	ramachandran	PROPN
bjos-8668902	173	13	r	r	PROPN
bjos-8668902	173	14	,	,	PUNCT
bjos-8668902	173	15	kaur	kaur	PROPN
bjos-8668902	173	16	h	h	PROPN
bjos-8668902	173	17	,	,	PUNCT
bjos-8668902	173	18	bhalla	bhalla	PROPN
bjos-8668902	173	19	a	a	PROPN
bjos-8668902	173	20	,	,	PUNCT
bjos-8668902	173	21	et	et	PROPN
bjos-8668902	173	22	al	al	PROPN
bjos-8668902	173	23	.	.	PROPN
bjos-8668902	173	24	coronavirus	coronavirus	PROPN
bjos-8668902	173	25	disease	disease	NOUN
bjos-8668902	173	26	(	(	PUNCT
bjos-8668902	173	27	covid-19	covid-19	PROPN
bjos-8668902	173	28	)	)	PUNCT
bjos-8668902	173	29	associated	associate	VERB
bjos-8668902	173	30	mucormycosis	mucormycosis	NOUN
bjos-8668902	173	31	(	(	PUNCT
bjos-8668902	173	32	cam	cam	NOUN
bjos-8668902	173	33	):	):	PUNCT
bjos-8668902	173	34	case	case	NOUN
bjos-8668902	173	35	report	report	NOUN
bjos-8668902	173	36	and	and	CCONJ
bjos-8668902	173	37	systematic	systematic	ADJ
bjos-8668902	173	38	review	review	NOUN
bjos-8668902	173	39	of	of	ADP
bjos-8668902	173	40	literature	literature	PROPN
bjos-8668902	173	41	.	.	PUNCT
bjos-8668902	174	1	mycopathologia	mycopathologia	PROPN
bjos-8668902	174	2	.	.	PUNCT
bjos-8668902	175	1	2021	2021	NUM
bjos-8668902	175	2	may;186(2):289	may;186(2):289	NUM
bjos-8668902	175	3	-	-	PUNCT
bjos-8668902	175	4	98	98	NUM
bjos-8668902	175	5	.	.	PUNCT
bjos-8668902	176	1	doi	doi	NOUN
bjos-8668902	176	2	:	:	PUNCT
bjos-8668902	176	3	10.1007	10.1007	NUM
bjos-8668902	176	4	/	/	SYM
bjos-8668902	176	5	s11046	s11046	NOUN
bjos-8668902	176	6	-	-	PUNCT
bjos-8668902	176	7	021	021	NUM
bjos-8668902	176	8	-	-	PUNCT
bjos-8668902	176	9	00528	00528	NUM
bjos-8668902	176	10	-	-	SYM
bjos-8668902	176	11	2	2	NUM
bjos-8668902	176	12	.	.	NOUN
bjos-8668902	176	13	11	11	NUM
bjos-8668902	176	14	ansari	ansari	X
bjos-8668902	176	15	et	et	PROPN
bjos-8668902	176	16	al	al	PROPN
bjos-8668902	176	17	.	.	PROPN
bjos-8668902	177	1	braz	braz	PROPN
bjos-8668902	177	2	j	j	PROPN
bjos-8668902	177	3	oral	oral	PROPN
bjos-8668902	177	4	sci	sci	PROPN
bjos-8668902	177	5	.	.	PUNCT
bjos-8668902	178	1	2023;22	2023;22	NUM
bjos-8668902	178	2	:	:	PUNCT
bjos-8668902	178	3	e238902	e238902	PROPN
bjos-8668902	178	4	5	5	X
bjos-8668902	178	5	.	.	PUNCT
bjos-8668902	179	1	oh	oh	INTJ
bjos-8668902	179	2	h	h	NOUN
bjos-8668902	179	3	,	,	PUNCT
bjos-8668902	179	4	ghosh	ghosh	PROPN
bjos-8668902	179	5	s.	s.	PROPN
bjos-8668902	179	6	nf	nf	PROPN
bjos-8668902	179	7	-	-	PUNCT
bjos-8668902	179	8	κb	κb	NOUN
bjos-8668902	179	9	:	:	PUNCT
bjos-8668902	179	10	roles	role	NOUN
bjos-8668902	179	11	and	and	CCONJ
bjos-8668902	179	12	regulation	regulation	NOUN
bjos-8668902	179	13	in	in	ADP
bjos-8668902	179	14	different	different	ADJ
bjos-8668902	179	15	cd4(+	cd4(+	NOUN
bjos-8668902	179	16	)	)	PUNCT
bjos-8668902	179	17	t	t	NOUN
bjos-8668902	179	18	-	-	PUNCT
bjos-8668902	179	19	cell	cell	NOUN
bjos-8668902	179	20	subsets	subset	NOUN
bjos-8668902	179	21	.	.	PUNCT
bjos-8668902	180	1	immunol	immunol	PROPN
bjos-8668902	180	2	rev	rev	PROPN
bjos-8668902	180	3	.	.	PROPN
bjos-8668902	180	4	2013	2013	NUM
bjos-8668902	180	5	mar;252(1):41	mar;252(1):41	NOUN
bjos-8668902	180	6	-	-	PUNCT
bjos-8668902	180	7	51	51	NUM
bjos-8668902	180	8	.	.	PUNCT
bjos-8668902	181	1	doi	doi	NOUN
bjos-8668902	181	2	:	:	PUNCT
bjos-8668902	181	3	10.1111	10.1111	NUM
bjos-8668902	181	4	/	/	SYM
bjos-8668902	181	5	imr.12033	imr.12033	NUM
bjos-8668902	181	6	.	.	NOUN
bjos-8668902	181	7	6	6	NUM
bjos-8668902	181	8	.	.	PUNCT
bjos-8668902	182	1	jose	jose	PROPN
bjos-8668902	182	2	a	a	PROPN
bjos-8668902	182	3	,	,	PUNCT
bjos-8668902	182	4	singh	singh	PROPN
bjos-8668902	182	5	s	s	PROPN
bjos-8668902	182	6	,	,	PUNCT
bjos-8668902	182	7	roychoudhury	roychoudhury	VERB
bjos-8668902	182	8	a	a	PRON
bjos-8668902	182	9	,	,	PUNCT
bjos-8668902	182	10	kholakiya	kholakiya	PROPN
bjos-8668902	182	11	y	y	PROPN
bjos-8668902	182	12	,	,	PUNCT
bjos-8668902	182	13	arya	arya	PROPN
bjos-8668902	182	14	s	s	PROPN
bjos-8668902	182	15	,	,	PUNCT
bjos-8668902	182	16	roychoudhury	roychoudhury	PROPN
bjos-8668902	182	17	s.	s.	PROPN
bjos-8668902	182	18	current	current	ADJ
bjos-8668902	182	19	understanding	understanding	NOUN
bjos-8668902	182	20	in	in	ADP
bjos-8668902	182	21	the	the	DET
bjos-8668902	182	22	pathophysiology	pathophysiology	NOUN
bjos-8668902	182	23	of	of	ADP
bjos-8668902	182	24	sars	sar	NOUN
bjos-8668902	182	25	-	-	PUNCT
bjos-8668902	182	26	cov-2	cov-2	ADV
bjos-8668902	182	27	-	-	PUNCT
bjos-8668902	182	28	associated	associate	VERB
bjos-8668902	182	29	rhino	rhino	NOUN
bjos-8668902	182	30	-	-	PUNCT
bjos-8668902	182	31	orbito	orbito	ADJ
bjos-8668902	182	32	-	-	PUNCT
bjos-8668902	182	33	cerebral	cerebral	ADJ
bjos-8668902	182	34	mucormycosis	mucormycosis	NOUN
bjos-8668902	182	35	:	:	PUNCT
bjos-8668902	182	36	a	a	DET
bjos-8668902	182	37	comprehensive	comprehensive	ADJ
bjos-8668902	182	38	review	review	NOUN
bjos-8668902	182	39	.	.	PUNCT
bjos-8668902	183	1	j	j	PROPN
bjos-8668902	183	2	maxillofac	maxillofac	NOUN
bjos-8668902	183	3	oral	oral	ADJ
bjos-8668902	183	4	surg	surg	NOUN
bjos-8668902	183	5	.	.	PUNCT
bjos-8668902	184	1	2021	2021	NUM
bjos-8668902	184	2	sep;20(3):373	sep;20(3):373	NOUN
bjos-8668902	184	3	-	-	PUNCT
bjos-8668902	184	4	80	80	NUM
bjos-8668902	184	5	.	.	PUNCT
bjos-8668902	185	1	doi	doi	NOUN
bjos-8668902	185	2	:	:	PUNCT
bjos-8668902	185	3	10.1007	10.1007	NUM
bjos-8668902	185	4	/	/	SYM
bjos-8668902	185	5	s12663	s12663	PROPN
bjos-8668902	185	6	-	-	PUNCT
bjos-8668902	185	7	021	021	NUM
bjos-8668902	185	8	-	-	PUNCT
bjos-8668902	185	9	01604	01604	NUM
bjos-8668902	185	10	-	-	PUNCT
bjos-8668902	185	11	2	2	NUM
bjos-8668902	185	12	.	.	NOUN
bjos-8668902	185	13	7	7	NUM
bjos-8668902	185	14	.	.	X
bjos-8668902	186	1	alqarihi	alqarihi	PROPN
bjos-8668902	186	2	a	a	X
bjos-8668902	186	3	,	,	PUNCT
bjos-8668902	186	4	gebremariam	gebremariam	PROPN
bjos-8668902	186	5	t	t	PROPN
bjos-8668902	186	6	,	,	PUNCT
bjos-8668902	186	7	gu	gu	PROPN
bjos-8668902	186	8	y	y	PROPN
bjos-8668902	186	9	,	,	PUNCT
bjos-8668902	186	10	swidergall	swidergall	PROPN
bjos-8668902	186	11	m	m	PROPN
bjos-8668902	186	12	,	,	PUNCT
bjos-8668902	186	13	alkhazraji	alkhazraji	PROPN
bjos-8668902	186	14	s	s	PROPN
bjos-8668902	186	15	,	,	PUNCT
bjos-8668902	186	16	soliman	soliman	PROPN
bjos-8668902	186	17	ss	ss	PROPN
bjos-8668902	186	18	,	,	PUNCT
bjos-8668902	187	1	et	et	PROPN
bjos-8668902	187	2	al	al	PROPN
bjos-8668902	187	3	.	.	PROPN
bjos-8668902	187	4	grp78	grp78	PROPN
bjos-8668902	187	5	and	and	CCONJ
bjos-8668902	187	6	integrins	integrin	NOUN
bjos-8668902	187	7	play	play	VERB
bjos-8668902	187	8	different	different	ADJ
bjos-8668902	187	9	roles	role	NOUN
bjos-8668902	187	10	in	in	ADP
bjos-8668902	187	11	host	host	NOUN
bjos-8668902	187	12	cell	cell	NOUN
bjos-8668902	187	13	invasion	invasion	NOUN
bjos-8668902	187	14	during	during	ADP
bjos-8668902	187	15	mucormycosis	mucormycosis	NOUN
bjos-8668902	187	16	.	.	PUNCT
bjos-8668902	188	1	mbio	mbio	PROPN
bjos-8668902	188	2	.	.	PUNCT
bjos-8668902	189	1	2020	2020	NUM
bjos-8668902	190	1	jun;11(3):e01087	jun;11(3):e01087	NOUN
bjos-8668902	190	2	-	-	PUNCT
bjos-8668902	190	3	20	20	NUM
bjos-8668902	190	4	.	.	PUNCT
bjos-8668902	191	1	doi	doi	NOUN
bjos-8668902	191	2	:	:	PUNCT
bjos-8668902	191	3	10.1128	10.1128	NUM
bjos-8668902	191	4	/	/	SYM
bjos-8668902	191	5	mbio.01087	mbio.01087	NOUN
bjos-8668902	191	6	-	-	PUNCT
bjos-8668902	191	7	20	20	NUM
bjos-8668902	191	8	.	.	NOUN
bjos-8668902	191	9	8	8	NUM
bjos-8668902	191	10	.	.	PUNCT
bjos-8668902	192	1	rai	rai	PROPN
bjos-8668902	192	2	s	s	PROPN
bjos-8668902	192	3	,	,	PUNCT
bjos-8668902	192	4	yadav	yadav	PROPN
bjos-8668902	192	5	s	s	PROPN
bjos-8668902	192	6	,	,	PUNCT
bjos-8668902	192	7	kumar	kumar	PROPN
bjos-8668902	192	8	d	d	PROPN
bjos-8668902	192	9	,	,	PUNCT
bjos-8668902	192	10	kumar	kumar	PROPN
bjos-8668902	192	11	v	v	PROPN
bjos-8668902	192	12	,	,	PUNCT
bjos-8668902	192	13	rattan	rattan	ADJ
bjos-8668902	192	14	v.	v.	ADP
bjos-8668902	192	15	management	management	NOUN
bjos-8668902	192	16	of	of	ADP
bjos-8668902	192	17	rhinomaxillary	rhinomaxillary	ADJ
bjos-8668902	192	18	mucormycosis	mucormycosis	NOUN
bjos-8668902	192	19	with	with	ADP
bjos-8668902	192	20	posaconazole	posaconazole	NOUN
bjos-8668902	192	21	in	in	ADP
bjos-8668902	192	22	immunocompetent	immunocompetent	ADJ
bjos-8668902	192	23	patients	patient	NOUN
bjos-8668902	192	24	.	.	PUNCT
bjos-8668902	193	1	j	j	PROPN
bjos-8668902	193	2	oral	oral	ADJ
bjos-8668902	193	3	biol	biol	PROPN
bjos-8668902	193	4	craniofac	craniofac	NOUN
bjos-8668902	193	5	res	re	NOUN
bjos-8668902	193	6	.	.	PUNCT
bjos-8668902	194	1	2016	2016	NUM
bjos-8668902	194	2	nov;6(suppl	nov;6(suppl	NOUN
bjos-8668902	194	3	1):s5	1):s5	NUM
bjos-8668902	194	4	-	-	PUNCT
bjos-8668902	194	5	s8	s8	NOUN
bjos-8668902	194	6	.	.	PUNCT
bjos-8668902	195	1	doi	doi	NOUN
bjos-8668902	195	2	:	:	PUNCT
bjos-8668902	195	3	10.1016	10.1016	NUM
bjos-8668902	195	4	/	/	SYM
bjos-8668902	195	5	j.jobcr.2016.10.005	j.jobcr.2016.10.005	NOUN
bjos-8668902	195	6	.	.	PUNCT
bjos-8668902	196	1	9	9	X
bjos-8668902	196	2	.	.	X
bjos-8668902	196	3	dilek	dilek	PROPN
bjos-8668902	196	4	a	a	PROPN
bjos-8668902	196	5	,	,	PUNCT
bjos-8668902	196	6	ozaras	ozara	NOUN
bjos-8668902	196	7	r	r	NOUN
bjos-8668902	196	8	,	,	PUNCT
bjos-8668902	196	9	ozkaya	ozkaya	NOUN
bjos-8668902	196	10	s	s	PROPN
bjos-8668902	196	11	,	,	PUNCT
bjos-8668902	196	12	sunbul	sunbul	PROPN
bjos-8668902	196	13	m	m	PROPN
bjos-8668902	196	14	,	,	PUNCT
bjos-8668902	196	15	sen	sen	PROPN
bjos-8668902	196	16	ei	ei	PROPN
bjos-8668902	196	17	,	,	PUNCT
bjos-8668902	196	18	leblebicioglu	leblebicioglu	PROPN
bjos-8668902	196	19	h.	h.	PROPN
bjos-8668902	196	20	covid-19	covid-19	PROPN
bjos-8668902	196	21	-	-	PUNCT
bjos-8668902	196	22	associated	associate	VERB
bjos-8668902	196	23	mucormycosis	mucormycosis	NOUN
bjos-8668902	196	24	:	:	PUNCT
bjos-8668902	196	25	case	case	NOUN
bjos-8668902	196	26	report	report	NOUN
bjos-8668902	196	27	and	and	CCONJ
bjos-8668902	196	28	systematic	systematic	ADJ
bjos-8668902	196	29	review	review	NOUN
bjos-8668902	196	30	.	.	PUNCT
bjos-8668902	197	1	travel	travel	VERB
bjos-8668902	197	2	med	me	VERB
bjos-8668902	197	3	infect	infect	PROPN
bjos-8668902	197	4	dis	dis	PROPN
bjos-8668902	197	5	.	.	PUNCT
bjos-8668902	198	1	2021	2021	NUM
bjos-8668902	198	2	nov	nov	NOUN
bjos-8668902	198	3	-	-	PUNCT
bjos-8668902	198	4	dec;44:102148	dec;44:102148	NOUN
bjos-8668902	198	5	.	.	PUNCT
bjos-8668902	199	1	doi	doi	NOUN
bjos-8668902	199	2	:	:	PUNCT
bjos-8668902	199	3	10.1016	10.1016	NUM
bjos-8668902	199	4	/	/	SYM
bjos-8668902	199	5	j.tmaid.2021.102148	j.tmaid.2021.102148	NOUN
bjos-8668902	199	6	.	.	PUNCT
bjos-8668902	200	1	10	10	NUM
bjos-8668902	200	2	.	.	PUNCT
bjos-8668902	201	1	patel	patel	PROPN
bjos-8668902	201	2	a	a	PRON
bjos-8668902	201	3	,	,	PUNCT
bjos-8668902	201	4	agarwal	agarwal	PROPN
bjos-8668902	201	5	r	r	PROPN
bjos-8668902	201	6	,	,	PUNCT
bjos-8668902	201	7	rudramurthy	rudramurthy	ADJ
bjos-8668902	201	8	sm	sm	NOUN
bjos-8668902	201	9	,	,	PUNCT
bjos-8668902	201	10	shevkani	shevkani	PROPN
bjos-8668902	201	11	m	m	PROPN
bjos-8668902	201	12	,	,	PUNCT
bjos-8668902	201	13	xess	xess	PROPN
bjos-8668902	202	1	i	i	PROPN
bjos-8668902	202	2	,	,	PUNCT
bjos-8668902	202	3	sharma	sharma	PROPN
bjos-8668902	202	4	r	r	PROPN
bjos-8668902	202	5	,	,	PUNCT
bjos-8668902	202	6	et	et	PROPN
bjos-8668902	202	7	al	al	PROPN
bjos-8668902	202	8	.	.	PROPN
bjos-8668902	203	1	multicenter	multicenter	PROPN
bjos-8668902	203	2	epidemiologic	epidemiologic	ADJ
bjos-8668902	203	3	study	study	NOUN
bjos-8668902	203	4	of	of	ADP
bjos-8668902	203	5	coronavirus	coronavirus	NOUN
bjos-8668902	203	6	disease	disease	NOUN
bjos-8668902	203	7	–	–	PUNCT
bjos-8668902	203	8	associated	associated	ADJ
bjos-8668902	203	9	mucormycosis	mucormycosis	NOUN
bjos-8668902	203	10	,	,	PUNCT
bjos-8668902	203	11	india	india	PROPN
bjos-8668902	203	12	.	.	PUNCT
bjos-8668902	204	1	emerg	emerg	PROPN
bjos-8668902	204	2	infect	infect	PROPN
bjos-8668902	204	3	dis	dis	PROPN
bjos-8668902	204	4	.	.	PUNCT
bjos-8668902	205	1	2021	2021	NUM
bjos-8668902	205	2	sep;27(9):2349	sep;27(9):2349	PROPN
bjos-8668902	205	3	-	-	PUNCT
bjos-8668902	205	4	59	59	NUM
bjos-8668902	205	5	.	.	PUNCT
bjos-8668902	205	6	doi	doi	NOUN
bjos-8668902	205	7	:	:	PUNCT
bjos-8668902	205	8	10.3201	10.3201	NUM
bjos-8668902	205	9	/	/	SYM
bjos-8668902	205	10	eid2709.210934	eid2709.210934	NOUN
bjos-8668902	205	11	.	.	PUNCT
bjos-8668902	206	1	11	11	NUM
bjos-8668902	206	2	.	.	PUNCT
bjos-8668902	207	1	sen	sen	PROPN
bjos-8668902	207	2	m	m	PROPN
bjos-8668902	207	3	,	,	PUNCT
bjos-8668902	207	4	honavar	honavar	PROPN
bjos-8668902	207	5	sg	sg	PROPN
bjos-8668902	207	6	,	,	PUNCT
bjos-8668902	207	7	bansal	bansal	NOUN
bjos-8668902	207	8	r	r	NOUN
bjos-8668902	207	9	,	,	PUNCT
bjos-8668902	207	10	sengupta	sengupta	PROPN
bjos-8668902	207	11	s	s	PROPN
bjos-8668902	207	12	,	,	PUNCT
bjos-8668902	207	13	rao	rao	NOUN
bjos-8668902	207	14	r	r	NOUN
bjos-8668902	207	15	,	,	PUNCT
bjos-8668902	207	16	kim	kim	PROPN
bjos-8668902	207	17	u	u	PROPN
bjos-8668902	207	18	,	,	PUNCT
bjos-8668902	207	19	et	et	PROPN
bjos-8668902	207	20	al	al	PROPN
bjos-8668902	207	21	.	.	PUNCT
bjos-8668902	207	22	epidemiology	epidemiology	NOUN
bjos-8668902	207	23	,	,	PUNCT
bjos-8668902	207	24	clinical	clinical	ADJ
bjos-8668902	207	25	profile	profile	NOUN
bjos-8668902	207	26	,	,	PUNCT
bjos-8668902	207	27	management	management	NOUN
bjos-8668902	207	28	,	,	PUNCT
bjos-8668902	207	29	and	and	CCONJ
bjos-8668902	207	30	outcome	outcome	NOUN
bjos-8668902	207	31	of	of	ADP
bjos-8668902	207	32	covid-19	covid-19	PROPN
bjos-8668902	207	33	-	-	PUNCT
bjos-8668902	207	34	associated	associate	VERB
bjos-8668902	207	35	rhino	rhino	NOUN
bjos-8668902	207	36	-	-	PUNCT
bjos-8668902	207	37	orbital	orbital	ADJ
bjos-8668902	207	38	-	-	PUNCT
bjos-8668902	207	39	cerebral	cerebral	ADJ
bjos-8668902	207	40	mucormycosis	mucormycosis	NOUN
bjos-8668902	207	41	in	in	ADP
bjos-8668902	207	42	2826	2826	NUM
bjos-8668902	207	43	patients	patient	NOUN
bjos-8668902	207	44	in	in	ADP
bjos-8668902	207	45	india	india	PROPN
bjos-8668902	207	46	–	–	PUNCT
bjos-8668902	207	47	collaborative	collaborative	ADJ
bjos-8668902	207	48	opai	opai	NOUN
bjos-8668902	207	49	-	-	PUNCT
bjos-8668902	207	50	ijo	ijo	NOUN
bjos-8668902	207	51	study	study	NOUN
bjos-8668902	207	52	on	on	ADP
bjos-8668902	207	53	mucormycosis	mucormycosis	NOUN
bjos-8668902	207	54	in	in	ADP
bjos-8668902	207	55	covid-19	covid-19	PROPN
bjos-8668902	207	56	(	(	PUNCT
bjos-8668902	207	57	cosmic	cosmic	ADJ
bjos-8668902	207	58	)	)	PUNCT
bjos-8668902	207	59	,	,	PUNCT
bjos-8668902	207	60	report	report	VERB
bjos-8668902	207	61	1	1	NUM
bjos-8668902	207	62	.	.	PUNCT
bjos-8668902	208	1	indian	indian	PROPN
bjos-8668902	208	2	j	j	PROPN
bjos-8668902	208	3	ophthalmol	ophthalmol	PROPN
bjos-8668902	208	4	.	.	PUNCT
bjos-8668902	209	1	2021	2021	NUM
bjos-8668902	209	2	jul;69(7):1670	jul;69(7):1670	PROPN
bjos-8668902	209	3	-	-	PUNCT
bjos-8668902	209	4	92	92	NUM
bjos-8668902	209	5	.	.	PUNCT
bjos-8668902	210	1	doi	doi	NOUN
bjos-8668902	210	2	:	:	PUNCT
bjos-8668902	210	3	10.4103	10.4103	NUM
bjos-8668902	210	4	/	/	SYM
bjos-8668902	210	5	ijo.ijo_1565_21	ijo.ijo_1565_21	NOUN
bjos-8668902	210	6	.	.	PUNCT
bjos-8668902	211	1	12	12	NUM
bjos-8668902	211	2	.	.	PUNCT
bjos-8668902	212	1	patel	patel	PROPN
bjos-8668902	212	2	a	a	PRON
bjos-8668902	212	3	,	,	PUNCT
bjos-8668902	212	4	kaur	kaur	PROPN
bjos-8668902	212	5	h	h	PROPN
bjos-8668902	212	6	,	,	PUNCT
bjos-8668902	212	7	xess	xess	PROPN
bjos-8668902	213	1	i	i	PRON
bjos-8668902	213	2	,	,	PUNCT
bjos-8668902	213	3	michael	michael	PROPN
bjos-8668902	213	4	js	js	PROPN
bjos-8668902	213	5	,	,	PUNCT
bjos-8668902	213	6	savio	savio	PROPN
bjos-8668902	213	7	j	j	PROPN
bjos-8668902	213	8	,	,	PUNCT
bjos-8668902	213	9	rudramurthy	rudramurthy	PROPN
bjos-8668902	213	10	s	s	PROPN
bjos-8668902	213	11	,	,	PUNCT
bjos-8668902	213	12	et	et	PROPN
bjos-8668902	213	13	al	al	PROPN
bjos-8668902	213	14	.	.	PUNCT
bjos-8668902	214	1	a	a	DET
bjos-8668902	214	2	multicentre	multicentre	ADJ
bjos-8668902	214	3	observational	observational	ADJ
bjos-8668902	214	4	study	study	NOUN
bjos-8668902	214	5	on	on	ADP
bjos-8668902	214	6	the	the	DET
bjos-8668902	214	7	epidemiology	epidemiology	NOUN
bjos-8668902	214	8	,	,	PUNCT
bjos-8668902	214	9	risk	risk	NOUN
bjos-8668902	214	10	factors	factor	NOUN
bjos-8668902	214	11	,	,	PUNCT
bjos-8668902	214	12	management	management	NOUN
bjos-8668902	214	13	and	and	CCONJ
bjos-8668902	214	14	outcomes	outcome	NOUN
bjos-8668902	214	15	of	of	ADP
bjos-8668902	214	16	mucormycosis	mucormycosis	NOUN
bjos-8668902	214	17	in	in	ADP
bjos-8668902	214	18	india	india	PROPN
bjos-8668902	214	19	.	.	PUNCT
bjos-8668902	215	1	clin	clin	PROPN
bjos-8668902	215	2	microbiol	microbiol	PROPN
bjos-8668902	215	3	infect	infect	PROPN
bjos-8668902	215	4	.	.	PUNCT
bjos-8668902	216	1	2020	2020	NUM
bjos-8668902	216	2	jul;26(7):944.e9	jul;26(7):944.e9	PROPN
bjos-8668902	216	3	-	-	PUNCT
bjos-8668902	216	4	944.e15	944.e15	PROPN
bjos-8668902	216	5	.	.	PUNCT
bjos-8668902	217	1	doi	doi	NOUN
bjos-8668902	217	2	:	:	PUNCT
bjos-8668902	217	3	10.1016	10.1016	NUM
bjos-8668902	217	4	/	/	SYM
bjos-8668902	217	5	j.cmi.2019.11.021	j.cmi.2019.11.021	NOUN
bjos-8668902	217	6	.	.	PROPN
bjos-8668902	218	1	13	13	NUM
bjos-8668902	218	2	.	.	PUNCT
bjos-8668902	218	3	singh	singh	PROPN
bjos-8668902	218	4	ak	ak	PROPN
bjos-8668902	218	5	,	,	PUNCT
bjos-8668902	218	6	singh	singh	PROPN
bjos-8668902	218	7	r	r	PROPN
bjos-8668902	218	8	,	,	PUNCT
bjos-8668902	218	9	joshi	joshi	PROPN
bjos-8668902	218	10	sr	sr	PROPN
bjos-8668902	218	11	,	,	PUNCT
bjos-8668902	218	12	misra	misra	ADJ
bjos-8668902	218	13	a.	a.	NOUN
bjos-8668902	218	14	mucormycosis	mucormycosis	NOUN
bjos-8668902	218	15	in	in	ADP
bjos-8668902	218	16	covid-19	covid-19	PROPN
bjos-8668902	218	17	:	:	PUNCT
bjos-8668902	218	18	a	a	DET
bjos-8668902	218	19	systematic	systematic	ADJ
bjos-8668902	218	20	review	review	NOUN
bjos-8668902	218	21	of	of	ADP
bjos-8668902	218	22	cases	case	NOUN
bjos-8668902	218	23	reported	report	VERB
bjos-8668902	218	24	worldwide	worldwide	ADV
bjos-8668902	218	25	and	and	CCONJ
bjos-8668902	218	26	in	in	ADP
bjos-8668902	218	27	india	india	PROPN
bjos-8668902	218	28	.	.	PUNCT
bjos-8668902	219	1	diabetes	diabete	VERB
bjos-8668902	219	2	metab	metab	NOUN
bjos-8668902	219	3	syndr	syndr	NOUN
bjos-8668902	219	4	.	.	PUNCT
bjos-8668902	220	1	2021	2021	NUM
bjos-8668902	220	2	jul	jul	PROPN
bjos-8668902	220	3	-	-	PUNCT
bjos-8668902	220	4	aug;15(4):102146	aug;15(4):102146	PROPN
bjos-8668902	220	5	.	.	PROPN
bjos-8668902	220	6	doi	doi	PROPN
bjos-8668902	220	7	:	:	PUNCT
bjos-8668902	220	8	10.1016	10.1016	NUM
bjos-8668902	220	9	/	/	SYM
bjos-8668902	220	10	j.dsx.2021.05.019	j.dsx.2021.05.019	PROPN
bjos-8668902	220	11	.	.	PROPN
bjos-8668902	220	12	14	14	NUM
bjos-8668902	220	13	.	.	PUNCT
bjos-8668902	221	1	alfishawy	alfishawy	PROPN
bjos-8668902	221	2	m	m	PROPN
bjos-8668902	221	3	,	,	PUNCT
bjos-8668902	221	4	elbendary	elbendary	VERB
bjos-8668902	221	5	a	a	PRON
bjos-8668902	221	6	,	,	PUNCT
bjos-8668902	221	7	younes	younes	PROPN
bjos-8668902	221	8	a	a	PRON
bjos-8668902	221	9	,	,	PUNCT
bjos-8668902	221	10	negm	negm	NOUN
bjos-8668902	221	11	a	a	X
bjos-8668902	221	12	,	,	PUNCT
bjos-8668902	221	13	hassan	hassan	PROPN
bjos-8668902	221	14	ws	ws	PROPN
bjos-8668902	221	15	,	,	PUNCT
bjos-8668902	221	16	osman	osman	PROPN
bjos-8668902	221	17	sh	sh	PROPN
bjos-8668902	221	18	,	,	PUNCT
bjos-8668902	221	19	et	et	PROPN
bjos-8668902	221	20	al	al	PROPN
bjos-8668902	221	21	.	.	PROPN
bjos-8668902	222	1	diabetes	diabete	VERB
bjos-8668902	222	2	mellitus	mellitus	NOUN
bjos-8668902	222	3	and	and	CCONJ
bjos-8668902	222	4	coronavirus	coronavirus	NOUN
bjos-8668902	222	5	disease	disease	NOUN
bjos-8668902	222	6	(	(	PUNCT
bjos-8668902	222	7	covid-19	covid-19	PROPN
bjos-8668902	222	8	)	)	PUNCT
bjos-8668902	222	9	associated	associate	VERB
bjos-8668902	222	10	mucormycosis	mucormycosis	NOUN
bjos-8668902	222	11	(	(	PUNCT
bjos-8668902	222	12	cam	cam	NOUN
bjos-8668902	222	13	):	):	PUNCT
bjos-8668902	222	14	a	a	DET
bjos-8668902	222	15	wake	wake	VERB
bjos-8668902	222	16	-	-	PUNCT
bjos-8668902	222	17	up	up	ADP
bjos-8668902	222	18	call	call	NOUN
bjos-8668902	222	19	from	from	ADP
bjos-8668902	222	20	egypt	egypt	PROPN
bjos-8668902	222	21	.	.	PUNCT
bjos-8668902	223	1	diabetes	diabete	VERB
bjos-8668902	223	2	metab	metab	NOUN
bjos-8668902	223	3	syndr	syndr	NOUN
bjos-8668902	223	4	.	.	PUNCT
bjos-8668902	224	1	2021	2021	NUM
bjos-8668902	224	2	sep	sep	NOUN
bjos-8668902	224	3	-	-	PUNCT
bjos-8668902	224	4	oct;15(5):102195	oct;15(5):102195	PROPN
bjos-8668902	224	5	.	.	PROPN
bjos-8668902	224	6	doi	doi	PROPN
bjos-8668902	224	7	:	:	PUNCT
bjos-8668902	224	8	10.1016	10.1016	NUM
bjos-8668902	224	9	/	/	SYM
bjos-8668902	224	10	j.dsx.2021.102195	j.dsx.2021.102195	NOUN
bjos-8668902	224	11	.	.	NOUN
bjos-8668902	224	12	15	15	NUM
bjos-8668902	224	13	.	.	PUNCT
bjos-8668902	224	14	pal	pal	ADJ
bjos-8668902	224	15	r	r	NOUN
bjos-8668902	224	16	,	,	PUNCT
bjos-8668902	224	17	singh	singh	PROPN
bjos-8668902	224	18	b	b	PROPN
bjos-8668902	224	19	,	,	PUNCT
bjos-8668902	224	20	bhadada	bhadada	PROPN
bjos-8668902	224	21	sk	sk	PROPN
bjos-8668902	224	22	,	,	PUNCT
bjos-8668902	224	23	banerjee	banerjee	PROPN
bjos-8668902	224	24	m	m	PROPN
bjos-8668902	224	25	,	,	PUNCT
bjos-8668902	224	26	bhogal	bhogal	ADJ
bjos-8668902	224	27	rs	rs	NOUN
bjos-8668902	224	28	,	,	PUNCT
bjos-8668902	224	29	hage	hage	PROPN
bjos-8668902	224	30	n	n	PRON
bjos-8668902	224	31	,	,	PUNCT
bjos-8668902	224	32	et	et	PROPN
bjos-8668902	224	33	al	al	PROPN
bjos-8668902	224	34	.	.	PROPN
bjos-8668902	224	35	covid‐19‐associated	covid‐19‐associate	VERB
bjos-8668902	224	36	mucormycosis	mucormycosis	NOUN
bjos-8668902	224	37	:	:	PUNCT
bjos-8668902	224	38	an	an	DET
bjos-8668902	224	39	updated	update	VERB
bjos-8668902	224	40	systematic	systematic	ADJ
bjos-8668902	224	41	review	review	NOUN
bjos-8668902	224	42	of	of	ADP
bjos-8668902	224	43	literature	literature	NOUN
bjos-8668902	224	44	.	.	PUNCT
bjos-8668902	225	1	mycoses	mycose	NOUN
bjos-8668902	225	2	.	.	PUNCT
bjos-8668902	226	1	2021	2021	NUM
bjos-8668902	226	2	dec;64(12):1452	dec;64(12):1452	NOUN
bjos-8668902	226	3	-	-	PUNCT
bjos-8668902	226	4	9	9	NUM
bjos-8668902	226	5	.	.	PUNCT
bjos-8668902	226	6	doi	doi	NOUN
bjos-8668902	226	7	:	:	PUNCT
bjos-8668902	226	8	10.1111	10.1111	NUM
bjos-8668902	226	9	/	/	SYM
bjos-8668902	226	10	myc.13338	myc.13338	NUM
bjos-8668902	226	11	.	.	NOUN
bjos-8668902	226	12	16	16	NUM
bjos-8668902	226	13	.	.	PUNCT
bjos-8668902	227	1	qadir	qadir	PROPN
bjos-8668902	227	2	mm	mm	PROPN
bjos-8668902	227	3	,	,	PUNCT
bjos-8668902	227	4	bhondeley	bhondeley	PROPN
bjos-8668902	227	5	m	m	PROPN
bjos-8668902	227	6	,	,	PUNCT
bjos-8668902	227	7	beatty	beatty	PROPN
bjos-8668902	227	8	w	w	PROPN
bjos-8668902	227	9	,	,	PUNCT
bjos-8668902	227	10	gaupp	gaupp	PROPN
bjos-8668902	227	11	dd	dd	PROPN
bjos-8668902	227	12	,	,	PUNCT
bjos-8668902	227	13	doyle	doyle	NOUN
bjos-8668902	227	14	-	-	PUNCT
bjos-8668902	227	15	meyers	meyer	NOUN
bjos-8668902	227	16	la	la	PROPN
bjos-8668902	227	17	,	,	PUNCT
bjos-8668902	227	18	fischer	fischer	PROPN
bjos-8668902	227	19	t	t	PROPN
bjos-8668902	227	20	,	,	PUNCT
bjos-8668902	227	21	et	et	PROPN
bjos-8668902	227	22	al	al	PROPN
bjos-8668902	227	23	.	.	PUNCT
bjos-8668902	228	1	sars	sars	PROPN
bjos-8668902	228	2	-	-	PUNCT
bjos-8668902	228	3	cov-2	cov-2	PART
bjos-8668902	228	4	infection	infection	NOUN
bjos-8668902	228	5	of	of	ADP
bjos-8668902	228	6	the	the	DET
bjos-8668902	228	7	pancreas	pancreas	NOUN
bjos-8668902	228	8	promotes	promote	VERB
bjos-8668902	228	9	thrombofibrosis	thrombofibrosis	NOUN
bjos-8668902	228	10	and	and	CCONJ
bjos-8668902	228	11	is	be	AUX
bjos-8668902	228	12	associated	associate	VERB
bjos-8668902	228	13	with	with	ADP
bjos-8668902	228	14	new	new	ADJ
bjos-8668902	228	15	-	-	PUNCT
bjos-8668902	228	16	onset	onset	NOUN
bjos-8668902	228	17	diabetes	diabetes	NOUN
bjos-8668902	228	18	.	.	PUNCT
bjos-8668902	229	1	jci	jci	PROPN
bjos-8668902	229	2	insight	insight	PROPN
bjos-8668902	229	3	.	.	PUNCT
bjos-8668902	230	1	2021	2021	NUM
bjos-8668902	230	2	aug;6(16):e151551	aug;6(16):e151551	X
bjos-8668902	230	3	.	.	PUNCT
bjos-8668902	231	1	doi	doi	NOUN
bjos-8668902	231	2	:	:	PUNCT
bjos-8668902	231	3	10.1172	10.1172	NUM
bjos-8668902	231	4	/	/	SYM
bjos-8668902	231	5	jci.insight.151551	jci.insight.151551	PROPN
bjos-8668902	231	6	.	.	PROPN
bjos-8668902	232	1	17	17	NUM
bjos-8668902	232	2	.	.	PUNCT
bjos-8668902	233	1	jose	jose	PROPN
bjos-8668902	233	2	a	a	PROPN
bjos-8668902	233	3	,	,	PUNCT
bjos-8668902	233	4	singh	singh	PROPN
bjos-8668902	233	5	s	s	PROPN
bjos-8668902	233	6	,	,	PUNCT
bjos-8668902	233	7	roychoudhury	roychoudhury	VERB
bjos-8668902	233	8	a	a	PRON
bjos-8668902	233	9	,	,	PUNCT
bjos-8668902	233	10	kholakiya	kholakiya	PROPN
bjos-8668902	233	11	y	y	PROPN
bjos-8668902	233	12	,	,	PUNCT
bjos-8668902	233	13	arya	arya	PROPN
bjos-8668902	233	14	s	s	PROPN
bjos-8668902	233	15	,	,	PUNCT
bjos-8668902	233	16	roychoudhury	roychoudhury	PROPN
bjos-8668902	233	17	s.	s.	PROPN
bjos-8668902	233	18	current	current	ADJ
bjos-8668902	233	19	understanding	understanding	NOUN
bjos-8668902	233	20	in	in	ADP
bjos-8668902	233	21	the	the	DET
bjos-8668902	233	22	pathophysiology	pathophysiology	NOUN
bjos-8668902	233	23	of	of	ADP
bjos-8668902	233	24	sars	sar	NOUN
bjos-8668902	233	25	-	-	PUNCT
bjos-8668902	233	26	cov-2	cov-2	ADV
bjos-8668902	233	27	-	-	PUNCT
bjos-8668902	233	28	associated	associate	VERB
bjos-8668902	233	29	rhino	rhino	NOUN
bjos-8668902	233	30	-	-	PUNCT
bjos-8668902	233	31	orbito	orbito	ADJ
bjos-8668902	233	32	-	-	PUNCT
bjos-8668902	233	33	cerebral	cerebral	ADJ
bjos-8668902	233	34	mucormycosis	mucormycosis	NOUN
bjos-8668902	233	35	:	:	PUNCT
bjos-8668902	233	36	a	a	DET
bjos-8668902	233	37	comprehensive	comprehensive	ADJ
bjos-8668902	233	38	review	review	NOUN
bjos-8668902	233	39	.	.	PUNCT
bjos-8668902	234	1	j	j	PROPN
bjos-8668902	234	2	maxillofac	maxillofac	NOUN
bjos-8668902	234	3	oral	oral	ADJ
bjos-8668902	234	4	surg	surg	NOUN
bjos-8668902	234	5	.	.	PUNCT
bjos-8668902	235	1	2021	2021	NUM
bjos-8668902	235	2	sep;20(3):373	sep;20(3):373	NOUN
bjos-8668902	235	3	-	-	PUNCT
bjos-8668902	235	4	80	80	NUM
bjos-8668902	235	5	.	.	PUNCT
bjos-8668902	236	1	doi	doi	NOUN
bjos-8668902	236	2	:	:	PUNCT
bjos-8668902	236	3	10.1007	10.1007	NUM
bjos-8668902	236	4	/	/	SYM
bjos-8668902	236	5	s12663	s12663	PROPN
bjos-8668902	236	6	-	-	PUNCT
bjos-8668902	236	7	021	021	NUM
bjos-8668902	236	8	-	-	PUNCT
bjos-8668902	236	9	01604	01604	NUM
bjos-8668902	236	10	-	-	PUNCT
bjos-8668902	236	11	2	2	NUM
bjos-8668902	236	12	.	.	NOUN
bjos-8668902	236	13	18	18	NUM
bjos-8668902	236	14	.	.	PUNCT
bjos-8668902	237	1	muthu	muthu	PROPN
bjos-8668902	237	2	v	v	PROPN
bjos-8668902	237	3	,	,	PUNCT
bjos-8668902	237	4	rudramurthy	rudramurthy	ADJ
bjos-8668902	237	5	sm	sm	NOUN
bjos-8668902	237	6	,	,	PUNCT
bjos-8668902	237	7	chakrabarti	chakrabarti	VERB
bjos-8668902	237	8	a	a	PRON
bjos-8668902	237	9	,	,	PUNCT
bjos-8668902	237	10	agarwal	agarwal	PROPN
bjos-8668902	237	11	r.	r.	PROPN
bjos-8668902	237	12	epidemiology	epidemiology	PROPN
bjos-8668902	237	13	and	and	CCONJ
bjos-8668902	237	14	pathophysiology	pathophysiology	NOUN
bjos-8668902	237	15	of	of	ADP
bjos-8668902	237	16	covid-19	covid-19	PROPN
bjos-8668902	237	17	-	-	PUNCT
bjos-8668902	237	18	associated	associate	VERB
bjos-8668902	237	19	mucormycosis	mucormycosis	NOUN
bjos-8668902	237	20	:	:	PUNCT
bjos-8668902	237	21	india	india	PROPN
bjos-8668902	237	22	versus	versus	ADP
bjos-8668902	237	23	the	the	DET
bjos-8668902	237	24	rest	rest	NOUN
bjos-8668902	237	25	of	of	ADP
bjos-8668902	237	26	the	the	DET
bjos-8668902	237	27	world	world	NOUN
bjos-8668902	237	28	.	.	PUNCT
bjos-8668902	238	1	mycopathologia	mycopathologia	PROPN
bjos-8668902	238	2	.	.	PUNCT
bjos-8668902	239	1	2021	2021	NUM
bjos-8668902	239	2	dec;186(6):739	dec;186(6):739	X
bjos-8668902	239	3	-	-	PUNCT
bjos-8668902	239	4	54	54	NUM
bjos-8668902	239	5	.	.	PUNCT
bjos-8668902	240	1	doi	doi	NOUN
bjos-8668902	240	2	:	:	PUNCT
bjos-8668902	240	3	10.1007	10.1007	NUM
bjos-8668902	240	4	/	/	SYM
bjos-8668902	240	5	s11046	s11046	NOUN
bjos-8668902	240	6	-	-	PUNCT
bjos-8668902	240	7	021	021	NUM
bjos-8668902	240	8	-	-	PUNCT
bjos-8668902	240	9	00584	00584	NUM
bjos-8668902	240	10	-	-	SYM
bjos-8668902	240	11	8	8	NUM
bjos-8668902	240	12	.	.	NOUN
bjos-8668902	240	13	19	19	NUM
bjos-8668902	240	14	.	.	X
bjos-8668902	241	1	weprin	weprin	PROPN
bjos-8668902	241	2	be	be	VERB
bjos-8668902	241	3	,	,	PUNCT
bjos-8668902	241	4	hall	hall	PROPN
bjos-8668902	241	5	wa	wa	PROPN
bjos-8668902	241	6	,	,	PUNCT
bjos-8668902	241	7	goodman	goodman	PROPN
bjos-8668902	241	8	j	j	PROPN
bjos-8668902	241	9	,	,	PUNCT
bjos-8668902	241	10	adams	adams	PROPN
bjos-8668902	241	11	gl	gl	PROPN
bjos-8668902	241	12	.	.	PROPN
bjos-8668902	241	13	long	long	ADJ
bjos-8668902	241	14	-	-	PUNCT
bjos-8668902	241	15	term	term	NOUN
bjos-8668902	241	16	survival	survival	NOUN
bjos-8668902	241	17	in	in	ADP
bjos-8668902	241	18	rhinocerebral	rhinocerebral	ADJ
bjos-8668902	241	19	mucormycosis	mucormycosis	NOUN
bjos-8668902	241	20	:	:	PUNCT
bjos-8668902	241	21	case	case	NOUN
bjos-8668902	241	22	report	report	NOUN
bjos-8668902	241	23	.	.	PUNCT
bjos-8668902	242	1	j	j	PROPN
bjos-8668902	242	2	neurosurg	neurosurg	PROPN
bjos-8668902	242	3	.	.	PUNCT
bjos-8668902	243	1	1998	1998	NUM
bjos-8668902	243	2	mar;88(3):570	mar;88(3):570	NOUN
bjos-8668902	243	3	-	-	PUNCT
bjos-8668902	243	4	5	5	NUM
bjos-8668902	243	5	.	.	PUNCT
bjos-8668902	244	1	doi	doi	NOUN
bjos-8668902	244	2	:	:	PUNCT
bjos-8668902	244	3	10.3171	10.3171	NUM
bjos-8668902	244	4	/	/	SYM
bjos-8668902	244	5	jns.1998.88.3.0570	jns.1998.88.3.0570	NOUN
bjos-8668902	244	6	.	.	PROPN
bjos-8668902	244	7	20	20	NUM
bjos-8668902	244	8	.	.	PUNCT
bjos-8668902	245	1	sosale	sosale	PROPN
bjos-8668902	245	2	a	a	PRON
bjos-8668902	245	3	,	,	PUNCT
bjos-8668902	245	4	sosale	sosale	PROPN
bjos-8668902	245	5	b	b	PROPN
bjos-8668902	245	6	,	,	PUNCT
bjos-8668902	245	7	kesavadev	kesavadev	PROPN
bjos-8668902	245	8	j	j	PROPN
bjos-8668902	245	9	,	,	PUNCT
bjos-8668902	245	10	chawla	chawla	PROPN
bjos-8668902	245	11	m	m	PROPN
bjos-8668902	245	12	,	,	PUNCT
bjos-8668902	245	13	reddy	reddy	PROPN
bjos-8668902	245	14	s	s	PROPN
bjos-8668902	245	15	,	,	PUNCT
bjos-8668902	245	16	saboo	saboo	PROPN
bjos-8668902	245	17	b	b	NUM
bjos-8668902	245	18	,	,	PUNCT
bjos-8668902	245	19	et	et	PROPN
bjos-8668902	245	20	al	al	PROPN
bjos-8668902	245	21	.	.	PUNCT
bjos-8668902	246	1	steroid	steroid	NOUN
bjos-8668902	246	2	use	use	NOUN
bjos-8668902	246	3	during	during	ADP
bjos-8668902	246	4	covid-19	covid-19	PROPN
bjos-8668902	246	5	infection	infection	NOUN
bjos-8668902	246	6	and	and	CCONJ
bjos-8668902	246	7	hyperglycemia	hyperglycemia	NOUN
bjos-8668902	246	8	–	–	PUNCT
bjos-8668902	246	9	what	what	PRON
bjos-8668902	246	10	a	a	DET
bjos-8668902	246	11	physician	physician	NOUN
bjos-8668902	246	12	should	should	AUX
bjos-8668902	246	13	know	know	VERB
bjos-8668902	246	14	.	.	PUNCT
bjos-8668902	247	1	diabetes	diabete	VERB
bjos-8668902	247	2	metab	metab	NOUN
bjos-8668902	247	3	syndr	syndr	NOUN
bjos-8668902	247	4	.	.	PUNCT
bjos-8668902	248	1	2021	2021	NUM
bjos-8668902	248	2	jul	jul	PROPN
bjos-8668902	248	3	-	-	PUNCT
bjos-8668902	248	4	aug;15(4):102167	aug;15(4):102167	PROPN
bjos-8668902	248	5	.	.	PUNCT
bjos-8668902	248	6	doi	doi	PROPN
bjos-8668902	248	7	:	:	PUNCT
bjos-8668902	248	8	10.1016	10.1016	NUM
bjos-8668902	248	9	/	/	SYM
bjos-8668902	248	10	j.dsx.2021.06.004	j.dsx.2021.06.004	NOUN
bjos-8668902	248	11	.	.	PUNCT
bjos-8668902	249	1	12	12	NUM
bjos-8668902	249	2	ansari	ansari	PROPN
bjos-8668902	249	3	et	et	PROPN
bjos-8668902	249	4	al	al	PROPN
bjos-8668902	249	5	.	.	PROPN
bjos-8668902	249	6	braz	braz	PROPN
bjos-8668902	249	7	j	j	PROPN
bjos-8668902	249	8	oral	oral	PROPN
bjos-8668902	249	9	sci	sci	PROPN
bjos-8668902	249	10	.	.	PUNCT
bjos-8668902	249	11	2023;22	2023;22	NUM
bjos-8668902	249	12	:	:	PUNCT
bjos-8668902	249	13	e238902	e238902	PROPN
bjos-8668902	249	14	21	21	NUM
bjos-8668902	249	15	.	.	PUNCT
bjos-8668902	250	1	selvamani	selvamani	PROPN
bjos-8668902	250	2	m	m	PROPN
bjos-8668902	250	3	,	,	PUNCT
bjos-8668902	250	4	donoghue	donoghue	PROPN
bjos-8668902	250	5	m	m	PROPN
bjos-8668902	250	6	,	,	PUNCT
bjos-8668902	250	7	bharani	bharani	PROPN
bjos-8668902	250	8	s	s	PROPN
bjos-8668902	250	9	,	,	PUNCT
bjos-8668902	250	10	madhushankari	madhushankari	ADJ
bjos-8668902	250	11	gs	gs	PROPN
bjos-8668902	250	12	.	.	PUNCT
bjos-8668902	250	13	mucormycosis	mucormycosis	NOUN
bjos-8668902	250	14	causing	cause	VERB
bjos-8668902	250	15	maxillary	maxillary	NOUN
bjos-8668902	250	16	osteomyelitis	osteomyelitis	NOUN
bjos-8668902	250	17	.	.	PUNCT
bjos-8668902	251	1	j	j	PROPN
bjos-8668902	251	2	nat	nat	PROPN
bjos-8668902	251	3	sci	sci	PROPN
bjos-8668902	251	4	biol	biol	PROPN
bjos-8668902	251	5	med	me	VERB
bjos-8668902	251	6	.	.	PUNCT
bjos-8668902	252	1	2015	2015	NUM
bjos-8668902	252	2	jul	jul	PROPN
bjos-8668902	252	3	-	-	PUNCT
bjos-8668902	252	4	dec;6(2):456	dec;6(2):456	NOUN
bjos-8668902	252	5	-	-	PUNCT
bjos-8668902	252	6	9	9	NUM
bjos-8668902	252	7	.	.	PUNCT
bjos-8668902	252	8	doi	doi	NOUN
bjos-8668902	252	9	:	:	PUNCT
bjos-8668902	252	10	10.4103/0976	10.4103/0976	NUM
bjos-8668902	252	11	-	-	PUNCT
bjos-8668902	252	12	9668.160039	9668.160039	NUM
bjos-8668902	252	13	.	.	PUNCT
bjos-8668902	253	1	22	22	NUM
bjos-8668902	253	2	.	.	PUNCT
bjos-8668902	253	3	gudmundsson	gudmundsson	PROPN
bjos-8668902	253	4	t	t	PROPN
bjos-8668902	253	5	,	,	PUNCT
bjos-8668902	253	6	torkov	torkov	NOUN
bjos-8668902	253	7	p	p	PROPN
bjos-8668902	253	8	and	and	CCONJ
bjos-8668902	253	9	thygesen	thygesen	PROPN
bjos-8668902	253	10	th	th	PROPN
bjos-8668902	253	11	.	.	PUNCT
bjos-8668902	253	12	diagnosis	diagnosis	NOUN
bjos-8668902	253	13	and	and	CCONJ
bjos-8668902	253	14	treatment	treatment	NOUN
bjos-8668902	253	15	of	of	ADP
bjos-8668902	253	16	osteomyelitis	osteomyelitis	NOUN
bjos-8668902	253	17	of	of	ADP
bjos-8668902	253	18	the	the	DET
bjos-8668902	253	19	jaw	jaw	NOUN
bjos-8668902	253	20	–	–	PUNCT
bjos-8668902	253	21	a	a	DET
bjos-8668902	253	22	systematic	systematic	ADJ
bjos-8668902	253	23	review	review	NOUN
bjos-8668902	253	24	of	of	ADP
bjos-8668902	253	25	the	the	DET
bjos-8668902	253	26	literature	literature	NOUN
bjos-8668902	253	27	.	.	PUNCT
bjos-8668902	254	1	j	j	PROPN
bjos-8668902	254	2	dent	dent	PROPN
bjos-8668902	254	3	oral	oral	ADJ
bjos-8668902	254	4	disord	disord	NOUN
bjos-8668902	254	5	.	.	PUNCT
bjos-8668902	255	1	2017	2017	NUM
bjos-8668902	255	2	jun;3(4):1066	jun;3(4):1066	PROPN
bjos-8668902	255	3	.	.	PUNCT
bjos-8668902	256	1	doi	doi	NOUN
bjos-8668902	256	2	:	:	PUNCT
bjos-8668902	256	3	10.26420	10.26420	NUM
bjos-8668902	256	4	/	/	SYM
bjos-8668902	256	5	jdentoraldisord.2017.1066	jdentoraldisord.2017.1066	NOUN
bjos-8668902	256	6	.	.	PROPN
bjos-8668902	257	1	23	23	NUM
bjos-8668902	257	2	.	.	PUNCT
bjos-8668902	258	1	singh	singh	PROPN
bjos-8668902	258	2	ak	ak	PROPN
bjos-8668902	258	3	,	,	PUNCT
bjos-8668902	258	4	singh	singh	PROPN
bjos-8668902	258	5	r	r	PROPN
bjos-8668902	258	6	,	,	PUNCT
bjos-8668902	258	7	joshi	joshi	PROPN
bjos-8668902	258	8	sr	sr	PROPN
bjos-8668902	258	9	,	,	PUNCT
bjos-8668902	258	10	misra	misra	ADJ
bjos-8668902	258	11	a.	a.	NOUN
bjos-8668902	258	12	mucormycosis	mucormycosis	NOUN
bjos-8668902	258	13	in	in	ADP
bjos-8668902	258	14	covid-19	covid-19	PROPN
bjos-8668902	258	15	:	:	PUNCT
bjos-8668902	258	16	a	a	DET
bjos-8668902	258	17	systematic	systematic	ADJ
bjos-8668902	258	18	review	review	NOUN
bjos-8668902	258	19	of	of	ADP
bjos-8668902	258	20	cases	case	NOUN
bjos-8668902	258	21	reported	report	VERB
bjos-8668902	258	22	worldwide	worldwide	ADV
bjos-8668902	258	23	and	and	CCONJ
bjos-8668902	258	24	in	in	ADP
bjos-8668902	258	25	india	india	PROPN
bjos-8668902	258	26	.	.	PUNCT
bjos-8668902	258	27	diabetes	diabete	VERB
bjos-8668902	258	28	metab	metab	NOUN
bjos-8668902	258	29	syndr	syndr	NOUN
bjos-8668902	258	30	.	.	PUNCT
bjos-8668902	259	1	2021	2021	NUM
bjos-8668902	259	2	jul	jul	PROPN
bjos-8668902	259	3	-	-	PUNCT
bjos-8668902	259	4	aug;15(4):102146	aug;15(4):102146	PROPN
bjos-8668902	259	5	.	.	PROPN
bjos-8668902	259	6	doi	doi	PROPN
bjos-8668902	259	7	:	:	PUNCT
bjos-8668902	259	8	10.1016	10.1016	NUM
bjos-8668902	259	9	/	/	SYM
bjos-8668902	259	10	j.dsx.2021.05.019	j.dsx.2021.05.019	PROPN
bjos-8668902	259	11	.	.	NOUN
bjos-8668902	259	12	24	24	NUM
bjos-8668902	259	13	.	.	PUNCT
bjos-8668902	260	1	brandão	brandão	NOUN
bjos-8668902	260	2	tb	tb	PROPN
bjos-8668902	260	3	,	,	PUNCT
bjos-8668902	260	4	gueiros	gueiros	PROPN
bjos-8668902	260	5	la	la	PROPN
bjos-8668902	260	6	,	,	PUNCT
bjos-8668902	260	7	melo	melo	PROPN
bjos-8668902	260	8	ts	ts	PROPN
bjos-8668902	260	9	,	,	PUNCT
bjos-8668902	260	10	prado	prado	PROPN
bjos-8668902	260	11	-	-	PUNCT
bjos-8668902	260	12	ribeiro	ribeiro	PROPN
bjos-8668902	260	13	ac	ac	PROPN
bjos-8668902	260	14	,	,	PUNCT
bjos-8668902	260	15	nesrallah	nesrallah	PROPN
bjos-8668902	260	16	ac	ac	PROPN
bjos-8668902	260	17	,	,	PUNCT
bjos-8668902	260	18	prado	prado	VERB
bjos-8668902	260	19	gv	gv	PROPN
bjos-8668902	260	20	,	,	PUNCT
bjos-8668902	260	21	et	et	PROPN
bjos-8668902	260	22	al	al	PROPN
bjos-8668902	260	23	.	.	PUNCT
bjos-8668902	261	1	oral	oral	ADJ
bjos-8668902	261	2	lesions	lesion	NOUN
bjos-8668902	261	3	in	in	ADP
bjos-8668902	261	4	patients	patient	NOUN
bjos-8668902	261	5	with	with	ADP
bjos-8668902	261	6	sars	sar	NOUN
bjos-8668902	261	7	-	-	PUNCT
bjos-8668902	261	8	cov-2	cov-2	PART
bjos-8668902	261	9	infection	infection	NOUN
bjos-8668902	261	10	:	:	PUNCT
bjos-8668902	261	11	could	could	AUX
bjos-8668902	261	12	the	the	DET
bjos-8668902	261	13	oral	oral	ADJ
bjos-8668902	261	14	cavity	cavity	NOUN
bjos-8668902	261	15	be	be	AUX
bjos-8668902	261	16	a	a	DET
bjos-8668902	261	17	target	target	NOUN
bjos-8668902	261	18	organ	organ	VERB
bjos-8668902	261	19	?	?	PUNCT
bjos-8668902	262	1	oral	oral	ADJ
bjos-8668902	262	2	surg	surg	NOUN
bjos-8668902	262	3	oral	oral	ADJ
bjos-8668902	262	4	med	med	ADJ
bjos-8668902	262	5	oral	oral	ADJ
bjos-8668902	262	6	pathol	pathol	NOUN
bjos-8668902	262	7	oral	oral	ADJ
bjos-8668902	262	8	radiol	radiol	NOUN
bjos-8668902	262	9	.	.	PUNCT
bjos-8668902	263	1	2021	2021	NUM
bjos-8668902	263	2	feb;131(2):e45	feb;131(2):e45	NUM
bjos-8668902	263	3	-	-	PUNCT
bjos-8668902	263	4	e51	e51	NOUN
bjos-8668902	263	5	.	.	PUNCT
bjos-8668902	264	1	doi	doi	NOUN
bjos-8668902	264	2	:	:	PUNCT
bjos-8668902	264	3	10.1016	10.1016	NUM
bjos-8668902	264	4	/	/	SYM
bjos-8668902	264	5	j.oooo.2020.07.014	j.oooo.2020.07.014	PROPN
bjos-8668902	264	6	.	.	PROPN
bjos-8668902	265	1	25	25	NUM
bjos-8668902	265	2	.	.	PUNCT
bjos-8668902	266	1	amorim	amorim	PROPN
bjos-8668902	266	2	dos	dos	PROPN
bjos-8668902	266	3	santos	santos	PROPN
bjos-8668902	266	4	j	j	PROPN
bjos-8668902	266	5	,	,	PUNCT
bjos-8668902	266	6	normando	normando	PROPN
bjos-8668902	266	7	ag	ag	PROPN
bjos-8668902	266	8	,	,	PUNCT
bjos-8668902	266	9	carvalho	carvalho	PROPN
bjos-8668902	266	10	da	da	PROPN
bjos-8668902	266	11	silva	silva	PROPN
bjos-8668902	266	12	rl	rl	PROPN
bjos-8668902	266	13	,	,	PUNCT
bjos-8668902	266	14	acevedo	acevedo	PROPN
bjos-8668902	266	15	ac	ac	PROPN
bjos-8668902	266	16	,	,	PUNCT
bjos-8668902	266	17	de	de	X
bjos-8668902	266	18	luca	luca	PROPN
bjos-8668902	266	19	canto	canto	PROPN
bjos-8668902	266	20	g	g	PROPN
bjos-8668902	266	21	,	,	PUNCT
bjos-8668902	266	22	sugaya	sugaya	PROPN
bjos-8668902	266	23	n	n	CCONJ
bjos-8668902	266	24	,	,	PUNCT
bjos-8668902	266	25	et	et	PROPN
bjos-8668902	266	26	al	al	PROPN
bjos-8668902	266	27	.	.	PUNCT
bjos-8668902	267	1	oral	oral	ADJ
bjos-8668902	267	2	manifestations	manifestation	NOUN
bjos-8668902	267	3	in	in	ADP
bjos-8668902	267	4	patients	patient	NOUN
bjos-8668902	267	5	with	with	ADP
bjos-8668902	267	6	covid-19	covid-19	PROPN
bjos-8668902	267	7	:	:	PUNCT
bjos-8668902	267	8	a	a	DET
bjos-8668902	267	9	living	live	VERB
bjos-8668902	267	10	systematic	systematic	ADJ
bjos-8668902	267	11	review	review	NOUN
bjos-8668902	267	12	.	.	PUNCT
bjos-8668902	268	1	j	j	PROPN
bjos-8668902	268	2	dent	dent	NOUN
bjos-8668902	268	3	res	re	NOUN
bjos-8668902	268	4	.	.	PUNCT
bjos-8668902	268	5	2021	2021	NUM
bjos-8668902	268	6	feb;100(2):141	feb;100(2):141	NOUN
bjos-8668902	268	7	-	-	PUNCT
bjos-8668902	268	8	54	54	NUM
bjos-8668902	268	9	.	.	PUNCT
bjos-8668902	269	1	doi	doi	NOUN
bjos-8668902	269	2	:	:	PUNCT
bjos-8668902	270	1	10.1177/0022034520957289	10.1177/0022034520957289	NUM
bjos-8668902	270	2	.	.	X
bjos-8668902	270	3	26	26	NUM
bjos-8668902	270	4	.	.	PUNCT
bjos-8668902	270	5	sanath	sanath	PROPN
bjos-8668902	270	6	ak	ak	PROPN
bjos-8668902	270	7	,	,	PUNCT
bjos-8668902	270	8	nayak	nayak	PROPN
bjos-8668902	270	9	mt	mt	PROPN
bjos-8668902	270	10	,	,	PUNCT
bjos-8668902	270	11	sunitha	sunitha	PROPN
bjos-8668902	270	12	jd	jd	PROPN
bjos-8668902	270	13	,	,	PUNCT
bjos-8668902	270	14	malik	malik	PROPN
bjos-8668902	270	15	sd	sd	PROPN
bjos-8668902	270	16	,	,	PUNCT
bjos-8668902	270	17	aithal	aithal	NOUN
bjos-8668902	270	18	s.	s.	PROPN
bjos-8668902	270	19	mucormycosis	mucormycosis	PROPN
bjos-8668902	270	20	occurring	occur	VERB
bjos-8668902	270	21	in	in	ADP
bjos-8668902	270	22	an	an	DET
bjos-8668902	270	23	immunocompetent	immunocompetent	ADJ
bjos-8668902	270	24	patient	patient	NOUN
bjos-8668902	270	25	:	:	PUNCT
bjos-8668902	270	26	a	a	DET
bjos-8668902	270	27	case	case	NOUN
bjos-8668902	270	28	report	report	NOUN
bjos-8668902	270	29	and	and	CCONJ
bjos-8668902	270	30	review	review	NOUN
bjos-8668902	270	31	of	of	ADP
bjos-8668902	270	32	literature	literature	NOUN
bjos-8668902	270	33	.	.	PUNCT
bjos-8668902	271	1	cesk	cesk	NOUN
bjos-8668902	271	2	patol	patol	NOUN
bjos-8668902	271	3	.	.	PUNCT
bjos-8668902	272	1	2020	2020	NUM
bjos-8668902	272	2	winter;56(4):223	winter;56(4):223	PROPN
bjos-8668902	272	3	-	-	PUNCT
bjos-8668902	272	4	6	6	NUM
bjos-8668902	272	5	.	.	NOUN
bjos-8668902	272	6	27	27	NUM
bjos-8668902	272	7	.	.	PUNCT
bjos-8668902	273	1	bains	bains	PROPN
bjos-8668902	273	2	mk	mk	PROPN
bjos-8668902	273	3	,	,	PUNCT
bjos-8668902	273	4	hosseini	hosseini	PROPN
bjos-8668902	273	5	-	-	PUNCT
bjos-8668902	273	6	ardehali	ardehali	ADJ
bjos-8668902	273	7	m.	m.	NOUN
bjos-8668902	273	8	palatal	palatal	PROPN
bjos-8668902	273	9	perforations	perforation	NOUN
bjos-8668902	273	10	:	:	PUNCT
bjos-8668902	273	11	past	past	NOUN
bjos-8668902	273	12	and	and	CCONJ
bjos-8668902	273	13	present	present	ADJ
bjos-8668902	273	14	.	.	PUNCT
bjos-8668902	274	1	two	two	NUM
bjos-8668902	274	2	case	case	NOUN
bjos-8668902	274	3	reports	report	VERB
bjos-8668902	274	4	and	and	CCONJ
bjos-8668902	274	5	a	a	DET
bjos-8668902	274	6	literature	literature	NOUN
bjos-8668902	274	7	review	review	NOUN
bjos-8668902	274	8	.	.	PUNCT
bjos-8668902	275	1	br	br	PROPN
bjos-8668902	275	2	dent	dent	NOUN
bjos-8668902	275	3	j.	j.	PROPN
bjos-8668902	275	4	2005	2005	NUM
bjos-8668902	275	5	sep;199(5):267	sep;199(5):267	NOUN
bjos-8668902	275	6	-	-	PUNCT
bjos-8668902	275	7	9	9	NUM
bjos-8668902	275	8	.	.	PUNCT
bjos-8668902	275	9	doi	doi	NOUN
bjos-8668902	275	10	:	:	PUNCT
bjos-8668902	275	11	10.1038	10.1038	NUM
bjos-8668902	275	12	/	/	SYM
bjos-8668902	275	13	sj.bdj.4812650	sj.bdj.4812650	PROPN
bjos-8668902	275	14	.	.	PUNCT